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ABSTRACT
Norovirus (NoV) cannot be routinely cultured in the laboratory and therefore existing 
methods for detection are based on molecular assays. Application of these assays has shown 
that a high percentage of bivalve molluscan shellfish (BMS) production areas in the UK are 
contaminated with NoV. It is unclear whether detection of viral genome always correlates 
with presence of whole infectious virus and thus public health risk.
This project aimed to investigate the significance of detecting norovirus in the environment 
and in BMS by real-time PCR. Murine norovirus (MNY), a closely related NoV, was used as 
a surrogate in experimental work to determine the behaviour of NoV in the environment and 
in the BMS matrix in terms of viability and infectivity. A real-time PCR assay for MNV was 
developed and characterised, and was determined to be equivalent to the in-house real-time 
PCR assay for human NoV at this laboratory. This assay was then used alongside an existing 
cell culture method for MNV that was adopted and optimised in this project. The 
development of a plaque assay with both sufficient robustness and sensitivity for application 
to bioaccumulated oysters was unsuccessful. These methods, and existing methods for human 
NoV were used to evaluate environmental persistence of the human NoV genome, human 
NoV and its surrogate in seawater under artificial environmental conditions simulating winter 
in the United Kingdom (U.K). The ability of Pacific oysters {Crassostrea gigas) to 
bioaccumulate both untreated and heat treated NoV particles (from human faeces) and RNA 
fragments was compared using real-time PCR. Finally, the potential application and 
incorporation of a pre-extraction treatment into the BMS testing method was assessed.
The results presented in this project indicated that NoV RNA may reside in seawater for up to 
2  weeks, and that there was no significant difference between the rates of degradation in 
seawater of naked RNA transcripts and NoV particles from faecal material. However MNV-1 
persisted longer in seawater than human NoV under the same conditions. The results 
presented also indicated that BMS bioaccumulate NoV RNA fragments signifcantly less 
efficiently than NoV particles from faecal material. Furthermore, the uptake of untreated 
human NoV and MNV occurred at similar rates to the uptake of heat-treated viruses. It was 
also determined that using RNaseONE as a pre-extraction treatment to remove PCR signal 
from ‘free’ RNA and damaged viruses provided scope for the inclusion into the BMS testing 
method to provide a better prediction of human health risk, however further work would be 
required to demonstrate its efficacy in a standardised method.
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1.0 General Introduction
Viruses are obligate intracellular parasites, yet they may be highly resistant to environmental 
pressures and persist in the environment. Enteric viruses are acid stable and can replicate to 
very large titres in the gastrointestinal tract before being shed in concentrated doses directly 
into domestic sewage via faeces. Because of the high virus levels in sewage, they can enter 
water systems and the marine environment via leaking sewage and septic systems, urban 
runoff, agricultural runoff, sewage outfall, storm events and vessel wastewater discharge 
(Fong and Lipp, 2005). Over 100 types of pathogenic viruses can be shed in human and 
animal wastes (Melnick, 1984); these viruses can contaminate seafood, particularly filter- 
feeding bivalve molluscan shellfish (BMS). Hepatitis A virus (HAV), which can survive up 
to one month in seawater (Lees, 2000), and human strains of norovirus (NoV) are examples 
of viruses that can be associated with BMS that can have significant human health 
implications.
1.1 Bivalve Molluscan Shellfish
Bivalve molluscan shellfish are defined as marine or freshwater molluscs of the class 
Pelecypoda (formerly Bivalvia or Lamellibranchid), having a laterally compressed body, a 
shell consisting of two hinged valves and gills for respiration. The group includes clams, 
cockles, oysters, and mussels. Many BMS species are an important food resource and these 
include native or flat oysters (Ostrea edulis). Pacific oysters {Crassostrea gigas, Figure 1.1), 
common blue mussels {Mytilus edilus) and Mediterranean blue mussels {Mytilus 
galloprovencialis). BMS have a static lifestyle generally on or within the seabed. They obtain
-1 -
nutrients by filtering large volumes of the surrounding water and absorbing particulate 
organic material. A single oyster is capable of filtering approximately 70 litres of water a day 
and can retain particles up to 2  pm in size.
1.2 In situ contamination of BMS and microbiological classification
Whilst microbe-contaminated sewage is diluted on entering seawater, BMS can reverse this 
process through filter-feeding. Most species feed mainly on suspended phytoplankton 
through ciliary action via a pair of specialised gills, although the process of filter feeding is 
non-specific (Lees, 2000). Specialised cilia transport trapped food toward the mouth and a 
range of microorganisms, including pathogens, are filtered through the gills and become 
concentrated in the digestive gland (stomach and digestive diverticula) (Shumway, 1992). 
Due to the residence of BMS in inshore waters the possibility of contact with sewage is high. 
Therefore, human and other sewage borne pathogens (both bacterial and viral) may 
bioaccumulate in BMS tissues (Schwab et al., 1998). This coupled with the traditional 
consumption of raw or lightly cooked BMS means that they are important vectors of human 
enteric disease transmission. Between 1975 and 1979 BMS were reported as the main food- 
vehicle associated with viral disease in the US (Oliver, 1984), and between 1973 and 1999 at 
least 12 large outbreaks (over 100 cases) of disease linked to BMS consumption were 
reported (summarised by Bosch et al, 2005). These reports highlight the importance of BMS 
as a vector for virus-associated gastrointestinal disease.
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Figure 1.1: Pacific oysters {Crassostrea gigas).
The association of human illness with BMS has been recorded since medieval times. The 
relationship between BMS-transmitted infectious disease and sewage pollution became well 
understood by the turn of the 20^  ^ century (Lees, 2000). A number of human viruses, 
transmitted by the faecal-oral route have been connected with BMS both through the 
detection of virus from BMS sampled from fisheries and from epidemiological linkages 
following outbreaks.
In the European Union, food hygiene regulations provide a framework of controls for placing 
live bivalve shellfish on the market (Anon. 2004, 2005). These include classification of BMS 
harvesting areas dependent on the levels of the faecal indicator organism; Escherichia coli 
measured in BMS flesh and intravalvular fluid (Table 1.1) and stipulate post harvest 
processing requirements for BMS from different harvesting areas. In Europe a process known 
as depuration is commonly used for this purpose. BMS are held in recirculation tanks and
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clean water is passed over them enabling the animals to purge themselves of microbial 
contaminants. The water is disinfected by UV treatment and recycled, thus inactivating 
circulating pathogens. Although depuration can rapidly remove most bacterial contaminants, 
viruses are known to persist in BMS tissues beyond the commonly practised 2 to 3-day 
depuration period (Grohmann et ah, 1981; Kingsley and Richards, 2003). Improvements in 
sanitation processes and water quality have substantially reduced the risk from bacterial 
disease. However viruses, predominantly human NoV and HAV are now considered the most 
significant microbiological hazard to the BMS consumer.
Table 1.1: Microbiological classification of production and relaying areas for BMS
Class Criteria Requirements
A Live bivalve molluscs from these 
areas must not exceed 230 MPN^ E  
.coli per lOOg o f flesh and intra­
valvular fluid^.
May be consumed without treatment
B Live bivalve molluscs from these 
areas must not exceed, in 90% of  
the samples, 4600 MPN E. Coli per 
lOOg o f flesh and infra-valvular 
fluid. In the remaining 10% must 
not exceed 46000 MPN E. Coli per 
lOOg o f flesh and infra-valvular 
fluid^
Purification, relaying in a class A area or cooking by an 
approved method.
C Live bivalve molluscs from these 
areas must not exceed 46000 MPN 
E. Coli per lOOg o f flesh and intra­
valvular fluid.'’
Relaying or cooking by an approved method
Prohibited >46,000 MPN E. Coli per lOOg of  
flesh and infra-valvular fluid.^
Harvesting not permitted.
^Most Probable Number.
^By eross reference from Regulation (EC) No 854/2004, via Regulation (EC) No 853/2004, to Regulation (EC) No  
2073/2005
^From Regulation (EC) No 1021/2008 
Trom  Regulation (EC) No 854/2004
^This level is not specifically provided in the Regulation but does not comply with classes A, B or C.
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1.3 Caliciviridae
The prefix ‘calici’ is derived from the Latin calix, meaning cup, describing the eup-shaped 
depressions that can be observed on the capsid surface. Caliciviruses are non-enveloped, 
positive-sense single stranded RNA viruses. The first calicivirus, vesicular exanthema of 
swine virus, was discovered in 1932 following a novel infection of pigs (reviewed by 
Bankowski, 1981). Calicivirus genomes are non-segmented and approximately 7.5 -  8.0 Kb 
in length (Matson, 1996). The genomes are poly-adenylated and consist of up to 4 open 
reading frames (ORFs). Typically, ORFl encodes a 5.3Kb long, non-structural polyprotein 
that contains the relatively conserved RNA-dependant RNA polymerase region (RdRp), in 
comparison to the rest of the genome which is not strongly conserved (Etherington et ah, 
2006; Jiang et al., 1993). 0RF2 encodes the major capsid protein while 0RF3 encodes a 
minor capsid protein (Etherington et al., 2006). In some caliciviruses ORFl and 0RF2 are 
fused to form a longer polyprotein (Clarke and Lambden, 1997). An additional ORF, named 
0RF4, was recently identified within the MNV-1 genome and encodes a single protein of 
unknown function (Thackray et a l, 2007).
The Caliciviridae family consists of five genera; Vesivirus, Lagovirus, Norovirus, Sapovirus 
and the more recently classified Nebovirus. The current taxonomic classification of 
caliciviruses is shown in Table 1.2, some examples of viruses and the host organism are also 
provided. The recent discovery of a novel rhesus monkey calicivirus, Tulane virus, has 
initiated discussion on the possible need for a new genus within the Caliciviridae. The 
proposed name for this genus is Recovirus, however at the present time (April 2011) this 
nomenclature has not been confirmed (Farkas et al, 2010).
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Table 1.2: Calicivirus classification
Genera Virus Host(s)
Vesivirus Vesicular exanthema o f swine virus Swine
San Miguel sea lion virus Marine mammals
Feline calicivirus Cats
Lagovirus Rabbit hemorrhagic disease virus Rabbits
European brown hare syndrome virus Brown hare
Norovirus Human noroviruses (GI, Oil, GIV) Humans
Bovine noroviruses (Gill) Cattle
Murine norovirus (GV) Mice
Sapovirus Porcine enteric calicivirus Swine
Human sapoviruses Humans
Nebovirus Newbury-1 virus Cattle
1.4 Human caliciviruses
Human calicivirus characterisation is difficult due to the lack of a repeatable cell culture 
system or small animal model for their study, although an in vitro 3-D cell culture infectivity 
assay for human NoV has been reported (Straub et al, 2007). However, the development of 
molecular biological techniques has helped in their characterisation and taxonomic 
determination (Berke et a l, 1997).
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1.4.1 Sapovirus -  biology and disease
Morphologically, sapovimses are considered representative of calieiviruses, possessing 
distinetive cup-like depressions on the eapsid surface, and having a diameter of 34 nm. The 
sapovirus genome eonsists of 2 ORFs. ORFl encodes the structural capsid protein (VPl) 
along with non-struetural proteins similar to those coded for by ORFl of other ealieiviruses 
(e.g. NoV). 0RF2 encodes a small structural protein VP2 (Phan et ah, 2007).
The first sapovirus, Sapporo virus, was deteeted in 1977 during an outbreak of acute 
gastroenteritis in a home for infants in Sapporo, Japan (Chiba et al, 1979). Sapovimses 
commonly cause gastrointestinal disease in ehildren and the elderly (Phan et al, 2007) but 
they can cause sporadic cases and limited outbreaks of gastroenteritis in all age groups 
(Lopman et al., 2002). Sapovimses are divided into five genogroups (GI-GV). GI, GII, GIV 
and GV are known to cause human infection. GUI sapovimses infect pigs (Logan et al.,
2007).
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Figure 1.2: A 3-D image of the structure of a noro virus virion (from
www.hpa.org.uk/.. ./images/norovirus .jpg).
1.4.2 Norovirus -  biology and disease
Noro viruses (Figure 1.2) possess similar characteristics to other calieiviruses including a 
positive sense single-stranded RNA genome of approximately 7.5Kb in length and consisting 
of 3 ORFs (Figure 1.3) (Zheng et al., 2006). ORFl encodes a non-structural polyprotein, 
which is cleaved by a viral 3C-like protease into 6  proteins including RNA dependant RNA 
polymerase (Belliot et al., 2003). 0RF2 encodes VPl, the major capsid protein (Green et al., 
2001; Jiang et al., 1990; Jiang et al., 1993), which forms 2 domains; S (shell) and P 
(protruding; encompassing PI and P2 sub-domains). The PI sub-domain forms a stem 
connecting the shell domain to a globular head region (P2) (Katpally et al, 2008), which 
extends above the viral surface. It is suggested that the capsid proteins provide receptor 
binding sites and viral serotype differences, as well as shell structure and genome protection
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(Zheng et a l, 2006). The P2 sub-domain possesses the greatest sequence divergence of any 
region of the genome, and the majority of immune recognition factors and receptor binding 
sites for attachment (Chakravarty et al., 2005; Nillson et al., 2003; Tan et al., 2004). The 
minor capsid protein VP2 is encoded by 0RF3, and is associated with the up-regulation of 
VPl expression and stabilization of VPl in virus structure (Bertolotti-Ciarlet et a l, 2003). 
The non-structural proteins, NS1-NS7 are involved in replication and the polyproteins are co- 
and post-translationally cleaved by the NS6 -proteinase (Bank-Wolf et al, 2009).
S
ORFl
(Non-stmctural coding region) 5374
0RF2 
(VPl Q # #
2A2-2B-like membrane protein 
NTf i^ e
----------- 1 p22
I Im
Pol
3 ’
0RF3 
6950 (VP2) 7388
Figure 1.3: A schematic diagram representing the norovirus genome and the non-structural 
protein products from ORFl (adapted from Wobus et al, 2006).
Noro viruses are antigenically and genetically diverse (Ando et al, 2000; Green et a l, 1995a; 
Katayama et a l, 2002). Historically, NoV nomenclature and taxonomic classification was 
based on cross-challenge studies and cross-reactivity analysis using human volunteers and 
immune electron microscopy (Green et a l, 1995b; Lewis et a l, 1995; Okada et al., 1990; 
Wyatt et a l, 1974). No routine cell culture assays are available for direct serotyping (Duizer 
et a l, 2004b). Characterization of NoV strains is currently facilitated by techniques such as
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reverse-transcription PCR (RT-PCR) and genomic sequencing (Jiang et ah, 1990; Ando et 
al., 2000). Currently NoV are divided into 5 genogroups which can be further sub-divided 
into distinet genetic clusters or genotypes (Logan et al, 2007). Genogroups GI, GII and GIV 
are known to infect humans; these genogroups have been further subdivided into 8 , 19 and 2 
genotypes respectively (although elassifieation of genotypes has not been universally agreed 
(Zheng et ah, 2006)), some of whieh infeet non-human hosts; GIL 11, GIL 18 and GII. 19 
strains infect swine (Wang et al, 2005) while GIV.2 strains infect camivorans (Martella et al,
2008). GUI and GV comprise the bovine and murine noroviruses respectively. The prototype 
NoV is the GI.l strain Norwalk virus, first discovered in 1972 using immune electron 
microscopy for direct visualization of viral particles (Kapikian et a l, 1972).
Human NoV are the most eommonly reported eause of non-bacterial gastroenteritis 
worldwide, with high attack rates in both children and adults (Billgren et al., 2002; Vipond et 
a l, 2004). The syndrome assoeiated with norovirus infeetion is often ealled ‘Winter 
Vomiting Disease’, first described by Zahorsky in the early part of the twentieth eentury 
(Zahorsky, 1929).
1.4.2.1 Norovirus disease characteristics
After an incubation period of 24-48 hours, a high level of explosive projeetile vomiting 
eharacterises the first sign of infeetion. Explosive diarrhoea along with nausea, fever and 
abdominal pain are also clinical symptoms. Adults demonstrate a non-bloody, mueus-lacking, 
watery diarrhoea (Treanor and Dolin, 2000). Primary infection is thought to occur in the 
proximal small bowel, whieh shows expansion of the villi and eontraction of the microvilli 
(Wilhelmi et a l, 2003) as well as dilation of the endoplasmic reticulum, swollen 
mitochondria and intracellular oedema (Agus et al., 1973; Sehreiber et a l, 1974). Nausea and
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vomiting are thought to result from a transient gastroparesis; delayed emptying of food from 
the stomach into the intestinal traet, which resolves after NoV infection has cleared (Meeroff 
et ah, 1980). Diarrhoea occurs after the development of lesions of the mucosa, and it is also 
thought that transient gastroparesis eontributes to the characteristie diarrhoeal disease 
(Wilhelmi et ah, 2003). It is suggested that symptomatically ill children are more likely to 
have episodes of vomiting, whereas symptomatieally ill adults are more likely to present 
diarrhoeal symptoms (Gotz et a l, 2001). As NoV gastroenteritis is generally self-limiting and 
short-term (24-48 hours), treatment is usually not neeessary. Where treatment is required 
however, oral rehydration and replacement of electrolytes, along with rest are usually 
preseribed (Hutson et a l, 2004). Those at the extremes on the age seale are at risk of 
dehydration (Thornton et a l, 2004) and NoV infeetion ean oecasionally be fatal in the most 
suseeptible individuals, for example the young, elderly and immune-eompromised.
The oceurrence of NoV assoeiated gastroenteritis in adults is highly eorrelated with the 
immunologieal response of the individual. Those individuals that are suseeptible to NoV 
infeetion only show boosted antibody levels after several repeated infeetions (Carter, 2005). 
Immunity is reported to be short-lived, protecting the individual for only a few months before 
reinfeetion with the same virus strain (Parrino et a l, 1977). Some people are however 
apparently not suseeptible to NoV infection (Johnson et al,. 1990; Matsui and Greenberg, 
2 0 0 0 ) and it has also been suggested that suseeptible individuals will show variable 
suseeptibility to different genotypes or strains of NoV. This is thought to be mediated through 
binding of NoV to human histo-blood group antigens (HBGA), earbohydrates linked to 
glyeoproteins or glyeolipids that are present on the mucosal epithelium as well as on the 
surfaces of red blood eells (Marionneau et a l, 2001; Ravn and Dabelsteen., 2000), or are 
present as free antigens in biological fluids. Polymorphisms in gene loci encoding various 
glycosyltransferases (the ABO, Lewis and secretor gene families) determine the exaet pattern
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of carbohydrate residues present in the HBGAs possessed by different individuals. In 
addition, individuals lacking the allele encoding FUT2 fucosyltransferase, which catalyses 
the addition of a fucose residue to the precursor chain to produce H antigens, do not express 
ABH antigens on the surface of most epithelial eells of the respiratory, genitourinary and 
digestive tracts, known as the “non-secretor” phenotype (reviewed by Marionneau et ah, 
2001).
Computational analysis and site-directed mutagenesis has indicated that a receptor-binding 
pocket in the P2 domain of the NoV eapsid protein is responsible for binding of NoV to 
HBGAs. Binding patterns to particular HBGA antigens are strain-speeifie due to structural 
variations in the receptor-binding pocket resulting from polymorphisms in 0RF2 of the NoV 
genome (Tan et al., 2004). Various authors have reported up to 8 distinct receptor-binding 
patterns amongst NoV strains (Harrington et al., 2002; Harrington et al., 2004; Huang et al., 
2003; Huang et al., 2005; Hutson et al., 2003; Marionneau et al., 2002; Tan et al., 2004). 
Individuals with the non-secretor phenotype have been found to be resistant to NoV infection 
due to the absence of ABH antigens in saliva and on most epithelial eells of the gut (reviewed 
by Tan and Jiang, 2007). Interestingly, it has also been reported that NoV persists in BMS 
through specific binding to HBGA-like carbohydrates in the shellfish digestive diverticula 
(Le Guyader et al., 2006; Tian et al., 2006).
1.5 Norovirus in the environment
Enteric viruses are very stable in the environment, a fact of much significance with respect to 
their transmission. The inherent resilience to fluctuations in environmental conditions enables 
many viruses to remain a public health hazard outside their immediate hosts. Enteric viruses
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are shed in large numbers by infected individuals into domestic sewerage systems and 
without adequate treatment wastewater effluents can contain infectious viral particles. Many 
viruses have been shown to survive sewage treatment and have been deteeted in wastewater, 
treated water and receiving waters (Dubrou et al., 1991; Goswami et al., 1993; Graff et al., 
1993; Jaykus et al., 1996; Schwab et al., 1996; Tsai et al., 1993). These viruses ean then 
impact upon estuarine and coastal waters via wastewater treatment pipes, and thus pose a risk 
to human activities.
1.5.1 Sewage treatment processes
Enteric viruses are acid stable and replicate to very large titres in the gastrointestinal tract 
before being shed in concentrated doses [ 1 x 1 0 ^ - 1 x 1 0 ^  particles per gram of faeces (Mori 
et al, 2005; Ozawa et al, 2007)]. NoV have been detected in both raw and treated sewage 
waters (Lodder et a l, 1999; Loisy et a l, 2005), and inadequate water treatment is a major 
cause of water-borne NoV outbreaks (Brugha et a l, 1999; Hafliger et a l, 2000; Kukkula et 
a l, 1999). Subsequently, numerous outbreaks of gastroenteritis caused by NoV 
contamination of drinking and recreational waters have been described (Boceia et al., 2002; 
Brown et a l, 2001; Hoebe et a l, 2004; Kukkula et a l, 1999). In addition sewage workers 
frequently exposed to raw sewage are at a higher risk of contracting intestinal disease 
(Rylander, 1999; Venczel et ah, 2003). Treated sewage water is of particular relevance when 
investigating BMS-bome outbreaks, as commonly these effluents are discharged into 
shallow, estuarine waters used for BMS cultivation (Laverick et a l, 2004; Lodder et a l, 
199^L
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There are approximately 9000 wastewater (sewage) treatment works in the UK discharging 
treated effluent into inland waters, estuaries and the sea. The purpose of wastewater treatment 
is to remove organic substances to protect the environment and public health. Most sewage 
treatment facilities provide primary and secondary treatments of wastewater with more 
substantial (tertiary) treatment used only for works discharging into sensitive waters (e.g. 
bathing waters). Primary treatment involves the settling out of the solid material, while 
secondary treatment utilises bacteria to ‘digest’ and break down organic substances. Tertiary 
treatment involves disinfection of the treated effluents using UV or ultra-flltration. The 
minimum requirements for the treatment of municipal waste water and for the disposal of 
sludge are set out in European Directive (917271/EEC). This directive is implemented in 
England and Wales through The Urban Waste Water Treatment Regulations (1994).
Primary and secondary sewage treatment procedures are relatively ineffleient at reducing 
virus concentrations when compared to tertiary sewage treatment processes (Fleischer et al., 
2000; Hovi et al., 2001; Sehvoerer et al., 2001; van den Berg et al., 2005). Primary and 
secondary treatment processes appear to have little effect on NoV titres as measured by 
quantitative polymerase chain reaction (PCR) (Carter, 2005; Lodder et al., 1999). Due to the 
presence of NoV in primary and secondary treated sewage, it has been suggested that 
additional treatment measures, such as UV light or ozone, could be used to reduce virus 
concentrations entering water courses and potentially impacting BMS harvesting areas (van 
den Berg a/., 2005).
1.5.2 The effects of environmental pressures
There are many factors that affect virus survival in the environment, which will be discussed 
in Sections 4.1 and 5.1. Outbreaks of NoV gastroenteritis increase during periods of colder,
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dryer weather, and it has been suggested that these factors contribute to the seasonal trends 
observed.
It has been suggested that most viruses oceur in the environment bound to particles within 
water. Behaviour of viruses depends on size, surface charge and morphology (Gerba, 1984). 
Most enteric viruses have been reported to survive longer during the winter, possibly due to 
lower UV intensities compared with summer months. UV light in sunlight possesses 
germicidal characteristics and can inactivate viruses; as a result, irradiation treatment is 
becoming more eommonly used for the disinfection of food and water (de Roda Husman et 
al., 2004). In addition, it has been suggested that higher (summer) temperatures can damage 
viral eapsids or nucleic acid, possibly preventing adsorption of the virus to the host or 
inactivating enzymes required for replication (Bitton, 1980).
1.6 Norovirus -  impact on public health
Gastroenteritis is very important in relation to public health (Bern and Glass, 1994). In terms 
of mortality diarrhoeal disease is more likely to be significant in developing countries 
(Lopman et al., 2002) and whilst mortality does oceur in developed countries the major 
impact of gastrointestinal disease is in its economic effects (Monroe et al., 2000).
Unlike other enteric viruses (e.g. rotavirus), whieh primarily eause illness in children, NoV 
also affects adults (Lopman et al., 2004a). Although it is not normally severe in healthy 
adults, NoV outbreaks in healthcare settings are common and due to the nature of such 
institutions vulnerable populations are affected. Acute illness or even death has been reported 
in undernourished, immunocompromised (Hutson et al., 2004) or elderly individuals (Carter, 
2005). In healthy adult populations the main impact of NoV infections is economic loss 
through staff illness and absenteeism, particularly within the health service sector where a
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large proportion of outbreaks oceur. For example, hospital outbreaks may spread through 
staff and patients alike, with staff infections causing serious problem as a result of workforce 
shortage and resultant reduced patient care, ultimately leading to ward closures (Lopman et 
al., 2003). NoV outbreaks were responsible for an estimated cost of £115m to the National 
Health Service (NHS) in the UK during 2004 through lost bed days and staff absences 
(Lopman et al, 2004b).NoV outbreaks are also eommonly reported in non-nosoeomial 
settings such as nursing homes, cruise ships, schools, camps, military installations and in 
restaurants (CDC, 2002; CDC, 2003), although outbreaks in hospitals may be more severe, 
with the duration of symptomatic illness increased by 24 hours (Lopman et al., 2004a). It is 
thought that the risk to those in health care settings is higher due to the close living conditions 
compounded by the fact that in general, the health of such individuals is already 
compromised making them more suseeptible to infeetion (CDC, 2001).
Although most infeetions are reported to be a result of person-person transmission, a 
significant number of illnesses are associated with consumption of contaminated food and/or 
water. Foodbome outbreaks are common in non-health care settings such as cruise ships, 
hotels and restaurants. It has been noted that the Hazard Analysis Critical Control Points 
(HACCP) approach and preventative measures aimed at the reduction of bacterial 
contaminants may not be effective against NoV contamination (CDC, 2003). Additionally, 
contamination of produce by food handlers is frequently reported (Widdowson et al, 2005). 
Modem lifestyles ean increase the spread and prevalence of NoV in the community; risks are 
compounded by the increased number of elderly people that live in communal settings (e.g. 
nursing homes), the increase in food handling and the elevated frequency of exposure to 
restaurants meals compared to former years (United States Department of Agriculture, 2005). 
Furthermore, food such as fmit and vegetables are being consumed on a larger scale than in 
previous years, and the potential for contamination through irrigation water is high, especially
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in products imported from countries with less well developed hygiene and sanitation controls 
(Widdowson et al., 2005). Travel also plays a major role in exposure to NoV, with an 
increase in the popularity and accessibility of recreational cruises, air travel and hotel usage. 
All these factors increase the risk of contact with NoV and subsequent development of 
disease.
1.7 BMS-associated norovirus outbreaks
Outbreaks of gastrointestinal disease associated with the consumption of raw or lightly 
cooked BMS are well documented (Halliday et ah, 1991; Lowry et al., 1989; Lowther et al., 
2010; Richards, 1985). Official reports of outbreaks assoeiated with BMS have been 
comparatively low (less than 6  per year) in England and Wales between 1993 and 2007 
(Lowther et al., 2010), however it is suggested that recognised outbreaks represent only a 
small part of the true burden of illness in most countries (Potasman et al, 2002; Wheeler et 
al, 1999). This assertion is supported by the reporting pyramid determined by the Infectious 
Intestinal Disease Study indicating a substantial level of under-reporting of NoV in the 
community (Figure 1.4). The study aimed to establish the incidence and aetiology of 
infectious intestinal disease in the community compared to the incidence and aetiology 
reaching national laboratory based surveillance (Wheeler et al, 1999).
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Figure 1.4: Laboratory reporting pyramid indicating under reporting of NoV gastroenteritis 
(Wheeler et al., 1999).
Historically, outbreaks of BMS-associated NoV gastroenteritis have been reported during 
winter periods in the UK (Doré et al, 1998). Unpublished data collected by Cefas in its role 
as the UK National Reference Laboratory for monitoring bacteriological and viral 
contamination of bivalve molluscs indicates that this winter seasonal trend is still apparent. 
Overall, 78% of BMS related illnesses from NoV in the US between 1991 and 1998 were 
associated with the consumption of oysters harvested between November and January 
(Burkhardt and Calci, 2000).
Compared to official reports received in previous years, an increased number of BMS- 
associated NoV outbreaks were reported in January -  March 2010 in the EU (Westrell et al, 
2010). This has been attributed to a number of factors. Firstly, the colder temperatures 
experienced during the winter 2009-2010 may have increased virus survival in the 
environment. Secondly, NoV has had increased press coverage due to hospital ward closures, 
and particularly in the UK, due to a BMS-associated outbreak from a high profile restaurant 
(Anon., 2009), potentially leading to increased awareness and subsequent reporting. The 
outbreak data for BMS-associated NoV outbreaks for 2009 in the UK are shown in Table 1.3.
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Table 1.3: BMS-associated outbreaks in the UK 2009 (HPA, Cefas, Personal 
Communication)
Place of outbreak Number of 
consumers 
affected
Number 
clinically 
confirmed as 
norovirus
Month of 
occurrence
Suspected vehicle
Berkshire 591* 16 Jan-Feb-09 Oysters/Razor Clams
Anon 29 Feb-09 Oysters
London 6 Feb-09 Oysters
London 2 1 Mar-09 Oysters
London 6 1 May-09 Oysters
Kent 2 Jun-09 Oysters
Avon 3 0 Jul-09 Oysters
Cornwall 3 3 Nov-09 Oysters
London 3 0 Dec-09 Oysters
London 85 1 Dec-09 Oysters
London 11 2 Dec-09 Oysters
Essex 12 Dec-09 Oysters
* Oysters/Razor Clams suspected vehicle, suspected food handling transmission increased number o f affected individuals. 
Blank cells indicate that the outbreak was not clinically confirmed.
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1.8 Detection of norovirus
Regulators of the microbiological quality of 'water and BMS rely on bacterial indicators such 
as enterococci and faecal coliform bacteria. However, faecal bacteria are not always 
indicative of the risk posed by viruses (Geldenhuys and Pretorius, 1989; Jiang et al., 2001; 
Noble and Fuhrman, 2001). It is thought that in coastal and marine waters, traditional 
bacterial indicators may degrade more rapidly than viruses (Borchardt et al., 2003; Solic and 
Krstulovic, 1992). BMS that are implicated in disease outbreaks with a viral aetiology are 
frequently compliant with the E.coli standard (Table 1; Chalmers and MacMillan, 1995), 
particularly when the shellfish are purified prior to sale (Heller et al, 1986). Because of this, 
it would be preferable to also gather data through the direct detection of virus in samples. 
Human NoV are non-cultivable and may be present in low numbers in foodstuffs, therefore 
more sensitive molecular techniques are currently required for detection.
1.8.1 Electron Microscopy
NoV morphology can be observed using Electron Microscopy (EM) carried out using direct 
EM or immune EM methods (Castriciano et al., 2006). NoV particles show cup-like 
depressions and are fuzzy and indistinct (Carter, 2005). For visualization by EM, a large titre 
of virus in a sample is required (Richards et al, 2003). It has been reported that more than 10  ^
morphologically intact particles per gram (ml) of stool sample are required (Richards et al.,
2003). Viral concentrations in foodstuffs are usually many orders of magnitude lower than in 
stool samples. Low levels of viral particles are frequently associated with illness [the 
infectious dose for norovirus is reported to be <100 virus particles (Kapikian et al., 1996)].
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The sensitivity limitations dictate that it is currently technically impossible to detect levels of 
NoV virus particles relevant to human health in a food or environmental sample using EM.
1.8.2 Enzyme Linked Immunosorbent Assay
A number of rapid and simple Enzyme Linked Immunosorbent Assay (ELISA) kits for 
detecting NoV antigens are currently available. Monoclonal and polyclonal antibodies against 
NoV antigens are produced for ELISA using virus-like particles (VLPs) produced from the 
spontaneous assembly of capsid proteins in protein expression systems (Jiang et al.,
1992).ELISA Kits such as the Dako kit (IDEIA NLV, Dakocytomation) possess microwells 
coated with GI or GII specific antibodies, and use a colorimetric enzyme-substrate reaction 
indicator for comparison between positive samples and positive/negative controls. ELISA 
kits enable the detection of both particulate and soluble antigens; positive results therefore do 
not necessarily originate from encapsidated and infectious virus. ELISA kits only allow for 
approximate quantification through spectrophotometric assessment of samples in comparison 
with the positive and negative controls. Furthermore, human NoV titres in BMS samples are 
usually low, and ELISA kits for human NoV are not sensitive enough to detect human NoV 
in BMS (Tian and Mandrell, 2007). For these reasons, ELISA is not currently used for 
detection of NoV in BMS and other foodstuffs.
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1.8.3 Conventional PCR
Molecular detection methods for NoV such as reverse-transcriptase-PCR (RT-PCR) detect 
viral nucleic acid. NoV is an RNA virus, thus PCR requires an initial reverse transcription 
stage, producing a complementary DNA (cDNA) copy. Development of broadly-reactive 
conventional PCR primers for the detection of multiple genotypes is hampered by the 
variability of the NoV genome at the genogroup and genotype level (Koopmans and Duizer,
2004), however numerous PCR primer sets for detection of NoV have been published. A 
number of conserved regions of the gepome have been targeted (Figure 1.5); primers have 
been designed to target the conserved viral RNA polymerase, located in ORF 1 (Ando et al., 
1995a; Ando et al., 1995b; Vinjé and Koopmans, 1996) while other regions used in primer 
design include the 2C protease and the 5’ end of the capsid region, as well as 0RF3. Region 
A primers target the RdRp region of ORFl. Different degenerate primer sets are required for 
the detection of GI and GII NoV; however these two sets allow the broad detection of NoV 
(Jiang et al., 1999). Using degenerate primers in the RdRp region is reported to reduce the 
sensitivity of the PCR assay however (Le Guyader et al, 1996).
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Figure 1.5: A schematic of the NoVgenome representing broadly reactive primer sets for 
regions A-D that are commonly used for detection of multiple NoVstrains and genotyping 
(adapted from Vinjé et al., 2004).
Region B broadly reactive primers amplify a 172bp region at the 3’ end of the RdRp in ORFl 
downstream of Region A. This primer pair allows for more sensitive detection and 
genotyping of GI NoV (Fankhauser et a l, 2002).Region C is located at the 5’ end of 0RF2 
[encoding the N-terminal/shell (N/S) domain of the VPl capsid protein (Kobayashi et al., 
2000)]. Kojima et al. (2002) adapted the primer sets developed by Kobayashi et al. (2000) by 
deleting 3 nucleotides at the 3’ end of the primers. Kojima et al. (2002) introduced 
degenerate nucleotides at positions of NoV heterogeneity and subsequently improved 
genogroup specific detection rates. Region D is also located in the capsid region (0RF2) and 
is downstream of the N/S domain. Primer sets in Region D target stretches of the genome 
which are conserved between genotypes (but within a genogroup) corresponding to the C- 
terminus of VPl. The target region set out by Vinje et al. (2003) is short due to the low level 
of homogeneity between genotypes in this area of the genome. Primers were designed using
-23-
mixed base or deoxyinosine residues, which can pair with all four bases (Martin et ah, 1985) 
at positions of genome polymorphisms, and were introduced with the aim to match various 
combinations (Vinje et a l, 2004).
The development of broadly reactive primers enables the detection of multiple genotypes of 
NoV within a genogroup. Sequencing and/or hybridisation techniques can be used to 
genotype NoV in an unknown sample if necessary. Genotyping assays sequence amplicons 
from primer sets that target regions within 0RF2 (Vinjé et al, 2004). However, simple 
genotyping has been complicated by the emergence of recombinant NoV that have 
polymerase and capsid regions derived from separate ancestral strains (Bull et al, 2006).0ne 
drawback of PCR for NoV is that it amplifies a short region of the genome, which does not 
allow for the determination of virus infectivity or the integrity of the rest of the genome 
(Carter, 2005). The lability of single stranded viral RNA adds further difficulty to PCR 
methods at the RNA extraction stage (Richards et a l, 2003). Furthermore, conventional PCR 
requires a confirmation step (sequencing or other e.g. Southern blotting) to remove doubt 
caused by the possibility of false amplification (false-positive results).
1.8.4 Real-Time RT-PCR
Quantitative real-time RT-PCR (qRT-PCR) provides empirical data for the presence of a 
fragment of the NoV genome (usually an area of the genome in ORF 1/2 junction). The 
technique uses fluorescent dyes or fluorochrome-tagged probes that bind to amplified cDNA 
or complementary sequences in the amplified region respectively (Fong and Lipp, 2005), thus 
eradicating the need for a confirmation step. Primer and probe design is difficult due to the 
genetic diversity within NoV genogroups. Broadly reactive real-time protocols often require
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several primer and probe sets, which are often degenerate in nature, to ensure all genotypes 
can be identified and detected in one assay (Kageyama et al., 2003; Pang e/ al., 2004; Pang et 
al., 2005; Richards et al., 2004). TaqMan (hydrolysis) probe-based assays for NoV are 
favoured. Many primer sets have been used to tackle the problem of genetic diversity 
between NoV genotypes and to take into account the potential for geographical and temporal 
variation with reference to the epidemiological importance of specific strains. (Kageyama et 
al., 2003; Le Guyader et al, 1996; Le Guyader et al, 2000; Le Guyader et al, 2003; Loisy 
et al., 2005).
Both one- and two-step qRT-PCR formats have been published. In one study, the authors 
compared 2-step qRT-PCR reaction sensitivity, using a separate reverse transcription (RT) 
step (using random primers), with a single step qRT-PCR (Antonishyn et a l, 2006). It was 
reported that both methods had similar levels of sensitivity. Some authors have reported that 
it is more difficult to detect GI than GII using qRT-PCR methods. It has been suggested that 
this is partly due to the higher level of sequence diversity within GI, complicating primer and 
probe design and reducing the sensitivity of the assay (Kageyama et al., 2003; Loisy et al., 
2005; Trujillo et al., 2006). Currently a two part (quantitative and qualitative) standardized 
method for the detection of NoV in foodstuffs (including BMS), utilizing real-time RT-PCR 
technology, is in development by an expert technical advisory group of the European 
Committee for Standardisation (CEN WG6  TAG4). As an internationally recognised and 
standardised method, this approach will have the ability to become part of legislative testing 
(Lees and CEN.WG6.TAG4, 2010).
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1.9 The use of cultivable surrogates for the study of human NoV
The absence of a cell culture assay or a small animal model for human NoV means that 
biologically similar viruses such as feline calicivirus (FCV) (di Martino et al., 2007), San 
Miguel sea lion virus (SMSV) (Calci et ah, 2002) and F-specific RNA coliphages (FRNA 
phage) (Brion et al., 2002; Doré et al., 2000; Formiga-Cruz et al., 2003; Havelaar et al.,
1993) have been used as surrogates for human NoV, and indicators of virological risk in the 
environment (Allwood et al., 2005).FCV is a member of the Vesivirus genus within the 
Caliciviridae, and possesses a positive-sense polyadenylated single-stranded RNA genome of 
approximately 7.7Kb (di Martino et al., 2007). FCV causes an upper respiratory tract disease 
in cats (Marsilio et al., 2005). It has similar molecular characteristics to NoV, with 3 ORFs 
encoding similar proteins to those of NoV, and similar capsid architecture (Prasad et al., 
2000). Because of the similar characteristics FCV shares with NoV, and its ability to grow in 
Crandell-Reese Feline Kidney (CRFK) cells, FCV has been used in many studies to aid in the 
understanding of NoV survival and inactivation (Cannon et al,. 2006; Tree et al,. 2005). FCV 
produces clear cytopathic effects (CPE) in cell culture, enabling the propagation and measure 
of infectivity by 50% tissue culture infective dose (TCID50) or plaque assay techniques, 
which to date is not possible using human NoV. However, FCV is not a human pathogen, and 
possesses different transmission routes and infects different cell types from human NoV, and 
this therefore raises questions regarding its suitability as a biologically-representative 
surrogate. Studies have shown that NoV are more acid stable than FCV (Cannon et al, 2006), 
as a result of the different site of infection. FCV and NoV behaviour in the environment may 
therefore differ and lower persistence of FCV in BMS tissues has been reported (Ueki et al., 
2007). However, this difference in behaviour may have been due to the differences in binding
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ability of the two viruses in oyster digestive tissues rather than differential environmental 
persistence between the two viruses.
SMSV is a Vesivirus, which can cause infection in marine mammals, and is non-enveloped 
and icosahedral, with a positive-sense, polyadenylated single-stranded RNA genome. It 
possesses three ORFs, with each ORF encoding proteins similar to those of NoV. However,
J
the virus causes a different illness to that caused by human NoV, causing abortion and 
vesicular lesions. SMSV can be grown in cell culture, but its different capsid structure (Chen 
et a l, 2006), and different pathogenesis makes it a poor surrogate for human NoV.
FRNA phage has been proposed as an indicator of enteric virus and faecal contamination 
(Brion et a l, 2002; Doré et al, 2000; Formiga-Cruz et a l, 2003; Havelaar et al, 1993). 
FRNA bacteriophages are single-stranded RNA viruses with simple cubic eapsids of 24- 
27nm in diameter (Furuse, 1987). Previous studies have compared bacterial and FRNA phage 
recovery in BMS before and after depuration, to indicate differences in inactivation kinetics 
between bacterial and viral contaminants (Doré et al., 1998; Doré et al., 2000; Doré and Lees, 
1995; Richards, 1988). However, because of its simple capsid structure, the use of FRNA 
phage to predict human NoV behaviour in the context of stability and inactivation analyses in 
the environment as well as interaction with BMS matrices has been questioned.
More recently, murine norovirus (MNV), a genetically distinct genogroup V NoVthat infects 
mice, has been identified (Karst et al, 2003; Wobus et a l, 2004). This virus shares several 
distinct and advantageous biological properties with other NoV (including human NoV), 
including its spread in faeces (Wobus et al., 2006) as well as similar physical and chemical 
structure. MNV is the only NoV to date that can be propagated in cell culture -  it replicates in 
murine macrophage cell line RAW 264.7, and can also be studied in laboratory mice (Karst et 
al., 2003; Wobus et al., 2004). Therefore basic mechanisms of NoV replication, pathogenesis
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and host immune responses can be studied directly through the study of MNV in the natural 
host and through cell culture techniques (Wobus et al., 2006).
MNV is an enteric pathogen, thought to spread via the faecal-oral route, with an increasing 
number of MNV strains being isolated from the faeces of laboratory mice. Further evidence 
indicates a possible additional respiratory route of spread (Wobus et al., 2006). It is suggested 
that MNV is endemic to mouse populations, due to its prevalence in research colonies in the 
US and Canada (Hsu et al., 2005; Mumphrey et al., 2007). MNV only causes symptomatic 
infection in immunocompromised mice, causing systemic disease, however MNV is 
asymptomatic in wild-type mice and MNV-1 RNA has been detected in the faeces of these 
mice (Wobus et al, 2006).
100 nm
Figure 1.6 -  Electron Micrograph of MNV-1 in virus lysate (taken at Cefas Weymouth 
Laboratory).
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At a molecular and biochemical level, MNV possesses many features comparable with 
human NoV. Its size, icosahedral shape (Figure 1.6), and three principle ORFs (translating 
proteins of similar functions to human NoV; Figure 1.7) represent strong links between MNV 
and human NoV (Wobus et al., 2006). Because of these characteristics, MNV has the 
potential to act as a good model or surrogate in studies of the pathogenesis, infectivity, 
viability of human NoV and its behaviour in the environment and BMS tissues,.
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Figure 1.7 - A schematic of the MNV-1 genome (adapted from Wobus et al., 2006). The 
7382 nucleotide (nt) genome is flanked by a short nt sequence at the 5’ end, and a 75nt 
sequence at the 3’ end, before a poly(A) tail (Karst et al., 2003). VP2 is a minor structural 
protein essential for infectious virions. 0RF4 has been recently identified and codes for an 
uncharacterised virulence determinant (Bailey et al, 2010).
1.10 Cultivation of human NoV
Historically, attempts to cultivate human NoV have been largely unsuccessful, and despite
numerous efforts, routine cell cultures have failed (Duizer et al, 2004b; Malik et al, 2005).
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Large numbers of different cell lines derived from both human and animals have been used, 
but no CPE or NoV growth has been observed. Because of this, more complicated methods 
for the study of human NoV replication and for human NoV cultivation have been attempted.
Two similar mammalian cell-based systems for the study of human NoV replication have 
been reported (Anasaka et al., 2005, Katayama et al., 2006). Human NoV RNA was 
replicated and in some cases packaged into virus particles composed of NoV capsid proteins 
in mammalian cells both infected with a recombinant vaccinia virus strain expressing T7 
RNA polymerase and transfected with a plasmid containing the NoV genome downstream of 
a T7 promoter. These studies have helped elucidate the mechanics of NoV RNA replication, 
indicating rapid cleavage of RdRp inside a human cell to produce mature and functional 
RNA-dependant RNA polymerase (RdRp) (Katayama et al., 2006).
Straub et al., (2007) reported an in vitro cell culture infectivity assay for human No Vs. The 
authors produced representative models of differentiated human intestinal epithelia cells by 
growing the epithelial cells in 3-dimension. This was achieved by growing the cells on 
collagen-I-coated porous microcarrier beads in a rotating-wall vessel, to simulate the fluid- 
shear conditions of the human intestine, (Honer zu Bentrup et al., 2006; Nickerson et al., 
2001; Nickerson et al., 2005) the tissue in which NoV replicates. The cell culture produced 
possessed multiple intestinal cell types, as the authors theorized that multi-cellularity was 
vital for NoV infectivity. The expression of HBGAs and cell surface receptors was also 
considered necessary for infectivity due to the known critical role of HBGAs in NoV 
infection. Samples were tested for the presence of NoV RNA using qRT-PCR before being 
added to the 3-D cell culture. CPE was used as a measure of virus infectivity, and was 
assessed using microscopy. CPE was reportedly observed along with the concentration of 
virus in certain areas of the 3-D model. RT-PCR and fluorescent in situ hybridization was 
also used to observe virus growth. Other observations included a shortening of the microvilli
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and vacuolization of the cells. Unfortunately neither the author nor other workers have been 
able to reproduce the reported replication of virus using these methods despite considerable 
research effort (Dr. Tim Straub, personal communication).
1.11 Real-time RT-PCR detection of norovirus in BMS
qRT-PCR detection of NoV in BMS involves the liberation, concentration and quantification 
of the virus from the BMS matrix. PCR is susceptible to matrix inhibition, which can lead to 
false-negative reactions. This is a particular problem for qRT-PCR detection of NoV in BMS 
due to often high level of PCR inhibitors present in a sample (Lees and CEN WG6 TAG4, 
2010). The virus extraction procedure is therefore critical, and it is vital that methods are 
suitable both for the removal of PCR inhibitors and for the recovery high purity intact nucleic 
acids to facilitate the detection of low levels of virus. The CEN WG6 TAG4 method 
recommends approachess based on that originally published by Boom et al. (1990) utilising 
lysis with guanidine thiocyanate and adsorption to silica. Extracted viral RNA is 
subsequently amplified and detected by qRT-PCR.
Several studies using qRT-PCR have demonstrated NoV contamination in a significant 
proportion of production area samples for both oysters and other bivalve shellfish. A previous 
study at this laboratory found NoV in 52% and 69% respectively of Pacific oyster (C. gigas) 
samples taken from two sites over an extended period (Lowther et al, 2008). Elsewhere 54% 
of packages of clams collected from supermarkets and fish markets in western Japan were 
found to be contaminated with human NoV (Hansman et al, 2008), while studies of BMS 
from France (Loisy et al, 2005), Tunisia (Elamri et al, 2006) and the United States 
(Constanti et al, 2006) have found human NoV in 20 - 41% of samples.
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1.12 Aims -  Interpretation of qRT-PCR data
NoV cannot be routinely cultured in the laboratory and therefore existing assays (qRT-PCR) 
for human NoV are based upon detection of a fragment of viral genome. Application of these 
assays has shown that a high percentage of BMS production areas in the UK appear to be 
contaminated with NoV during winter months (Doré and Lees, 1995). The implications for 
the UK shellfish production sector of implementation of a European standard for NoV in 
BMS may therefore be significant. However, it is unclear whether detection of viral genome 
always correlates with presence of infectious virus and thus indicates a potential health risk to 
the consumer. Some BMS producers and others have questioned the validity of qRT-PCR 
detection of NoV (McLeod et al, 2008; Richards, 1999), suggesting that as qRT-PCR detects 
a relatively short region of the NoV genome, it is possible that positive results may be 
generated from the presence of small, non-infectious fragments of the NoV genome, or 
through the detection of damaged, non-infectious NoV virions. This PhD project sets out to 
address the question of the public health implications of PCR results for human NoV 
contamination in BMS.
1.13 Research Objectives
• Based on the evidence described in Chapter 1 the assumption that MNV-1 is a suitable 
surrogate for human NoV has been made. Therefore, MNV-1 will be used in a number of 
studies to assess the behaviour of NoV in the environment and in the BMS matrix. The 
development and performance characterization of cell culture and molecular methods will 
be undertaken and MNV-1 will be used as a cultivable surrogate for the study of human 
Nov.
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• The stability of NoV RNA, NoV and MNV-1 under artificial environmental conditions 
will be analysed using qRT-PCR. The degradation dynamics of free RNA following 
exposure to UV irradiation simulating winter sunlight will then be assessed by application 
of the standardised qRT-PCR assay. Degradation data will be compared with the 
disappearance of PCR signals obtained from human NoV positive faecal samples held 
under the same conditions. Furthermore, comparisons of the effects of differing 
environmental conditions on MNV-1 virus samples, MNV-1 RNA and infectivity are 
proposed to generate information on relative disappearance rates of MNV-1 PCR signals 
and infectivity as determined by cell culture.
• Potential uptake of naked NoV RNA by BMS will be studied to determine its relevance in 
terms of NoV positivity in BMS samples. The bioaccumulation of inactivated NoV and 
MNV-1 by BMS will be assessed.
• The use of RNaseONE as a pre-extraction treatment to differentiate viable and non-viable 
viruses from faecal solutions and BMS matrices will be evaluated, with the aim of 
determining a more accurate prediction of the level of infectious NoV present in BMS, 
and therefore a more accurate prediction of consumer risk.
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2.0 Materials and Methods
2.1 Nucleic Acid Extraction
Total nucleic acid was extracted from faecal material from the Cefas reference collection 
(samples provided courtesy of Health Protection Agency Centre for Infections, Colindale, 
London, UK), BMS homogenates, water samples or MNV-1 virus lysates using NucliSens® 
magnetic extraction reagents (bioMerieux, Marcy TEtoile, France). For each sample, 2 ml of 
NucliSens lysis buffer was added to a 15 ml centrifuge tube. A volume of test material (500 
pi unless stated otherwise) was then added to the lysis buffer and incubated at room 
temperature for 10 minutés. A separate volume of molecular grade water was prepared in the 
same way as a negative extraction control. Following incubation, 50 pi of magnetic silica 
solution was added to each tube and mixed by vortexing. The tubes were again incubated at 
room temperature for 10 minutes before centrifugation at 1500 x g for 2 minutes. The 
supernatant was aspirated, and the pellet resuspended in 400 pi of wash buffer 1. The 
suspension was transferred to a 1.5 ml screw cap tube on a MiniMag™ magnetic extraction 
apparatus (bioMerieux). The magnet of the MiniMag™ was raised and the suspension was 
washed twice in 400 pi wash buffer for 30 seconds each followed by 2 further washes in 500 
pi of wash buffer 2. An aliquot of 500 pi of wash buffer 3 was then added, and a wash step 
for 15 seconds was carried out. An aliquot of 100 pi of elution buffer was added and the 
tubes were capped and transferred to a thermoshaker for 5 minutes at 60°C. The tubes were 
then transferred to a portable magnet and the RNA supernatant was collected and stored at - 
20°C.
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2.2 Reverse Transcription of extracted RNA
Complementary DNA (cDNA) was synthesised in a reverse transcription (RT) step as 
follows; a 3.9 pi volume of a reaction mix containing 0.5 pi (20 U) of Rnasin (Promega, 
Madison, WI, USA) and 1 pi (500 ng) random hexamers (Promega) per reaction was added 
to three separate PCR tubes per sample containing 5 pi aliquots of extracted RNA each. The 
tubes were then overlaid with a drop of mineral oil. The reactions were incubated at 70°C for 
5 min. on a thermal cycler (MJ Research, PTC-100, USA) then snap-cooled on a freezer 
block. A reaction mix containing 0.6 pi deoxynucleotide triphosphate mix (dNTPs; 25 mM 
each) (Promega), 2 pi of lOx PCR buffer II (GeneAmp®, Applied Biosystems, Foster City, 
CA, USA), 3 pi of 25 mM MgC^ and 0.5 pi (25 U) of MuLV-RT enzyme (Applied 
Biosystems) per reaction was prepared. A volume of 6.1 pi of this mix was then added to 
each reaction tube underneath the mineral oil layer, and reactions were incubated for 10 
minutes at 23 °C followed by 60 minutes at 37°C to generate cDNA. The reaction was 
stopped by incubation for 5 minutes at 95°C. For each sample the three resulting cDNA 
preparations were pooled together in a single tube (overlaid with mineral oil) and stored at 
4°C until needed.
2.3 Semi-nested (Polymerase Region) and single-round PCR (Capsid Region) for 
detection of human NoV
PCR primers used for NoV genotyping of archived faecal material are presented in Table 2.1. 
To amplify region A (polymerase), a semi-nested PCR was carried out. Primer sets NV4562 
and PI 10, and NV4611 and PI 10 were used in the first round PCR reaction for GI and GII 
NoV respectively. A mastermix was prepared containing 10 pi of 1 Ox reaction buffer, 5 pi of
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MgCli (25 mM), 0.5 pi of dNTP mix, 0.5 pi of forward primer (100 pM), 0.5 pi reverse 
primer (100 pM), 0.25 pi (1.25 U) Go Taq Flexi DNA Polymerase (Promega) and 18.25 pi 
molecular grade water per reaction. For each sample a 35pi volume of this mastermix was 
added to 15 pi of stored cDNA to give a 50 pi total volume. These were then subjected to 
PCR using the following cycles; 94°C for 3 minutes, followed by 40 cycles of 1 minute each 
at 94°C, 45°C and 72°C, and a final incubation of 7 minutes at 72°C. For the second round, 
primer sets SR48 and PI 10 (GI) and Ni and PI 10 (GII) were used to amplify the target 
fragment. A mastermix containing these primers was prepared as described for the first 
round PCR with the exception that 30.75 pi of molecular grade water per reaction was used. 
For each sample a 47.5 pi volume of this mastermix was added to 2.5 pi of first round PCR 
product. Tubes were placed on a thermal cycler and were subjected to PCR using the same 
parameters as for the first-round.
Table 2.1: Primers used in semi-nested and conventional PCR for detection of NoV
im er
im e
G enogroup
target
Region Prim er
orientation
Sequence Com m ents Reference
162 GI Polymerase 
(Region A)
F GAT GCD GAT TAC A C A  GCH TGG G F* round Yuen et al., 2001
i l l O il Polymerase 
(Region A)
F KGC AGC M CT DG A AA T CAT GG F* round Yuen et al., 2001
(Ando) GI Polymerase 
(Region A)
F GTG AAC AG Y A TA  A A Y  CAN TGG 2"  ^round Ando et al., 1995a
GII Polymerase 
(Region A)
F GAA TTC CAT CGC CCA CTG GCT 2"  ^round Green et al., 1995
GI and GII Polymerase 
(Region A)
R ACD ATY TCA TCA TCA CCA TA F ‘ and2"‘'
round
Lees é ta l ,  1995
T GI Capsid 
(Region C)
F CTG CGC G AA TTY GTA AA T GA Kojima etal.2001
H GI Capsid 
(Region C)
R CCA ACC CAR CCA TTR TAC A Kojima et al.2001
T GII Capsid 
(Region C)
F CNT GGG AGG GCG ATC GCA A Kojima etal.2001
R GII Capsid 
(Region C)
R CCR CCN GCA TRH CCR TTR TAC AT Kojima et a l, 2001
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To amplify region C (capsid), single-round PCR was carried out. Primer sets GISKF and 
GISKR, and G2SKF and G2SKR were used to detect NoV GI and GII respectively. A 
mastermix containing these primers was prepared as described for the polymerase region first 
round PCR. For each reaction, a 35pl volume of this mastermix was added to 15 pi of the 
stored cDNA to give a 50 pi total volume. These were then subjected to PCR using the same 
parameters as for the polymerase region.
2.4 Agarose Gel Electrophoresis
PCR products were analysed on a 2% Tris-Acetate-Ethylenediaminetetraacetic acid (TAE) 
agarose gel with approximately 1 pg/ml ethidium bromide. Gels were subjected to 
electrophoresis at 120 V for approximately 30 minutes, viewed under UV light on a 
transilluminator and digitally photographed using GelDoc software (Applied Biosystems).
2.5 Gel purification of PCR products
Bands representing the expected size of PCR product were excised using a scalpel, placed 
into a spin module tube (Anachem, Bedfordshire, UK) and frozen. The frozen fragments were 
then compressed using a sterile pipette tip, and centrifuged at 13000 x g for 5 minutes. The 
filtrate was transferred to a 1.5 ml Eppendorf tube and made up to 400 pi with molecular 
grade water. A 40 pi aliquot of 3 M sodium acetate and 1000 pi 100% ethanol was added to 
the filtrate and the tubes were vortexed. The tubes were then centrifuged at 13000 x g  for 20 
minutes to pellet the DNA. The supernatant was carefully removed and 200 pi of 70% 
ethanol was added to each tube. The tubes were centrifuged at 13000 x g  for 10 minutes, and
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the supernatant removed by aspiration. The DNA pellet consisting of the purified PCR 
product was resuspended in 26 pi of molecular grade water and stored at -20°C.
2.6 Ligation and Transformation of purified PCR products
A ligation mix was made up using the pGEM-T Easy cloning kit (Promega) by adding 1 pi of 
T4 DNA ligase, 1 pi of pGEM-T Easy vector solution and 5 pi of 2x rapid ligation buffer per 
reaction. A 3 pi aliquot of purified PCR product (-200 ng/pl) was then added to 7 pi of the 
ligation mix for each sample. The reaction tubes were incubated at room temperature for 2 
hours then centrifuged for 1 minute at 13000 x g  before 2 pi of the each ligation reaction mix 
was added to a separate 1.5 ml Eppendorf tube. Fifty microlitres of JM109 competent cells 
(Promega; thawed on ice) were added to each tube and these were then held on ice for 20 
minutes. The tubes were transferred to a water bath at 42°C for 45 seconds to heat shock the 
competent cells then returned to ice for 2 minutes. A 950 pi volume of LB broth (10 g/1 
Bactotryptone, 5 g/1 yeast extract, 10 g/1 Sodium Chloride; equilibrated to room temperature) 
was added to the transformation reaction, and the reactions were incubated with shaking (160 
rpm) at 37°C for 90 minutes. Whilst the reactions were incubating, LB agar plates (LB broth 
supplemented with 15 g/1 of agar and 50 pg/ml ampicillin) were spread with 100 pi of 500 
mM isopropyl-beta-D-thiogalactopyranoside (IPTG) and 20 pi of 50 mg/ml of 5-bromo-4- 
chloro-3-indolyl-p-D-galactopyranoside (X-Gal), and were incubated at 37°C for 40 minutes 
to allow for the reagents to be absorbed by the agar. A 100 pi volume of each transformation 
reaction was then spread onto a plate and incubated overnight at 37°C.
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2.7 Overnight cultures, plasmid preparation and purification
The presence of the selected insert in transformants was determined using blue-white 
screening. In this system, presumptive transconjugant cells (which have taken up plasmid 
constructs containing an inserted target and which are therefore unable to hydrolyse X-gal) 
appear as white while those cells containing non-recombinant plasmid appear blue. Single 
white colonies were selected, streaked onto separate LB-ampicillin plates and incubated at 
37°C overnight. After incubation, colonies were screened by conventional PCR as described 
in Section 2.3 but using p-GEM-T Easy plasmid specific primers (100 pM; Table 2.2). A 
single colony from the clone containing a plasmid with the desired PCR target, as determined 
by gel electrophoresis of the resulting colony PCR product, was inoculated into 5 ml of LB 
broth containing ampicillin (100 pg/ml) and incubated at 37°C overnight with shaking at 260 
rpm.
Primer Name Primer Direction Sequence
pTag5’ F GCT ATG ACC ATG ATT ACG CCA A
pTag3’ R TGT AAA ACG ACG GCC AGT GAA
Following incubation cultures were split into 3 separate volumes of 1.5 ml in Eppendorf 
tubes and cells were pelleted by centrifugation at 13000 x g  for 5 minutes. Plasmids were 
prepared from the pelleted cells using a QIAprep® spin minprep kit (Qiagen, Valencia, CA) 
using the manufacturer’s instructions. Briefly, the cells were resuspended in a single volume 
of 250 pi of buffer PI (with RNase A), added stepwise to each of the three pellets per culture. 
Two hundred and fifty microlitres of buffer P2 was then added to the resuspended cells and 
mixed by inversion, followed by the addition of 350 pi of buffer P3. The tube was then 
centrifuged at 13000 x g for 10 minutes. The supernatant was transferred to a separate spin
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column in a collection tube and centrifuged at 13000 x g. The flow-through was discarded 
and 500 pi of buffer PB was added to the spin column, and this was centrifuged at 13000 x g  
for 1 minute. The flow-through was discarded and 750 pi of buffer PE (with ethanol) was 
added. The spin column was centrifuged twice at 13000 x g for 1 minute. After the second 
centrifugation, the column was transferred to clean 1.5 ml Eppendorf tubes, and 50 pi of 
buffer EB (elution buffer) was added. The tubes were incubated at room temperature for 1 
minute before being centrifuged at 13000 x g for 1 minute. A ftirther 50 pi of buffer EB was 
added and the incubation and centrifugation repeated. A secondary purification process was 
then performed on the plasmid using the QIAquick® PCR purification kit (Qiagen) following 
the manufacturer’s instructions. Briefly, 500 pi of buffer PBl was added to the 100 pi 
purified plasmid and the solution was mixed by vortexing. The mixture was then added to a 
spin column and centrifuged at 13000 x g for 1 minute. The flow-through was discarded and 
750 pi of buffer PE (with ethanol) was added to the column, which was then centrifuged 
twice at 13000 x g for 1 minute, discarding the flow-through after the first centrifugation. The 
spin column was then transferred to a clean 1.5 ml Eppendorf tube and 50 pi of buffer EB 
was added. The tube was incubated at room temperature for 1 minute, and then centrifiiged at 
13000 X g for 1 minute. The concentration in ng/pl of the purified plasmid was then 
quantified by measuring absorbance at 260 nm using the ND-1000 spectrophotometer and 
software (Thermo Scientific, Pittsburgh, PA). The absorbance measurement was then 
converted into a concentration in copies/pl using a standard conversion factor related to the 
length of the plasmid in base pairs.
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2.8 Sequencing
Sequencing reactions were prepared in 0.2 ml PCR tubes using 2 pi of either pTag5 (forward) 
or pTagS (reverse) primers (100 pM), 4 pi BigDye® Terminator v3.1 and 4 pi BigDye® 
Buffer (5x) (Applied Biosystems). A 10 pi aliquot of purified plasmid was then added. Each 
forward and reverse reaction was then placed on a therrnal cycler for amplification using 
parameters of 94°C for 30 seconds, followed by 40 cycles of 96°C for 10 seconds, 50°C for 
10 seconds and 60°C for 40 seconds before a final stage of 72°C for 7 minutes. Following the 
sequencing reaction cycles, 10 pi of 3 M sodium acetate, 70 pi of molecular grade water and 
250 pi of 100% ethanol were added to a separate Eppendorf tube for each sequencing 
reaction. The 20 pi sequencing reaction was added and mixed by vortexing. Tubes were 
centrifuged at 13000 x g  for 20 minutes to pellet the DNA then the supernatant was removed 
by aspiration before 200 pi of 70% ethanol was added to each tube. The tubes were again 
centrifuged at 13000 x g  for 10 minutes and the supernatant was removed by aspiration. The 
pellet was dried at room temperature for 10 minutes, before being re-suspended in 25 pi of 
HiDi® Formamide (Applied Biosystems) and denatured at 95°C for 2 minutes. The samples 
were then run on a sequencer (ABI Prism 3130x1 Genetic Analyser, Applied Biosystems).
2.9 Real-time RT-PCR (qRT-PCR)
Primer and probe sets for the detection of human NoV GI and GII are provided in Table 2.3. 
The primer and probe set for the detection of MNV-1 is given in Chapter 3. For NoV GI, GII 
or MNV-1, duplicate or triplicate aliquots (dependent on the particular experiment) of 5 pi 
sample or extraction control RNA were added to adjacent wells of a 96-well optical reaction
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plate and made up to 25 pi with a reaction mix prepared using the RNA Ultrasense one-step 
qRT-PCR system (Invitrogen, Carlsbad, CA) (final concentrations of Ix Reaction Mix, 500 
nM forward and 900 nM reverse primers, and 250 nM probe, plus 0.5 pi Rox and 1.25 pi 
Enzyme Mix per reaction). Wells containing nuclease free water and the same one-step 
reaction mixes were also included on each plate as a negative control. To enable 
quantification of each sample RNA in copies/pl, logio dilution series of plasmids containing 
the GI or GII PCR target (range ~1 x 10  ^ to ~1 x 10® copies/pl; supplied by Dr. Soizick 
LeGuyader, Ifremer, Nantes, France) were included on each qRT-PCR plate. The plate was 
subjected to incubation conditions of 55°C for 60 minutes, 95°C for 5 minutes, and then 45 
cycles of 95°C for 15 seconds, 60°C for 1 minute and 65°C for 1 minute on an SDS7000 
(Applied Biosystems) or MX3005p real-time PCR machine (Stratagene).
Table 2.3: Primers used for qRT-PCR detection of human NoV
Primer/probe name Sequence Reference
Norovirus GI assay
QNIF4 CGC TGG ATG CGN TTC CAT Da Silva et al,  2007.
NVILCR CCT TAG ACG CCA TCA TCA TTT AC Svraka et al,  2007.
TM9 FAM-TGG ACA GGA GAT CGC-MGB Adapted from Hoehne and Schreier, 2006.
Norovirus GII assay
QNIF2 ATG TTC AGR TGG ATG AGR TTC TCW GA Loisy et al,  2005
C0G2R TCG ACG CCA TCT TCA TTC ACA Kageyama et al,  2003.
QNIFS FAM-AGC ACG TGG GAG GGC GAT CG-BHQ-1 Adapted from Loisy et al,  2005
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2.10 MNV-1
2.10.1 Maintenance of RAW 264.7 Cells
RAW 264.7 cells were purchased from the European Collection of Cell Cultures [ECACC; 
(HPA, Porton Down, UK)] and maintained in Dulbecco’s Modified Eagle’s Medium 
(DMEM-10; DMEM supplemented with 10% heat-inactivated foetal calf serum (PCS; 
Sigma-Aldrich), 1% Penicillin/Streptomycin (Pen/Strep; Sigma-Aldrich) 1% N-2- 
hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; Sigma-Aldrich), and 1% L- 
glutamine (Sigma-Aldrich); Wobus et a l, 2004). Cultures were incubated at 37°C with 5% 
CO2 and were passaged when 80-90% confluent by pouring off the old medium and by 
adding 10ml of fresh medium. The cells were then mechanically removed from the base of 
the tissue culture flask by scraping. Cells were then split at 1:2, 1:3, 1:5 or 1:10 dilutions into 
new flasks containing 30 ml of fresh medium, and incubated at 37°C with 5% CO2 until 
semi-confluent (80 - 90%).
2.10.2 MNV-1 growth
MNV-1 lysates were received from Prof. Ian Clarke (University of Southampton, Hampshire, 
UK) and Dr Ian Goodfellow (Imperial College, London, UK), following permission granted 
under a material transfer agreement from Professor Herbert Virgin IV (Washington
University, St Louis, MO, USA). MNV-1 was grown on a semi-confluent layer of RAW
2 ’■264.7 cells in a 75 cm vented tissue culture flask by applying 1 ml of virus stock to the flask 
and incubating at 37°C with 5% CO2 for 24 - 48 hours. After this incubation period, infected
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cells were manually scraped and the lysate was freeze-thawed 3 times to lyse infected cells 
and release virus particles. The lysate underwent centrifugation at 13000 x g  for 10 minutes. 
The supernatant was subsequently split into 0.5 ml and 1 ml aliquots and stored at -80°C.
2.10.3 MNV-1 Plaque Assay (Final Method)
Semi-confluent RAW 264.7 cells from a 175 cm^ flask were used to seed 6 well tissue culture 
plates. Maintenance medium (DMEM-10) was removed and 30 ml of DMEM-5 (DMEM 
supplemented with 5% heat-inactivated PCS, 1% Pen/Strep) 1% HEPES, and 1% L- 
glutamine) was added to the cells. Cells were manually re-suspended by scraping and 
pipetting, and 2 ml of the cell suspension was added to each well of the plate. Seeded six well 
plates were rocked gently by hand before incubation overnight at 37°C with 5% CO2. A 10- 
fold dilution series of MNV-1 (range: 1 x 10'  ^ to 1 x 10'^) was prepared in DMEM-5. The 
medium was aspirated from the plate wells and replaced with 0.5 ml of diluted virus (two 
wells for each dilution). The plates were rocked for 2 hours at 37°C in a 5% CO2 atmosphere. 
After rocking, the supernatants were aspirated and the wells were overlaid with 2 ml of a 1:1 
mixture of 3% (w/v) SeaPlaque® Agarose (Lonza, Switzerland) and 2x MEM (Invitrogen) 
supplemented with 10% PCS, 2% L-Glutamine, 2% Pen/Strep and 1% HEPES (this mixture 
was maintained at 37°C to prevent premature solidification). The plates were pre-incubated 
for 10 minutes at room temperature to allow solidification of the agarose mixture then 
transferred to 37°C with 5% CO2 for 48 hours before being overlaid with 2 ml of 0.00013 % 
neutral red (MP Biomedicals, OH, USA) in Dulbecco’s PBS (Sigma), equilibrated to 37°C. 
Plates were incubated for 2 hours at 37°C and 5% CO2. The neutral red solution was then 
removed by aspiration and the plates incubated for a further 2 hours at 37°C and 5% CO2. 
Plaques were counted after this incubation period using a light box to aid visualisation.
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2.11 Testing oysters for human NoV and MNV-1 contamination
Oysters were opened aseptically, and the flesh removed from their shells. The peripheral 
flesh and organs of each animal were then cut away from the digestive gland and discarded. 
The digestive glands were then finely chopped using a sterile razor blade and an equal 
volume (per weight) of a 100 pg/ml proteinase K solution (Promega) was added before 
incubation at 37°C for 1 hour with shaking at 320 rpm. The reaction mixture was 
subsequently incubated at 60°C for 15 minutes, before being centrifuged at 3,000 x g  for 5 
minutes. The supernatant was removed, its volume was measured and it was retained, stored 
at 4°C, prior to nucleic acid extraction (Section 2.1) and qRT-PCR analysis (Section 2.9).
- 45 -
3.0 Method development and performance analysis for the use of murine norovirus-1 
as a surrogate for the study of human noroviruses
3.1 Introduction
The absence of a cell culture assay or a small animal model for human NoV has led to the use 
of other viruses which possess similar properties as potential surrogates. A genetically 
related, genogroup V (GV) NoV, murine norovirus-1 (MNV-1), has been identified (Karst et 
al, 2003; Wobus et a l, 2004). This is the first known cultivable NoV, grown in murine 
macrophage cell line RAW 264.7, and it has been studied as a model for human NoV.
MNV-1 is predominantly an enteric virus, spread via the faecal-oral route, and it can be 
readily isolated from the faeces of laboratory mice (Wobus et al., 2006). It has been 
suggested that MNV-1 is endemic to mouse populations due to its observed prevalence in 
research colonies in the US and Canada (Hsu et a l, 2005; Mumphrey et a l, 2007). MNV-1 
causes asymptomatic infection in wild-type mice however both MNV-1 and MNV-1 RNA 
have been detected in faecal samples (Hsu et a l, 2005). Systemic, symptomatic disease is 
only observed in immunocompromised mice (Wobus et al, 2006). However, even in 
immunocompetent mice MNV-1 replication is associated with histopathological changes in 
the intestine and spleen (Mumphrey et al, 2007) and, as with human NoV infection; this 
includes lesions (Cheetham et al, 2006; Ward et al, 2006). Clinical disease is controlled by 
STAT1 -dependent interferon responses (direct inhibition of viral replication and prevention 
of virus dissemination) (Mumphrey et al, 2007). Previous studies using other caliciviruses 
(FCV and rabbit haemorrhagic disease virus) to study replication mechanisms have reported
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the triggering of apoptosis and apoptotic changes in infected cells (Al-Molawi et al, 2003; 
Alonso et al, 1998; Jung et al, 2000; Roberts et al, 2003; Sosnovtsev et al, 2003). Bok et 
al, (2009) showed that an association existed between MNV-1 replication and the down- 
regulation of the BIRC5 gene resulting in a reduction in the production of survivin (encoded 
by the BIRC5 gene). Survivin is an apoptosis inhibitor that increases the activation of 
caspases (involved in catalysing apoptosis). Induction of apoptosis in this way facilitates the 
release and dissemination of the virus. On the other hand it has been suggested that other 
RNA viruses initiate increased production of survivin, which delays apoptosis and allows 
more time for intracellular virus replication (Borbély et al, 2007; Pina-0viedo et al, 2007; 
Zhang et al, 2005; Zhu et al, 2003; Zhou and Gong, 2006). At a molecular and biochemical 
level MNV-1 possesses many features comparable with human (and other) NoV. Its size, 
icosahedral shape and its 3 principal ORFs (translating proteins of similar function to human 
NoV) illustrate the substantial structural and functional similarities between murine and 
human NoV. MNV-1 is therefore considered to be a suitable surrogate for the analysis of 
pathogenesis, infectivity and viability of human NoV (GI and GII), and MNV-1 is therefore 
used as a surrogate for human NoV in these studies.
A qRT-PCR assay targeting the ORFl/2 junction has been published (Baert et al, 2008a). 
This primer and probe set was used in this study, however for comparative purposes the one- 
step qRT-PCR parameters from the assay used for the detection of human NoV at this 
laboratory were adopted. The MNV-1 qRT-PCR assay was then validated to determine if the 
assay performance was equivalent to the performance of the human NoV qRT-PCR assay at 
this laboratory, to enable direct comparisons between qRT-PCR results between the two 
assays. Thus, a tractable platform to use MNV-1 as a surrogate for human NoV was 
established and was subsequently the direct focus of the following work.
3.2 Aims
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The characterisation of a qRT-PCR assay for MNV-1, to determine if the assay was 
equivalent to the human NoV assay at this laboratory..
The optimisation of plaque assay quantitation of MNV-1.
The development of methods to quantify MNV-1 from artificially contaminated 
environmental samples by plaque assay.
-48
3.3 Materials and Methods
3.3.1 MNV-1 lysate production
Multiple working stocks of MNV-1 were prepared using macrophage cell line RAW 264.7 
(ECACC, Health Protection Agency, Porton Down, UK). Cells were maintained in 
Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% foetal calf serum 
(PCS), 1% Penicillin/Streptomycin (Pen/Strep) 1% N-2-hydroxyethylpiperazine-N'-2- 
ethanesulfonic acid (HEPES), and 1% L-glutamine (all constituents supplied by Sigma- 
Aldrich) as described by Wobus et al, 2004. One ml of MNV-1 virus stock (supplied by Prof. 
Skip Virgin, University of Washington, St Louis, MO, USA) was applied to a semi-confluent 
(70-80% confluence) monolayer of cells and incubated at 37°C with 5% CO2 for 24-48 hours. 
Infected cells were scraped manually, and subjected to 3 freeze-thaw cycles at -80°C. The 
lysate was then centrifuged at 3000 x g  for 10 minutes and the supernatant retained and stored 
at -80°C.
3.3.2 qRT-PCR for the detection of MNV-1
MNV-1 nucleic acid was extracted as described in Section 2.1. MNV-1 detection in BMS 
followed the procedure described in Section 2.11. The MNV-1 primers and probe used in this 
assay are given in Table 3.1. The MNV-1 dsDNA control plasmid (containing the MNV-1 
PCR target) was constructed by amplifying the ORFl/2 fragment by conventional PCR using 
the qRT-PCR primers. The PCR products were gel purified as described in Section 2.5, and
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were ligated and transformed into the p-GEM T-Easy vector as in Sections 2.6 and 2.7. qRT- 
PCR analysis was carried out as described in Section 2.9. Aliquots of the control plasmid 
(range -1 x 10"^  to -1 x 10® copies/pl) were included on each qRT-PCR plate for positive 
control and quantitation purposes.
Table 3.1: Primer and probe sequences for the detection of the MNV-1 ORFl/2 junction
Primer/probe name Primer orientation 
and location
Sequence Modifications
MNV-1 1/2 For 
MNV-1 1/2 Rev 
MNV-1 1/2 Probe
F n t4972-4991. 
R nt 5064-5080  
N /A nt 5001 -5015
CAC GCC ACC GAT CTG TTC TG
GCG CTG CGC CAT CAC TC
CCG GCG AGG ACC AGC TGA ACC T 5’ F AM, 3 ’ TAMRA
3.3.2.1 Performance characterisation of MNVl qRT-PCR assay.
The qRT-PCR assay for the detection of MNV-1 was characterised in terms of repeatability 
and linearity. Limit of detection (LCD) and limit of quantitation (LOQ) were also 
determined. For the purposes of this study definitions of linearity and LCD were based upon 
and adapted from EN ISO 16140:2003 Protocols for validation of alternative methods 
(Anon., 2003). In this study, these are defined as:
Linearity - the ability of the method to give results that are in proportion to the amount of 
target present in that sample, i.e. an increase in target corresponds to a linear increase in 
signal.
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Limit of detection (LOD) -  a level that constitutes the smallest amount of target that can be 
detected but not quantified as an exact value at the 95% confidence level.
Limit of quantitation (LOQ) - the smallest amount of target (in this instance, the lowest 
number of virus template copies) that can be measured with defined precision and accuracy 
under experimental conditions by the method under validation. In this study, LOQ was 
calculated as the level at which 95% of quantities calculated from duplicate or triplicate 
combinations of measurements fell within ±0.5 logio of the expected value (the expected 
value was derived from spectrophotometric determination of dsDNA).
Repeatability- closeness of agreement between independent results obtained by the same 
method on identical test material, under the same conditions.
3.3.2.2. Statistical analysis
Statistical analyses were undertaken using Stata 9 ™, S-Plus 6.1 and Minitab Version 14 for 
Windows.
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3.3.2.3. MNV-1 assay linearity
The linearity of the qRT-PCR assay was determined on positive control material (dsDNA 
controls) containing the target sequence (Section 3.3.2). Briefly, the absorbance of the 
plasmid DNA was measured spectrophotometrically at a wavelength of 260 nm. DNA purity 
was ascertained by measurement of spectral absorption at 280 nm (highly pure DNA should 
have an A260/280 ratio of around 1.8). The A260 value was multiplied by 5 x 10'  ^to give the 
concentration of DNA in g/pl. This value was then divided by the mass of a single plasmid 
molecule (-3.15 x 10'^  ^g for a plasmid of 3124 bp) to give the concentration in template 
copies/pl. Purified plasmid was diluted by a factor of 1 x 10  ^ in molecular grade water. This 
was considered as the neat working dsDNA stock thereafter. The qRT-PCR analysis was 
carried out on a serial logio dilution of dsDNA control material from neat to 10'^ ® under the 
same conditions on two occasions. Data were considered as independent and normally 
distributed.
Cycle threshold (CJ values (the number of cycles required for the fluorescence to cross the 
threshold for any given reaction) were transformed to copy numbers/pl using a separately 
constructed standard curve for each qRT-PCR run produced using dsDNA control material 
from neat to lO'"^  (as described in Section 3.3.2). Briefly, the standard curve was plotted 
providing an value, intercept and gradient. The number of RNA copies in each reaction was 
then estimated by comparing the sample Ct value to the standard curve. Copies/pl values 
were then transformed to logio copies/pl, and these were plotted against multiple analyses (2 
X 8 replicates) of each logic dilution series.
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3.3.3 Plaque assay development
3.3.3.1 Initial method
Initially the MNV-1 plaque assay followed the method described by Wobus et a l, (2004). 
Briefly, semi-confluent RAW 264.7 cells from a 175cm^ flask were used to seed 6 well tissue 
culture plates. Maintenance medium (DMEM-10) was removed and 10 ml of DMEM-5 
(DMEM supplemented with 5% heat-inactivated PCS, 1% Pen/Strep, 1% HEPES, and 1% L- 
glutamine) was added to the cells. Cells were manually re-suspended by scraping and 
pipetting. Aliquots of 10 pi of cell suspension in DMEM-5 were counted using a 
haemocytomometer. Cell density was adjusted by the addition of further DMEM-5 to 
produce a final density of 1 x 10  ^per ml. Two ml cell volumes were added to sterile 6 well 
plates giving an estimated starting density of 2 x 10  ^per well. Cells were rocked immediately 
by hand and allowed to attach for 24 hours at 37°C with 5% CO2, prior to spiking with MNV- 
1.
Serial logio virus dilutions were prepared in DMEM-5 using MNV-1 lysates (prepared as in 
Section 2.10.2). The medium was aspirated from each well and replaced with 0.5 ml of 
diluted virus (two wells for each dilution) or DMEM-5 (negative control). The plates were 
rocked for 1 hour at room temperature (-23°C). After rocking, the virus supernatants were 
aspirated and the wells were overlaid with 2 ml of a 1:1 mixture of 3% SeaPlaque® Agarose 
(Lonza) and 2x Minimum Essential Medium (MEM; Gibco), supplemented with 10% PCS, 
2% L-Glutamine, 2% Pen/Strep and 1% HEPES; this mixture was maintained at 37°C to 
prevent premature solidification. The plates were incubated at 37°C with 5% CO2 for 48
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hours before being overlaid with 2 ml of a 1:1 mixture of 3 % SeaKem HGT agarose (Lonza; 
maintained at 56°C to prevent premature solidification) and 2x MEM (Sigma), with 
0.00013% neutral red (MP Biomedicals). Plates were incubated for 2 hours 37°C and 5% 
CO2.
3.3.4 Optimisation of the plaque assay
A number of changes were made to optimise the initial method. Improvements and 
standardisation focused on the staining stage (second overlay), however other experimental 
work was also carried out to optimise the procedure. Multiple trials were undertaken to 
examine the effects of these modifications.
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3.3.4.1 Cell density determination
In the initial method, cells were counted and 6 well plates were seeded with 2x10® cells per 
well. The effect of changing the concentration of the seeding inoculum was examined 
following the recommendations of Dr M. Carter, University of Surrey (Personal 
Communication). Media were removed from growing cells (in 175cm^ flasks) that had 
reached 80 -  90% confluence and differing volumes (20 ml and 30 ml) of DMEM-5 were 
added. Cells were removed by scraping, resuspended by pipetting and 2 ml were added to 
each well of a 6-well plate before incubation at 37°C with 5% CO2. Media were removed by 
aspiration before inoculating with dilutions of MNV-1 lysates in DMEM-5.
3.3.4.2 Incubation and rocking of inoculated plates
The effects of pre-incubation at 37°C with 5% CO2 on initial cell attachment were examined. 
In the initial method (post inoculation), plates were rocked at room temperature, this was 
modified to include rocking at 37°C with 5% CO2. In brief, duplicate 6-well plates were 
seeded with RAW 264.7 cells, the media removed then the cells inoculated with serial logio 
dilutions of MNV-1 lysates. Plates were rocked with incubation at 37°C with 5% CO2 for 2 
hours. The effects of the rocking conditions were compared by subsequently performing the 
stages of the original plaque assay method.
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3.3.4.3 Second overlay, staining procedures and incubation after second overlay
In the initial method, plates were incubated at 37°C with 5% CO2 for 48 hours before being 
overlaid with 2 ml of a 1:1 mixture of 3 % SeaKem HGT agarose (maintained at 56°C to 
prevent premature solidification) and 2x MEM, with 0.00013% neutral red. Plates were 
incubated for 2 hours 37°C and 5% CO2 to stain cells and visualise plaques for quantitation. 
As a result of an observed nucléation reaction during the neutral red staining stage, 
modifications were made. The second overlay step was omitted and wells were overlaid 
directly with a 0.00013% solution of neutral red in Dulbecco’s PBS. Plates were incubated 
for 2 hours at 37°C with 5% CO2, the neutral red stain was removed by aspiration, and the 
plates were further incubated at 37°C with 5% CO2 for 2 hours. After this incubation period 
plaques were visualised on a light box and counted.
3.3.5 Final method
Semi-confluent RAW 264.7 cells from a 175 cm flask were used to seed 6 well tissue culture 
plates. Maintenance medium (DMEM-10) was removed and 30 ml of DMEM-5 was added to 
the cells. Cells were manually re-suspended by scraping and pipetting and 2 ml of the cell 
suspension were added to each well of the plate. Seeded six well plates were rocked gently by 
hand before incubation overnight at 37°C with 5% CO2. A serial logio dilution series of 
MNV-1 (range: 1 x 10'  ^ to 1 x 10'^) was prepared in DMEM-5. The medium was aspirated 
from each well and replaced with 0.5 ml of diluted virus (two wells for each dilution). The 
plates were rocked for 2 hours at 37°C in a 5% CO2 atmosphere. After rocking, the virus
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supernatants were aspirated and the wells were overlaid with 2 ml of a 1:1 mixture of 3% 
SeaPlaque® Agarose (Lonza) and 2x MEM, supplemented with 10% PCS, 2% L-Glutamine, 
2% Pen/Strep and 1% HEPBS; this mixture was maintained at 37°C to prevent premature 
solidification. The plates were pre-incubated for 10 minutes at room temperature to allow 
solidification of the agarose mixture then transferred to 37°C with 5% CO2 for 48 hours 
before being overlaid with 2 ml of 0.00013 % neutral red in Dulbecco’s PBS (Sigma) 
equilibrated to 37°C. Plates were incubated for 2 hours at 37°C and 5% CO2. The neutral red 
solution was removed by aspiration and the plates incubated for a further 2 hours at 37°C and 
5% CO2. Plaques were counted after this incubation period using a light box to aid 
visualization.
3.3.6 Plaque assay quantitation of MNV-1 in environmental samples
MNV-1 lysates used in this series of studies were quantified using the final plaque assay 
method and qRT-PCR. The pfu/ml and genome copies/ml of multiple MNV-1 lysates used 
for spiking and bioaccumulation experiments are shown in Table 11 in Section 3.4.3.
3.3.6.1 Plaque assay for the detection of MNV-1 in seawater
Ninety-nine ml of filtered seawater (Salinity 35 ppt; Turbidity 0.09 NTU) or molecular grade 
water (control) were spiked with 1 ml of MNV-1 lysate [lysate 5: containing -2.32 x 10  ^pfu 
(qRT-PCR equivalent 2.81 x 10  ^copies)] and mixed. One ml of spiked sample was removed 
and diluted 1:1 in DMEM-5. Further serial logio dilutions in DMEM-5 were made to 10' .^ 
Dilutions were applied in duplicate to RAW 264.7 cells in 6-well plates. Plaque assay
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quantitation of MNV-1 in seawater was carried out following the final plaque assay method. 
A serial logio dilution of MNV-1 [lysate 5: containing -2.32 xlO^ pfu (qRT-PCR equivalent 
2.81 X 10  ^copies)] in DMEM-5 was included on a separate 6-well plate as a positive control.
3.3.6.2 Bioaccumulation of MNV-1 by Pacific oysters for use as positive material for 
plaque assay
Thirty L of filtered seawater (Salinity 35 ppt; Turbidity 0.09 NTU) were added to an aerated 
48 L tank and equilibrated to 18°C. Thirty Pacific oysters were then added to the tank (Figure 
3.1) and left to acclimatise for 96 hours in order to allow resumption of filter-feeding activity. 
After this period, 2 ml of MNV-1 lysate (lysate 4) containing 2.78 x 10  ^ pfu (1.26 x 10^ ® 
copies) were added to the tank. Oysters were allowed to bioaccumulate for 16 hours, and 
after this period all 30 oysters were removed. Oysters were opened aseptically, their digestive 
glands excised and finely chopped as described previously (Section 2.11). Two g of chopped 
glands were tested for MNV-1 RNA by qRT-PCR as described previously (Section 2.9). The 
remaining glands were stored at -80°C until plaque assay quantitation.
3.3.6.3 Method 1
Fifteen g of chopped, MNV-1 negative (by qRT-PCR) digestive glands from Pacific oysters 
were spiked with 0.5 ml of MNV-1 (lysate 3; containing 4.85 x 10  ^pfu, 7.58 x 10  ^copies). 
Spiked and bioaccumulated glands were diluted 1:1 (w/v) with glycine buffer (0.05 M, pH 
9.0). The samples were then vortex mixed and freeze-thawed, before being centrifuged at
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8000 X g  for 15 minutes at 4°C. One hundred times antibiotic-antimycotic solution 
[containing 10000 units/ml penicillin G sodium, 10000 qg/ml streptomycin sulphate and 25 
pg/ml amphotericin B in 0.85% saline; Gibco, Invitrogen (added to 1:40 v/v)] was added per 
ml of supernatant and samples were stored at 4°C overnight. A second equal volume of lOOx 
antibiotic-antimycotic solution was added and the sample was incubated at 37°C for 2 hours. 
The sample was diluted 1:1 in DMEM-5 and further logio dilutions to 10'  ^were made. RAW
264.7 cells were inoculated with 0.5 ml of each of the sample dilutions in duplicate. A serial 
logic dilution of MNV-1 lysate 1 was included on a separate 6-well plate as a positive 
control.
\
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Figure 3.1: Preparation of MNV-1 positive BMS by bioaccumulation of MNV-1 by Pacific 
oysters in laboratory conditions. Thirty Pacific oysters were bioaccumulated with MNV-1.
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3.3.6.4 Method 2
Six g of chopped, MNV-1 negative digestive glands were spiked with 0.5 ml of MNV-1 
(lysate 3). Spiked and bioaccumulated digestive glands were diluted 1:10 (w/v) in 10% 
tryptose phosphate broth (Sigma-Aldrich)-0.05 M glycine buffer (pH 9.5) and homogenized 
in a blender (4 bursts of 15 seconds blending). The homogenate was shaken at 100 rpm for 5 
minutes at room temperature, sonicated with a 10 mm probe (Soniprep 150, Measuring and 
Scientific Equipment, UK) for 2 min at level 8 and centrifuged at 3000 x g  for 30 minutes at 
4°C. Supernatants were adjusted to pH 1.2-1 A. Polyethylene glycol 6000 (PEG 6000) was 
added to the supernatants at a final concentration of 8% (w/v) and the mixture was stirred for 
2 hours at 4°C. The mixture was centrifuged at 3000 x g for 1 hour at 4°C, the supernatant 
removed and discarded, and the pellet resuspended in 15 ml of 0.15 M di-sodium hydrogen 
orthophosphate. The resuspended pellet was sonicated for 30 seconds at level 8, agitated at 
room temperature for 20 minutes using a rotating shaker at 100 rpm, further sonicated for 30 
seconds, and centrifuged at 10000 x g for 30 minutes at 4°C. The supernatant was adjusted to 
pH 7.4, treated with lOOx antibiotic-antimycotic solution (added to 1:40 v/v) and incubated 
for 45 minutes at 37°C. The supernatant was stored at -80°C.
Prior to plaque assay, poly-diallyldimethylammonium chloride solution (low molecular 
weight) was added to the supernatant at a final concentration of 0.1%. The mixture was 
shaken at 80 rpm for 20 minutes at room temperature and centrifuged at 3000 x g for 20 
minutes. The supernatant was diluted 1:1 in DMEM-5 and further logio dilutions to 10'^ were 
made. RAW 264.7 cells were inoculated with 0.5 ml of each of the sample dilutions in 
duplicate. A serial logic dilution of MNV-1 lysate 1 was included on a separate 6-well plate 
as a positive control.
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3.3.6.S Method 3
Chopped MNV-1 negative (by qRT-PCR) digestive glands were spiked with 0.5 ml of MNV- 
1 lysate 3. An equal volume (v/w) of 0.05 M glycine buffer (pH 9.0) was added to 6 g of 
spiked or bioaccumulated chopped digestive glands and homogenized in a blender 
intermittently for a total of 3 minutes. The homogenate was placed in an ice bath for 5 
minutes before centrifugation at 12000 x g  for 15 minutes at 4°C. The supernatant was 
collected and neutralized to pH 7.2. One hundred times antibiotic-antimycotic solution 
(added toi :40 v/v) was added to the supernatant and incubated at 4°C for 1 hour. The solution 
was diluted 1:1 in DMEM-5 and further logio dilutions to 10'  ^were made. Duplicates at each 
dilution point were applied to RAW 264.7 cells in 6 well plates for MNV-1 quantitation by 
plaque assay. A serial logio dilution of MNV-1 lysate 1 was included on a separate 6-well 
plate as a positive control.
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3.4 Results
3.4.1 Performance analysis for the detection of MNV-1 using qRT-PCR
3.4.1.1 Linearity
The linearity of the qRT-PCR was assessed through analysis of serial logio dilutions of 
dsDNA material tested under repeatability conditions on two occasions. The results indicated 
both a linear response to dilution 1 x 10’"^ (Figure 3.2) and suggested a low level of variability 
between replicates and within replicates {p > 0.05). Regression analysis was carried out for 
MNV-1 logio copies/pl against dilution series. This analysis approximately fitted a linear 
regression model up to dilution 5. The standard deviations increased at 1 x 10'  ^ and at this 
dilution, 10 from 16 replicates were not detected. Consequently the model appears to be a 
linear fit from dilutions neat to 1 x 10'  ^and a constant (non linear) for dilutions 1 x 10  ^-  1 x 
10*^ . The linear fit for dilutions neat to 1 x 10'"^  had a slightly better value (0.9825) than the 
linear fit for dilutions neat to 1 x 10'  ^(0.9727) (Figure 3.2). Linearity was further tested by 
fitting the quadratic term (broken stick), this gave a significant coefficient and further, albeit 
small reduction in mean squared error (Figure 3.3). The broken stick model indicated 
linearity from dilutions neat to 1 x 10' .^
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Figure 3.2: Logio copies/jil values for multiple dilution series of dsDNA containing the 
MNV-1 qRT-PCR target. Individual replicates are plotted. Equations for regression lines 
calculated using data from dilutions neat -  10"^  and neat to 10’^  respectively are shown to 
indicate differences in linearity to these points.
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Figure 3.3: Broken stick model indicating linearity at dilutions N to 1 x 10'  ^ of dsDNA 
containing the MNV-1 qRT-PCR target. Replicates from two separate experiments are 
plotted. Linear, quadratic and broken stick lines are fitted to the data to show where the data 
is no longer linear (1 x 10 )^.
3.4.1.2 Limit of detection
To determine limits of detection for assays using single, duplicate and triplicate reactions, a 
logistic fit graph was plotted (Figure 3.4). From this, the dilutions at which there is 95% 
confidence for detection of RNA in a single reaction, in duplicate reactions (equivalent to 
77.6% confidence of detection in a single reaction) and in triplicate reactions (equivalent to 
63.2% confidence of detection in a single reaction) were determined. Initially all data points 
were included in the logistic fit (green broken line). However, a second fit was undertaken
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omitting positive data points at dilutions -10' ,10" and 10' (purple line). These points were 
omitted because they were considered improbable based on spectrophotometric data and the 
theoretical LOD of the assay (detection of a single target copy) and were therefore suggestive 
of a cross-contamination during preparation of the dilution series. Their exclusion did not 
substantially change the observed LODs of the assay.
Based upon these assumptions the calculated LODs for the assay were:
- single reactions -  Dilution 4.1 = 2.72 copies/pl or 13.62 copies/reaction.
- duplicate reactions- Dilution 4.7 = 0.68 copies/pl or 3.42 copies/reaction.
- triplicate reactions -  Dilution 5.0 = 0.3 copies/pl or 1.7 copies/reaction.
3.4.1.3 Limit of quantitation
The limit of quantitation was based on analysis of all possible theoretical duplicate and 
triplicate result combinations from the logio dilution series. The maximum and minimum 
values (based on 95^  ^ percentile) for both assay formats for dilutions neat to 10'  ^
(corresponding to 34300 -  0.343 copies/pl) are given in Tables 3.2 and 3.3, and plotted in 
Figures 3.5 and 3.6.
The precision determinants for the assay were set as ±0.5 logic i.e. any value derived falling 
outside 0.5 logic of the expected values were considered outside of the quantitifiable range. 
For triplicate and duplicate assay formats expected values (as determined 
spectrophotometrically) were plotted against the 95% confidence intervals of the obtained
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values determined as the mean of all potential combination measurements +/- 2x SD (Figures
3.5 and 3.6). The lines of equivalence and upper and lower 0.5 logio were also plotted. At 
dilution point 10'  ^ the lower 95% confidence interval fell more than 0.5 logic below the 
expected value.
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Figure 3.4: Logistic fit graph for determining LOD for singlet, duplicate and triplicate qRT- 
PCR reactions for the detection of dsDNA containing the MNV-1 qRT-PCR target. Green 
dashed line shows fit where data points from dilutions 10'^, 10'  ^and 10'  ^(false positives) are 
included. Purple line shows fit with these points omitted.
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Table 3.2: Maximum and minimum values (logio copies/ml) for duplicate results 
combinations
Dilution Min Max N (Icop)
0 4.28 4.69 16
1 3.27 3.71 16
2 2.26 2.88 16
3 1.20 1.73 16
4 0.16 0.78 16
5 - 0.01 10
Table 3.3: Maximum and minimum values (logic copies/ml) for triplicate results 
combinations
Dilution Min Max N (Icop)
G 4.35 4.66 16
1 3.35 3.68 16
2 2.38 2.84 16
3 1.30 1.69 16
4 0.28 0.74 16
5 - -0.05 10
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Figure 3.5: LOQ determination for duplicate measurement combinations. The central 
diagonal is the line of equivalence; the parallel diagonals indicate equivalence±0.5 logs.
Minimum and maximum log^  ^copies/ml (based on the 95"^  percentile) are plotted.th
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Figure 3.6: LOQ determination for triplicate measurement combinations. The central 
diagonal is the line of equivalence; the parallel diagonals indicate equivalence±0.5 logs. 
Minimum and maximum log^  ^copies/ml (based on the 95^  ^percentile) are plotted.
The visual observations of the dataset plotted as box and whisker plots (Figures 3.7 and 3.8) 
showed that variability increased at dilution point 10'  ^ This was further tested using Bartlett 
and Levine tests for variance. Both indicated that dilutions 0 - 10"'^  showed similar variance 
(Bartlett signifieance = 0.148 and Levene significance. = 0.37;p  > 0.005), whereas at dilution 
point 10'  ^ the variance was different (Bartlett significance < 0.0005 and Levene significance 
< 0.005). This confirmed the observation of significant difference in variance at dilution point 
10'^
The practical LOQ was therefore set pragmatically as dilution points 10’"^ for both triplicate 
and duplicate measurements calculated from the logio transformed means of the observed 
values using the slope (at dilution 10' ,^ the minimum 95% confidence interval was outside of
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the 0.5 logio difference from the line of equivalence). Based upon this the calculated LOQ for 
the assay was 3.9 copies/pl or 19.5 copies per reaction.
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Figure 3.7: Box and whisker plots for duplicate measurements from neat to 10' .^
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Figure 3.8: Box and whisker plots for triplicate measurements from neat to 10-5
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3.4.1.4 Repeatability estimations
The method precision determined under repeatability conditions was assessed by analysis of 
the data obtained from individual sets of dilution series for each experimental run (between 
dilution series neat to up to 10'^) and on the entire dataset. Independent test results were 
obtained using the same method using identical equipment repeated in rapid temporal 
succession. Visual examination of the datasets did not indicate outlying data points however 
initially Grubb’s test for outliers was applied to data obtained (Run 1 Z = 3.08, Run 2 Z = 
3.08, Runs 1 and 2 Z = 3.38). No outliers were identified and therefore the entire dataset was 
included in further analyses. The one way (unstacked) analysis of variance indicated no 
significant differences within or between runs at any dilution point up to lO'"^  or across the 
entire dataset {p > 0.05).
At dilution point 10' ,^ was equal to 0.035 which is suggestive of significant differences at 
this level. The results are given in Table 3.4.
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Table 3.4: Repeatability estimations based on one way ANOVA at each dilution point and 
across the entire dataset.
Dilution F  statistic P  value
N 2.11 0.168
-1 0.66 0.431
-2 0.38 0.549
-3 1.55 0.234
-4 2.57 0.131
-5 6.41 0.035
Combined 0.06 0.807
3.4.2 Plaque assay development
The initial plaque assay method used produced unsatisfactory results (Figure 3.9). Under the 
light microscope cells were widely spread across the surface of the plate and plaques were 
not observed.
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Figure 3.9: Photograph of an unsuccessful plaque assay using the initial method showing 
poor cell attaehment, poor staining of the eell monolayer and no visible plaques.
Adjusting the initial cell density and altering the rocking and incubation conditions resulted 
in an improvement in the confluence of the eells and virus attachment however the second 
overlay stage appeared to cause nueleation of the neutral red stain. This was finally resolved 
by omitting the seeond agarose overlay stage and substituting it for neutral red in PBS. The 
combined effects of experiments resulted in the ability to visualise plaques and quantify 
MNV-1 pfu in lysates (Figure 3.10).
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'45’-^  I
Figure 3.10: Photograph of a successful plaque assay using the final method. Cells are well 
stained and plaques (examples highlighted by arrows) can be easily observed and counted.
3.4.3 qRT-PCR and plaque assay detection of MNV-1 in virus lysates
Multiple MNV-1 lysates were produced as described in Section 3.3.1, and MNV-1 was 
quantified in lysates by qRT-PCR and plaque assay. Table 3.5 gives the determined copies/ml 
and pfu/ml by qRT-PCR and plaque assay respectively. In all MNV-1 lysates, copies of 
MNV-1 genome (as determined by qRT-PCR) were orders of magnitude higher (Range 2.06 
-  5.08 logio units) than the titre of MNV-1 determined by plaque assay quantitaion.
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Table 3.5: qRT-PCR and plaque assay determinations for lysates used throughout this study
MNV-1 lysate 
designation
Genome titre (qRT-PCR: 
copies/ml)
Virus titre (plaque assay: 
pfu/ml)
L ogic  difference between 
genome titre and virus titre
I 6.35x10^ 2.32 xlO'* 4.44
2 1.54x10* 1.34x10^ 2.06
3 1.52x10* 9.70x10* 4.20
4 6.29 X 10^ 1.39 X 10* 4.66
5 2.81 X 10^ 2.32 X 10^ 5.08
3.4.4 Plaque assay quantitation of MNV-1 in spiked filtered seawater
To reduce the effect of the salinity of seawater on the cell monolayer, seawater containing 
MNV-1 was diluted 1:1 in DMEM-5 before subsequent serial logio dilutions in DMEM-5. 
When the cell monolayer was inoculated with a 1:1 dilution of MNV-1 positive seawater and 
DMEM-5 (Figure 3.11) non-uniform plaques and plaque assay counts that were higher than 
the original spike were observed. Because of this, pfu quantitation was undertaken from the 1 
X 10'^  dilution of the initial 1:1 dilution (total 1:20 dilution). Results for MNV-1 plaque assay 
quantitation from seawater were then compared to plaque assay detection of MNV-1 from 
molecular grade water; no inhibition was observed (students t test on pfu/ml counts from 
molecular grade water and seawater; p  = 0.19). Table 3.6 gives the plaque assay results from 
spiked seawater (result taken from dilution 10' ;^ Figure 3.12) and molecular grade water.
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Table 3.6: Plaque assay quantitation of MNV-1 from spiked seawater samples. Expeeted 
pfu/ml based on 1:100 dilution of measured inocula = 1.52x 10 .^ Duplicate results for 
molecular grade water and filtered seawater shown.
Positive control Molecular Grade Water Filtered seawater
[(pfu/ml) lysate 5]^ (pfu/ml of water) (pfu/ml of seawater)
1.13 X 10- 1.45 X 10  ^pfu/ml 1.60 X 10^ pfu/ml
1.72 X 10^ pfli/ml 1.80 X 10^ pfu/ml
Figure 3.11: Example of a plaque assay of MNV-1 spiked seawater. Large, non-uniform 
plaques are observed.
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3.4.5 Plaque assay detection of MNV-1 from BMS digestive glands
3.4.5.1 Plaque assay detection of MNV-1 from spiked and bioaccumulated digestive 
glands
Spiked and bioaccumulated digestive glands were processed in 3 different ways as described 
in Sections 3.3.5.S, 3.3.5.4 and 3.3.5.5. From spiked glands, MNV-1 from each experimental 
procedure was detected by plaque assay at differing pfu/ml dependent upon the method 
(Table 3.7). As a result of the successful detection of MNV-1 from spiked oyster glands, each 
method was applied to glands from bioaccumulated Pacific oysters. However, MNV-1 was 
not detected by plaque assay from bioaccumulated glands, although these bioaccumulated 
glands were confirmed positive for MNV-1 RNA by qRT-PCR both before and each method. 
Bioaccumlated glands contained -1.43 x 10  ^copies/g of MNV-1.
Table 3.7: MNV-1 pfu/ml in homogenates of spiked BMS after preparation for plaque assay
from BMS
Sample name MNV-1 pfu/ml of homogenate
Method 1 homogenate 1.45 X 10^
Method 2 homogenate 1.30 X 10^
Method 3 homogenate 9.30 X 10^
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3.5 Discussion
3.5.1 Performance characterisation of qRT-PCR for the detection of MNV-1
It is important to characterise the performance of laboratory assays in order to understand 
their capabilities and limitations and to ensure that they are ‘fit for purpose’ (Armbruster 
and Pry, 2008). If MNV-1 is to be used as a surrogate for human NoV study, it is critical 
that the performance attributes of the qRT-PCR assay used for its detection are fully 
understood. An existing primer/probe set for the detection of MNV-1 (Baert et al. 2008a) 
was used as the basis for the characterised method. This primer/probe set targets the 
ORFl/2 junction; this region of the genome is also used as a target for many qRT-PCR 
methods for the detection of human NoV GI and GIL Previously at this laboratory, a 
quantitative method for detection of human NoV in BMS (oysters and mussels) using a 
one-step qRT-PCR has been developed. This method is derived from the draft CEN 
TAG4 standard for the quantitative determination of norovirus and hepatitis A virus in 
foodstuffs (Appendix I; Lees and CEN.WG6.TAG4, 2010), is well standardised in-house, 
and incorporates a comprehensive suite of controls. It has recently been accredited to EN 
ISO 17025, an internationally recognised standard setting out the general requirements for 
the competence of testing and calibration laboratories (Anon., 2005). The qRT-PCR assay 
developed in this study was therefore based upon the accredited human NoV format and 
incorporated many of its key features, to ensure that during future experimental work, 
data could be extrapolated fi-om the surrogate model with confidence that the performance 
of the 2 assays were equivalent. Many of the controls recommended by the CEN WG6 
TAG4 standard were introduced in part, including positive control material, negative
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extraction controls and negative qRT-PCR controls. Double stranded DNA control 
plasmids containing the qRT-PCR target were produced and utilised as both positive 
control material and for quantitation through the inclusion of standard curves comprising 
serial logio dilutions of control plasmids in each run.
Although a full validation undertaken as a multi-laboratory collaborative trial to establish 
method reproducibility was not possible within the scope of this work, the results presented 
in Section 3.4.1 demonstrate the utility of the optimised qRT-PCR assay for MNV-1. The 
assay demonstrated a linear response over the dynamic range of 3.43 x 10"* copies/pl to 3.43 x 
10'  ^ copies/pl and provided consistent results in replicate analyses, indicating that the method 
was repeatable and showed good precision. The measured LODs were calculated as 3.42 
copies per reaction for duplicate qRT-PCR reactions and 1.7 copies per reaction for triplicate 
reactions (equivalent to ~68 copies/g in digestive glands). This is comparable to the observed 
LOD for the human NoV qRT-PCR assay at this laboratory of -  1.0 copy/reaction (-40 
copies/g of digestive gland; Dr James Lowther, Personal Communication). Baert et al., 
(2008a) reported consistent detection of a minimum of 10 copies of MNV-1 per reaction, 
while the detection of 1 genomic copy occurred on only 33% of occasions in an experimental 
regime comprising 10 independent runs. The LOD observed in this study suggests that the 
one-step qRT-PCR assay developed in this study was sufficiently optimised. Relatively few 
data exist in the published literature with respect to method performance analysis of RT-PCR 
assays. The lack of standardisation or transparency in materials and methods sections of 
published studies has been identified as a significant problem in evaluating the quality of 
reported quantitative PCR data (Bustin et a l, 2009). However available information indicated 
that the MNV-1 assay presented here is comparable in terms of performance to detection 
methods for other viruses using similar approaches. Welzel et al., (2006) reported an LOD of 
11 copies per reaction of Hepatitis B virus from sera. Similar LODs for other viruses have
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been reported i.e. 50 copies/ml of HIV from plasma (Lewin et al, 1999); 10 DNA 
copies/reaction of Hepatitis B virus (Abe et al, 1999) and 10 RNA copies/reaction of 
Influenza A and B (Ward et al, 2004). The LOQs for both duplicate and triplicate qRT-PCR 
reactions were determined at 3.9 copies/pl or 19.5 copies per reaction respectively. This 
equates to an LOQ of approximately 780 genome copies/g for triplicate analysis of digestive 
tissue and is broadly equivalent to the inferred LOQ for HAV reported for shellfish samples 
of >1 X 10^  genomes per g of digestive tissue (Costafreda et a / . ,  2006). Several authors have 
reported substantially lower limits of quantitation using similar methods for human NoV in 
environmentally contaminated oysters in Ireland (Doré et al, 2010) and France (LeGuyader 
et al, 2009). However the precision determinants for demonstration of LOQs are not fiilly 
presented in these studies.
In summary a qRT-PCR method was optimised based upon a standardised, accredited NoV 
assay and a published primer/probe set targeting the ORF 1/2 junction. The assay was robust 
and linear over the dynamic range neat to 10'^. The assay LOD was determined as 0.7 
copies/pl or 0.3 copies/pl for duplicate and triplicate measurements respectively with a 
practical LOQ of 3.9 copies/pl. This was considered broadly equivalent to the in-house NoV 
assay and demonstrated adequate performance for further experimental work using MNV-1 
as a surrogate for human NoV in the context of this work.
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3.5.2 Plaque assay development
3.5.2.1 qRT-PCR and plaque assay detection of MNV-1 in virus lysates
In order to examine the relationship between the number of genomic copies and infectious 
units (pfu/ml), MNV-1 lysates were produeed as described in Section 3.3.1 and were 
quantified by both qRT-PCR and plaque assay. One lysate preparation (lysate 2) gave 
genome copy numbers 2.2 orders of magnitude higher than the virus titre as determined by 
plaque assay. However, in 4 out 5 occasions MNV-1 lysate preparation genome copy 
numbers (as determined by qRT-PCR) were between 4 and 5 orders of magnitude higher than 
the virus titre by plaque assay quantitation (average logio difference: 4.09). Baert et al., 
(2008a) demonstrated the presence of approximately 100 times more genomic copies than pfu 
in serial logic dilutions of virus lysates.
A number of authors have reported limited correlation between qRT-PCR data and 
quantitative virus culture (Perelygina et al., 2003, Perkins et al., 2004, Vliegen g/ a l, 2003). 
The correlation between infectivity and the detection of enteroviral genomes has been studied 
previously utilising environmental samples (Choi and Jiang, 2005; Enriquez et al, 1993; 
Gasilloud et al, 2003). A lack of correlation between molecular and tissue culture techniques 
has been demonstrated for HAV (Hewitt and Greening, 2006), FCV and poliovirus 
(Gassilloud et al, 2003), and adenoviruses (Choi and Jiang, 2005). Gassilloud et al, (2003) 
demonstrated differences in degradation kinetics between infectious viruses and viral 
genomes in water. In the current work (Chapters 4 and 5) and in other studies (Baert et al, 
2008a) it has been indicated that the viral genome, or fragments of the viral genome, may
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withstand environmental pressures or heat treatment and remain detectable by qRT-PCR even 
though infectivity is lost. Gassilloud et al, (2003) further suggested that the inactivation of 
the infectious viral particles of surrogates for human NoV (FCV and poliovirus 1) is more 
rapid than the viral genomes. Conversely, Slomka and Appleton, (1998) have argued that the 
detection of fragments of genome indicates the presence of infectious particles because of the 
unstable nature of free or unprotected RNA, asserting that any nucleic acid detected must 
therefore originate from encapsidated and thus infectious particles. In this study significant 
differences in qRT-PCR titres and plaque assay titres from untreated virus lysates (i.e. those 
not exposed to environmental stressors) were observed. Thus the observed discrepancies 
between virus titres as measured using the two methods could in this case be attributed to 
reduction in infectivity during freeze-thawing, through incomplete replication during growth 
or inadequate storage. Several factors have been shown to be implicated in reduced 
sensitivity of cell culture, among these improper storage conditions resulting in damage to 
virus particles (Jerome et al, 2002). Whilst inappropriate storage of viral lysates was not 
thought to be a notable source of error in this study, in order to study the relationship between 
genome titre and pfu, future work should be aimed at determining the stability following 
differing storage times and conditions, to estimate if infectious virus degrades more quickly 
than detectable genomes.
Another potential factor affecting the comparative sensitivities of qRT-PCR assays and tissue 
culture detection may be an inherent greater sensitivity of PCR methods. Theoretically, both 
culture-based methods and PCR techniques are able to detect a single virion, however 
practically the number of viral DNA copies detected always exceeds the number of infectious 
viral particles in any given sample (Perelygina et al., 2003). A number of studies have 
confirmed this using both viral and bacterial detection systems (Rose et al, 1997, He and 
Jiang, 2005).
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In summary, in accordance with other studies on virus determination by PCR and tissue 
culture techniques the work presented demonstrates a lack of correlation between the two 
approaches. This is considered indicative of the presence of a mixture of infectious and non- 
infectious viral particles in MNV-1 lysates in this study. This is considered further in 
subsequent chapters of this thesis.
3.S.2.2 Quantitation of MNV-1 in water and BMS matrices
The discovery of MNV-1, a cultivable NoV, has enabled the direct study of the behaviour of 
this genus of viruses and obviates the problems associated with the use of non-related 
surrogates (Wobus et al, 2006). Thus the potential benefits of the use of MNV-1 as a proxy 
for human NoV are substantial. In this study qRT-PCR and tissue culture assays to quantify 
MNV-1 have been developed and evaluated to facilitate accurate determination of its 
behaviour in the environment and in BMS. Various pre-plaque assay preparations of samples 
for the quantitation of MNV-1 from seawater and from BMS tissues were undertaken to this 
end with varying degrees of success.Studies have shown the successful quantitation of 
cultivable viruses from environmental waters, including seawater, and BMS (Santos et al, 
2002^ using cell culture techniques. Successful cell culture quantitation of enteroviruses from 
activated sludge (Kopecka et al, 1993), adenoviruses from river water (Choi and Jiang, 
2005), and poliovirus-1 and FCV from mineral water (Gassilloud et al, 2003) have all been 
demonstrated. There are relatively fewer studies examining the use of MNV as a model for 
human NoV in environmental samples. Bae and Schwab (2008) carried out studies to 
evaluate the use of four surrogates for human NoV, including MNV, in surface and 
groundwater in the US, concluding that MNV showed great promise in terms of genetic
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similarity and environmental stability. In this study application of MNV-1 positive seawater 
to RAW 264.7 cells induced toxic effects (possible osmotic stress). Further serial logio 
dilutions enabled the cultivation and quantitation of MNV-1 in natural seawater, seeming to 
remove the toxic effect of the matrix such that the cell monolayer was only affected by the 
virus. No studies in the published literature evaluating direct effects of seawater on MNV 
could be identified. However Lee et al, (2008) showed that whilst inactivation of MNV was 
a function of salt concentration; with high salt concentration facilitating inactivation of the 
virus, prolonged survival at salinities equivalent to natural seawaters should be expected. The 
authors further suggested that studies to evaluate its use in the environment should be 
undertaken. The methods developed in this work enable direct quantitation of MNV-1 in 
seawaters for use in further studies.
Recently several reports have been published on the use of MNV to evaluate NoV 
inactivation in bivalve shellfish particularly by high pressure processing (Kingsley et a l, 
2007, Li et a l, 2009). In this study bivalve mollusc digestive tissues spiked with MNV-1 
lysates produced positive plaque assay results within the range 1.30 x 10  ^ to 1.45 x 10^  
pfu/ml. However, bioaccumulated Pacific oysters failed to yield plaques irrespective of the 
experimental protocol used and despite the replication of the methods of Li et a l (2009) 
(Section 3.3.5.5). When MNV-1 RNA was quantified in the bioaccumulated digestive glands 
using qRT-PCR positive results it was determined that the digestive glands contained -143 
copies/g. Bioaccumulation levels reported by Kingsley et a l (2007) and Li et a l (2009) were 
in excess of 1.12 x 10"^  pfu. These findings together with the observed >4 logio difference 
detection efficiency between qRT-PCR and plaque assay suggest that the levels of the virus 
in the bioaccumulated oysters were not sufficiently high to enable culture detection using the 
methods utilised in this work. This may have occurred because the Pacific oysters used 
simply failed to take up expected levels of virus. In addition, it is possible that the methods
- 84 -
reported here were inefficient at removing virus closely associated with oyster digestive 
diverticula. There is evidence that bioaccumulation of viruses in bivalve molluscs may be 
assisted by the ionic bonding of viral particles to the mucopolysaccharide moiety of shellfish 
mucus (DiGirolamo et al, 1977) and by the presence of human blood group antigen-like 
structures in oyster gastrointestinal tissues (Tian et al, 2006). These studies have indicated 
that human NoV binds preferentially to type A-like histoblood group antigens (HBGA) on 
oyster gastrointestinal cells (Le Guyader et al, 2006; Tian et al, 2006; Tian et al, 2007). 
Whilst there are few reports analysing the binding of MNV-1 to HBGAs (Taube et al, 2009), 
one study suggests similar bioaccumulation and retention rates by oysters for MNV-1 (using 
qRT-PCR), human NoV and HAV (Nappier et al, 2008), which may indicate similar binding 
properties for MNV-1 and human NoV. Furthermore, Kingsley et al, (2007) suggested that 
MNV-1 could be sequestered in a number of different anatomical structures within the oyster 
including the mucous membranes within the digestive gland contents. Thus it can be 
postulated that the oysters did not bioaccumulate MNV-1 to a level which could be detected 
by plaque assay, possibly as a result of an inherently low sensitivity of the method due to 
efficient sequestration of virus particles within the tissues. Adding increased amounts of 
MNV-1 to the bioaccumulation tanks did not lead to any apparent increase in levels (data not 
shown).
The problem with low levels of virus was compounded by the fact that it was difficult to 
determine CPE (if any) when applying MNV-1 positive glands to wells of a plaque assay 
plate. The methods attempted for MNV-1 quantitation had been used in or adapted from 
previously published methods for the detection of viruses from the BMS matrix (Croci et al, 
2003; Lewis and Metcalfe, 1988; Li et al 2009). Undiluted gland preparations, and gland 
preparations diluted 1:1 in DMEM-5 may have had a toxic effect on the RAW 264.7 cell 
monolayer, killing the cells and therefore making quantitation of MNV-1 impossible. It was
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therefore necessary to dilute the gland preparations further to avoid killing the cells. Baert et 
al, (2008b) reported similar requirements when quantifying MNV-1 fiom raspberries 
(extracts had to be diluted 100 times). Deboosere al, (2004) also noted that for the plaque 
assay detection of HAV in mashed strawberries, samples had to be diluted 100 times to 
enable accurate quantitation. The dilution of BMS extracts in this study resulted in 
consistently negative results however; the level of dilution necessary to reduce toxicity 
rendered virus numbers below the limit of sensitivity even when PEG 6000, a concentrating 
agent, was used. The use of Magnofloc [poly(diallyldimethylammoriium chloride). Sigma 
Aldrich], a flocculating agent, was evaluated according to the method described in Section 
3.3.5.4. Previous experimental work on cell culture quantitation of Poliovirus from spiked 
BMS at this laboratory had used this agent to reduce the toxicity of BMS homogenates to cell 
monolayers, without significantly affecting the number of poliovirus recovered (Tree, 1997) 
and flocculating agents were also used successfully by Lewis and Metcalfe (1988). In this 
study however, when BMS extracts were applied after treatment with Magnofloc, the cell 
monolayer was destroyed. Further work is therefore required to develop techniques for the 
removal of toxicity of the BMS extracts and increase the efficiency of the extraction 
procedure to enable the detection of MNV-1 in the BMS matrix.
3.6 Conclusion
Since its discovery in 2003 (Karst et a l, 2003) MNV-1 has been used increasingly as a 
surrogate for human NoV in studies carried out into the mechanisms of replication, 
attachment and virus behaviour in the environment and the BMS matrix. To be effective as a 
surrogate for human NoV, it is important that the methods used to detect it must be
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characterised and fit-for-purpose. One of the major aims of this study was to characterise a 
one-step qRT-PCR assay for MNV-1 to provide a quantitative method that is equivalent to 
the in-house one-step qRT-PCR method for human NoV in BMS, and to the developing 
European standard method developed by the working group CEN WG6 TAG4 (Lees and 
CEN.WG6.TAG4, 2010). The qRT-PCR method characterised in this study shows similar 
performance in terms of LOD and LOQ to the method used for human NoV and to qRT-PCR 
methods for the detection of other viruses. Although performance characterisation was 
performed in the absence of the BMS matrix, subsequent experiments on Pacific oysters 
bioaccumulated with MNV-1 produced repeatable and robust quantitative results.
In this study, adaptations to the plaque assay method described by Wobus et al, (2006) were 
performed to allow quantitation of plaque forming units of MNV-1 in virus lysates, seawater 
and spiked BMS digestive glands. The development of a plaque assay with both sufficient 
robustness and sensitivity for application to bioaccumulated oysters was unsuccessful 
however. Future work in this area should focus on increasing the initial virus levels in oyster 
glands. Also, to enable assessment of environmentally relevant levels of NoV, the 
development of more efficient methods that can reduce the toxicity of BMS tissues to the 
RAW 264.7 cell monolayer without recourse to overdilution should be investigated.
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4.0 Stability of NoV/NoV RNA under artificial environmental conditions
4.1 Introduction
NoV particles are stable inside the human host and in the environment, and may survive for a 
considerable time in seawater or in BMS. Consequently, it has been suggested that they 
remain a risk to public health for extended periods of time (Lees, 2000). There are a number 
of factors that affect virus survival in the environment, including water temperature, the 
intensity of UV irradiation by sunlight, salinity and the presence of particulate-matter; several 
authors have reported that most viruses (and bacteria) occur in the environment as particle- 
associated-organisms (Bitton, 1975; Meschke and Sobsey, 1998; Sakoda et a l, 1997). Many 
enteric viruses have been reported to survive longer during periods of lower temperatures in 
the winter, than during the summer months (Green and Lewis, 1999; Lipp et al, 2001; Lipp 
et al, 2002). In addition, it has been suggested that during periods of higher temperatures, 
damage to both viral capsids and nucleic acids can be more severe, possibly preventing 
adsorption of the virus to host receptors or causing inactivation of the enzymes required for 
replication by damaging the genes encoding these enzymes (Bitton, 1980). The germicidal, 
inactivation properties of UV are well documented (Fujioka and Yoneyama, 2002; Johnson et 
al, 1997) and, for example, poliovirus-1 has been reported to survive longer in the absence of 
sunlight in laboratory studies (Johnson et al, 1997). NoV possesses a single stranded RNA 
(ssRNA) genome. Several authors have suggested that because of this it could be less 
resistant to UV light than double stranded DNA or RNA viruses (Gerba et a l,  2002; 
Thurston-Enriquez et a l, 2003); it is postulated that double stranded DNA viruses are more 
resistant to UV light because they are able to use host cell enzymes to repair damage to their
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genomes (Gerba et al., 2002). The survival of naked RNA in the environment is thought to be 
transient (Simonet and Gantzer, 2006).
MNV-1, a cultivable NoV, can be used to study the behaviour of this group of viruses in the 
environment. Previous studies have used other cultivable surrogates such as FCV (Allwood et 
al, 2003) and Poliovirus-1 (Wetz et al, 2004) to predict the stability of NoV in the 
environment. Generally, those studies that have compared the stability of infectious units (by 
cell culture) with the stability of PCR signal have shown that infectivity is lost far more 
rapidly than PCR signal (Le Guyader et al, 1994; Wetz et al, 2004).
In this study, qRT-PCR signal decay rates for human NoV RNA, human NoV GI (from 
faecal material) and MNV-1 (from virus lysates) were analysed in filtered seawater held 
under artificial conditions simulating those of winter in the UK. Filtered natural seawater was 
used in this series of experiments to ensure that the action of the UV light was not affected by 
particulate matter, but it was expected that RNases and predatory organisms would be 
present. The determination of the loss of infectivity of NoV (using MNV-1 as a cultivable 
surrogate) under these conditions was also examined.
4.2 Aims
To assess the stability of human NoV RNA, human NoV from positive faecal material and 
MNV-1 in seawater under winter conditions.
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4.3 Materials and Methods
4.3.1 Production of RNA sequences
Purified ssRNA species of 126 bases (NoV GI; Figure 4.1) carrying the qRT-PCR target 
sequence (spanning the ORFl/2 junction of the NoV genome) were transcribed from 
plasmids (supplied by Dr. Soizick LeGuyader, Ifremer, Nantes, France) produced by ligating 
the target sequences from the Norwalk strain of NoV GI into vector pGEM-3Zf (+) 
(Promega). Prior to RNA transcription the plasmids were linearised using Xbal restriction 
enzyme. In brief, 37.5 pi molecular grade water, 5 pi of reaction buffer (Promega) and 2.5 pi 
Xba\ restriction enzyme (Promega) was added to 5 pi (-500 ng) of each plasmid and 
incubated at 37°C for 2 hours. The linearised plasmid DNA was then purified using the 
QIAquick PCR purification kit (Qiagen) following the manufacturer’s instructions. In-vitro 
RNA transcription was carried out using the Riboprobe® in vitro transcription system 
(Promega). A reaction mix containing 20 pi of transcription buffer (5x), 10 pi of 
dithiothreitol (DTT;100 mM), 2.5 pi of RNasin, 20 pi of a mix of rATP, rGTP, rCTP, rUTP 
(2.5 mM each), 3 pi of T7 polymerase and 39.5 pi of nuclease free water was added to 5 pi of 
linearised DNA. The reactions were mixed by pipetting and incubated at 37°C for 2 hours. 
Following incubation, 5 pi of RQl RNase-free DNase was added to each reaction and 
incubated at 37°C for 15 minutes to degrade the remaining DNA template. The RNA 
transcripts were then purified using the RNeasy mini kit (Qiagen) following the 
manufacturers’ instructions. The RNA preparations were then checked for DNA 
contamination by testing with a qRT-PCR mastermix in which the RT enzyme had been heat 
inactivated at 95°C. In both cases, there was <0.03 % DNA contamination. The concentration
-90-
of RNA in copies/pl was calculated for each preparation by extrapolation from absorbance at 
260 nm as measured using a NanoDrop® spectrophotometer (Thermo Scientific). RNA 
transcripts were stored at -20°C until required.
5'
(Non structural polyprotein coding region) (V P l major capsid)
3'
(VP2 minor capsid)
ORFl 0RF2
cgctggatgcgcttccatGACCTCGGATTGTGGACAGGAGATCGCGATCTTCTGCCCGAATTCgtaaatgatgatggcgtctaagg
Figure 4.1: The sequence and original location within the NoV genome of the NoV GI RNA 
transcript. Primer binding sites are shown in lower case. Plasmid-derived sequence 
fragments, present at both 5’ and 3’ ends are not shown.
4.3.2 Degradation and stability of norovirus RNA sequences in the environment
Two equal volumes (500 ml) of seawater [Salinity: 35ppt; Turbidity: 0.09 Nephelometric 
Turbidity Units (NTU)] were equilibrated to 8±0.5°C in 3 L beakers. The beakers were 
placed into a UV box (Figure 4.2). One beaker was entirely enclosed in a light proof material 
(tin foil) to act as a dark control, the other was exposed to UV light adjusted to 1 mW/cm^ 
through the use of plastic filter sheets to simulate typical British winter conditions based upon 
daytime light intensity measurements made daily between November 2008 -  March 2009 
(average UV levels of 1.13 mW/cm^, range 0.0 -  3.2 mW/cm^). Each volume was then 
seeded with approximately 1 x 10  ^ copies (quantified spectrophotometrically) of NoV GI 
RNA sequences and 1 ml samples were taken from each beaker after 0 minutes, 15 minutes,
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30 minutes, 1 hour, 2 hours, 4 hours, 8 hours, 1 day, 2 days, 1 week and weekly from thereon 
up to 4 weeks. All samples were frozen immediately at -20±0.5°C, prior to extraction of viral 
RNA (Section 2.1) from 500 pi and one-step qRT-PCR analysis (Section 2.9).
&
Figure 4.2: The UV light box (Top) and photograph of experimental work (bottom).
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4.3.3 Degradation and stability of human NoV GI (from positive faecal material) in 
seawater in winter
Two equal volumes (500 ml) of seawater (Salinity: 35ppt; Turbidity: 0.09 NTU) were 
equilibrated to 8±0.5°C and subsequently seeded with positive faecal material containing 
approximately 1x10^ copies of NoV GI [GI.4; 98.6% sequence homology to HaklD-2000-jp 
(AB046349); Genotyping carried out on archived faecal material using methods described in 
Sections 2.2 -  2.8]. Experimental conditions were as described in Section 4.3.2, although 
sampling time was extended to include weekly intervals from 4 to 6  weeks. All samples were 
frozen immediately at -20°±0.5C, prior to extraction of viral RNA (Section 2.1) from 500 pi 
and one-step qRT-PCR analysis (Section 2.9).
4.3.4 Degradation and stability of MNV-1 in seawater in winter
Two equal volumes (500 ml) of seawater (Salinity: 35ppt; Turbidity: 0.09 NTU) were 
equilibrated to 8±0.5°C. Both volumes were seeded with approximately 1 x 10  ^ genome 
copies (-8.74 x lO"^  pfu) of MNV-1. Experimental conditions were as described in Section 
4.3.2. All samples were frozen immediately at -20±0.5°C, prior to extraction of viral RNA 
(Section 2.1) from 500 pi and one-step qRT-PCR analysis (Section 2.9).
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4.4 Results
4.4.1 Stability of GI RNA genomic fragments in seawater in artificial environmental 
conditions of winter in the UK
Average logio copies/ml of GI (as RNA genomic fragments) held in seawater exposed to UV 
and held in the dark are presented in Table 4.1. NoV GI RNA spiked into seawater held under 
simulated winter conditions (8±0.5°C, 1 mW/cm^ UV irradiation) was detected by qRT-PCR 
for up to 14 days post contamination. Decay of detectable RNA was exponential (r^ = 0.976) 
with a Too (time taken for 90% of PCR signal to disappear) of -141 hours (Figure 4.3). The 
Too for RNA genomic fragments held in the dark was calculated as -303 hours (r^ = 0.334), 
however this value was calculated from a set of data with a very low value, due to data 
points collected at 168 and 336 hours lying far from the line of best fit. For this reason it is 
difficult to draw any fair conclusions in this case comparing the degradation rates of those 
RNA fragments exposed to UV light and those fragments not exposed.
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Table 4.1: qRT-PCR results for the detection of human NoV GI RNA in seawater over time
Time (hours) UV average logio copies/ml Dark average logic copies/ml
0 5.15 ±0.03 5.37 ±0.12
2 5.06 ±0.13 5.28 ±0.09
4 5.06 ±0.04 5.21 ±0.03
8 4.80 ±0.05 5.13 ±0.03
24 4.72 ± 0.00 5.13 ±0.22
48 4.43 ±0.05 4.72 ±0.27
168 3.78 ±0.27 3.30 ±0.01
336 2.65 ±0.10 4.63 ±0.06
504 ND" ND"
N D  =  N ot detected
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Figure 4.3: Graph showing the exponential degradation of human NoV GI RNA in seawater 
in artificial winter conditions with and without UV irradiation.
4.4.2 Stability of NoV GI (GI positive faecal material) in artifîcial winter conditions
LoglO copies/ml of human NoV within faecal material in seawater exposed to UV light and 
held in the dark are presented in Table 4.2. Human NoV GI was detected in seawater samples 
which had been exposed to UV light for up to 168 hours. Under dark conditions, human NoV 
GI was still detectable at the end of the experimental run after 1008 hours (42 days). GI NoV 
from faecal material degraded at a faster rate when exposed to low intensity UV light (T90: ~ 
116 hours, for exponential regression line = 0.754) when compared to the GI NoV in 
seawater held in the dark ( T 9 0 :  ~ 257 hours, = 0.974); although the difference between the 
two rates was not significant using linear model analysis (performed using R version2.11.1),
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it was approaching statistical significance (F = 0.002, p  = 0.063). Figure 4.4 illustrates the 
exponential degradation of human NoV GI qRT-PCR signal in filtered seawater.
Table 4.2: qRT-PCR results for the detection of human NoV GI (in faecal material) in 
seawater over time
Time (hours) UV average logio copies/ml Dark average logio copies/ml
0 4.25 ±0.14 4.47 ± 0.03
4 3.98 ±0.12 4.56 ±0.05
8 3.93 ±0.03 4.53 ±0.01
24 3.59 ±0.05 4.68 ±0.47
48 2.93 ±0.15 4.28 ±0.38
168 2.64 ±0.07 3.90 ±0.04
336 n d '’ 3.33 ±0.48
504 2.98 ±0.69
672 1.49 ± 0 .19
840 -tLOD^
1008 -tLOD^
hLOD (theoretical limit o f  detection) = 1 0  copies/ml or 1 logjo copies/ml. 
*ND =  N ot Detected
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Figure 4.4: Graph showing the exponential degradation of human NoV GI (from faecal 
material) in seawater under artificial winter conditions with and without UV irradiation.
4.4.2.1 Comparisons between stability of GI RNA and GI NoV (in faecal material)
Table 4.3 and Figure 4.5 show the differential degradation of GI RNA and GI NoV (from 
faecal material). Under UV irradiation degradation of GI NoV (from faecal material) 
occurred at a slightly faster rate than GI RNA fragments, however there was no significant 
difference found between the rates {F= 0.002, p  = 0.426).
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Table 4.3: Differential degradation of GI RNA and GI NoV under artificial winter 
conditions and in the dark
T90 (hrs)
Determinant UV Dark
GI RNA 141 306"
G INoV 116 257
C'
5
4
E
g
a.
8 5
wo
I
1
0
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Time (Hrs)
♦ GIF: H A UV av erag e  loglO 
c o p ie s /m l
GI NoV UV av erag e  loglO 
c o p ie s /m l
350 40 0
Figure 4.5: Graph showing the degradation of human NoV GI RNA and human NoV GI 
(from faecal material) in seawater under artificial winter conditions in the presence of UV 
irradiation.
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4.4.3 Stability of MNV in artificial winter conditions: qRT-PCR determination
MNV-1 was detected in seawater samples taken after up to 504 hours exposure to 1 mW/cm2 
UV light at 8±0.5°C (Table 4.4). Degradation was exponential (r^ for exponential regression 
line = 0.980) with a T90 of ~ 246 hours (Figure 4.6). In comparison, no decrease in levels of 
MNV-1 was noted from seawater held in the dark even at the end of the experimental run 
(672 hours). The difference in MNV-1 degradation kinetics between the two conditions was 
highly significantly different {F = 2.538,p  = \ .305 x 10'^).
Table 4.4: qRT-PCR results for the detection of MNV-1 in seawater over time
Time (hours) UV average logic copies/ml Dark average logic copies/ml
0 3.52 ±0.49 3.71 ±0.04
2 3.68 ±0.71 3.81 ±0.05
4 3.81 ±0.15 3.83 ±0.09
8 3.70 ±0.15 3.71 ±0.17
24 3.40 ±0.05 3.58 ±0.29
48 3.41 ±0.02 3.65 ± 0 .20
168 2.96 ±0.09 3.43 ±0.10
336 2.37 ±0.21 3.81 ±0.03
504 1.55 ±0.19 3.15 ±0.71
672 ND® 3.74 ±0.01
ND  =  N ot Detected
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Figure 4.6: Graph showing the degradation of MNV-1 in seawater under artificial winter 
conditions with and without UV irradiation
Applying the same samples (taken at identical times) for plaque assay quantitation yielded 
consistently negative results.
4.4.4 Comparisons of MNV-1 and GI NoV stability in seawater in winter conditions
Figure 4.7 shows the differential degradation of MNV-1 (from virus lysate) and human NoV 
GI (from faecal material) when exposed to UV light. Human NoV GI degraded at a
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significantly faster rate than MNV-1 ( T 9 0  for NoV GI: -116 hrs, MNV-1: -246 hrs; F 
0.002,/? = 0.027) with NoV GI detected at up to 168 hours and MNV-1 up to 504 hours.
♦ <3 1 UV ar-/e rage I o f  10 
copiss/m l
■ MMVUV a /e  rage loglO 
copieî/ml
100 200 500 40 0 500
Time (Hrs)
Figure 4.7: Differential degradation of MNV-1 and human NoV GI in seawater in artificial 
winter eonditions in the presence of UV irradiation.
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4.5 Discussion
4.5.1 Degradation and stability of fragments of the norovirus RNA genome in the 
environment
It has been suggested that the predominant effect of UV light on RNA viruses is damage to 
viral RNA (Helentjaris and Ehrenfeld, 1977; Wetz et al, 1983). Nucleic acid is thought to be 
10 times more sensitive to UV light when compared to protein or amino acid, as nucleic acid 
bases absorb UV well and rarely have a tertiary structure, although UV may also cause 
significant damage to the capsid (Nuansualuwan and Cliver, 2003).0n the other hand Tsai et 
a l  (1995) showed that naked poliovirus-1 RNA was detectable by PCR in filtered seawater 
held at 4°C for up to 21 days. Both poliovirus 1 and F-specific RNA bacteriophage genome 
fragments have been shown to persist in solution following exposure to germicidal UV 
(Simonet and Gantzer, 2006). The authors suggested that survival was a function of fragment 
size with preferential survival of small fragments (<145 bases). In this study small NoV RNA 
transcripts (126 bases) were used. These remained detectable up to 336 hours (14 days) after 
their addition to seawater. Also, somewhat surprisingly, exposure to low levels of UV 
irradiation corresponding to a daytime winter average appeared to have little impact upon the 
degradation kinetics of NoV RNA, although this comparison was difficult to make due to 
uncertainty around the rate of degradation in the absence of UV resulting from a number of 
outlying data points in the series. RNA damage might, however, occur more rapidly in 
periods of above average UV irradiation. Previous studies have shown that viral RNA is more 
stable in artificial, filtered or sterile seawater than in natural seawater, due to the antiviral 
activity of the microflora present and endogenous RNases (Fujioka et al, 1980; Tsai et al,
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1995). However, in this study, natural seawater was used after filtration through sand filter 
systems with 50 pm pore size, so although larger particles were likely to be removed, it is 
probable that endogenous RNases remained in the seawater. Double-stranded RNA viruses 
have been reported to be more resistant than single-stranded RNA to UV radiation (Harris et 
a l, 1987). The potential for secondary structure formation from NoV GI RNA sequences 
used in this study was determined in silico using RNAfold software (University of Vienna 
RNA Webserver, http://ma.tbi.univie.ac.at). This indicated that formation of RNA complexes 
was theoretically possible (a minimum free energy of -27.60 kcal/mol was determined for the 
optimal secondary stmcture) potentially reducing the rate of degradation due to UV. 
Notwithstanding this possibility, detection of NoV RNA fragments for an extended period 
demonstrates the potential for naked RNA to persist in the marine environment. This 
preliminary finding supports the hypothesis that an element of the qRT-PCR signal in 
norovims positive seawater samples may be derived from non-encapsidated RNA.
4.5.2 Stability of NoV GI (GI positive faecal material) in artificial winter conditions and 
comparisons with GI RNA stability
Compared to the viral capsid, nucleic acid is thought to be more susceptible to the effects of 
UV light (Nuansualuwan and Cliver, 2003) suggesting that encapsidation of RNA ought to 
offer some protection against UV damage. However, in this study the T90 determined for GI 
RNA in UV irradiated seawater was higher than the T90 determined for GI NoV from faecal 
material under the same conditions (although there was no significant difference found 
between the rates of degradation), indicating that RNA genomic fragments may persist in the 
environment at least as long as intact virus particles. This surprising finding may be partially 
explained by the presence of other factors present in the faecal material (compared to the
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sterile nature of the RNA preparation used). For example, it is likely that other 
microorganisms indigenous to the human intestine may aid in the degradation of the viral 
capsid and genome (Deng and Cliver, 1992; Deng and Cliver, 1995; Spillman et al, 1987; 
Ward, 1982), thus reducing virus titres at a faster rate. The inactivation of many enteroviruses 
and coliphages by both Gram positive and Gram negative bacteria has been reported 
(Nuansualuwan and Cliver, 2003). Furthermore, evidence suggesting a positive correlation 
between fragment length and degradation rate of encapsidated RNA fragments is available 
for poliovirus (Hegedus et al., 2003; Newland et al., 2001; Shin and Sobsey, 2003; Simonet 
and Gantzer, 2006; Sobsey et a l, 1998). It is therefore possible that the short RNA fragments 
used in this study are inherently more stable than the full length virus genome. The 
combination of these factors may therefore provide a hypothesis for the observed similarity in 
degradation rates of naked and encapsidated RNA in this study. Conversely, when comparing 
the stability of GI NoV particles in seawater with and without UV irradiation, the data 
suggest that, regardless of any influence from substances in the seawater matrix or the faecal 
material, UV light has a major impact on the degradation of the qRT-PCR signal.
4.5.3 Stability of MNV in artificial winter conditions and comparisons to human NoV 
GI
Studies with other enteric viruses have shown that infectivity as determined using tissue
culture techniques may be affected to a far greater extent than nucleic acid signal as measured
by PCR assays by environmental damage (Le Guyader et ah, 1994; Tsai et al, 1995; Wetz et
al, 2004). The qRT-PCR signal from MNV-1 virions (from cell culture lysates) persisted for
longer and degraded significantly more slowly in seawater in winter conditions than that from
GI NoV virions (from faecal material; T% for GI NoV: 116 hours; T90 for MNV-1: 246
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hours). Furthermore in the absence of UV light no decrease in qRT-PCR signal was observed. 
This raises questions about the validity of using MNV-1 as a surrogate for studies evaluating 
NoV behaviour and stability in the environment, as persistence in the environment may have 
a major impact on bioaccumulation of NoV by BMS. The suitability of MNV-1 as a surrogate 
for human NoV has been evaluated for heat inactivation studies using qRT-PCR analysis, and 
it has been reported that caution should be used when extrapolating surrogate data (Hewitt et 
al, 2009). The authors suggest that human NoV is less susceptible to heat than either 
Hepatitis A virus or MNV, and therefore the authors suggest that MNV may not be an 
appropriate surrogate for human NoV studies. In this study however MNV-1 was seeded into 
seawater in lysate material, rather than the more complex matrix of faecal material so as not 
to complicate the attempted cell culture quantitation further. The virus lysate is produced in 
aseptic conditions and therefore, unlike human faecal material, is unlikely to contain other 
microorganisms and RNases that may aid in the degradation of the virus. Future experiments 
mixing MNV-1 with human faecal material, prior to analysis of the degradation kinetics of 
the qRT-PCR signal, would possibly be useful in establishing the validity of MNV-1 as a 
surrogate for the behaviour of human NoV in the seawater matrix.
Although MNV-1 was successfully quantified from spiked seawaters in Chapter 3 under 
identical salinity and turbidity conditions, plaque assay quantitation of MNV-1 in seawater at 
each time point was negative after multiple trials. The reasons for this are unclear, however, 
as a result the determination of the loss of infectivity over time was not possible, and no 
predictions on the persistence of infectious NoV in the environment can be made. Attempts to 
circumvent the problems experienced by using increased levels of MNV-1 spiking material 
also yielded negative plaque assay results. It is possible that MNV-1 in seawater is not stable 
at the storage temperature used (-20°C), however this seems improbable. MNV-1 has been 
applied in environmental studies and has been successfully quantified using plaque assays,
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and one study reports that MNV-1 is one of the most persistent viruses in environmental 
waters (Bae and Schwab, 2008). This is also the case for MNV-1 on surfaces, and in other 
food matrices such as fruit (Baert et al, 2008b). In order to better investigate the viability of 
noroviruses in seawater it will first be necessary to develop a robust and reliable cell culture 
method for MNV-1 from this matrix.
4.6 Conclusions
If important risk management decisions are to be made on the basis of qRT-PCR results it is 
important that these results are understood in the context of risk. The findings presented in 
this study suggest that in typical UK winter conditions of comparatively low UV irradiation 
and low temperatures, short fragments of non-encapsidated NoV RNA may persist in the 
marine environment for 2 weeks or more. Studies using qRT-PCR to investigate the 
persistence of human NoV in rivers and marine environments, and transportation of human 
NoV from pollution sources to receiving waters may therefore overestimate levels of 
infectious NoV. Unfortunately, data for the survival of infectious MNV-1 under these 
conditions could not be ascertained, and it is therefore not possible to extrapolate from this 
data to determine whether human NoV would remain a human health risk in seawater for 
extended periods of time under winter conditions. However, the qRT-PCR data indicates that 
such methods might potentially detect NoV RNA in the marine environment that is of no risk 
to human health. This finding is of significance with respect to interpretation of qRT-PCR 
results for NoV in Pacific oysters and other shellfish species. If BMS are able to 
bioaccumulate ‘free’ RNA from the marine environment, qRT-PCR detection may over­
estimate risk to the consumer. To determine whether free RNA or inactivated viruses will
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contribute to qRT-PCR results in BMS the bioaccumulation of NoV RNA and inactivated 
NoV (and MNV-1) is studied in Chapter 5.
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5.0 Bioaccumulation of human NoV and MNV-1, heat inactivated human NoV and
MNV-1 and human NoV RNA by BMS
5.1 Introduction
Human NoV are non-cultivable, and although it is possible to accurately quantify NoV RNA 
contamination using qRT-PCR, this approach does not determine the proportion of infectious 
human particles of greatest clinical relevance. Because of this, little is known about how or to 
what extent NoV is inactivated by wastewater treatment processes and the positive qRT-PCR 
signal in human NoV-contaminated sewage, environmental water and BMS samples may in 
theory be derived from a mixture of infectious and non-infectious NoV. In studies using NoV 
surrogates, such as FCV and MNV, viral inactivation induced by temperatures above 80°C 
(Baert et al., 2008a) and 72°C (Lamhoujeb et al., 2008) has been demonstrated. In such cases 
it has been suggested that virus infectivity is reduced or eradicated by damaging both the 
capsid acid and the nucleic acid (Nuanualsuwan and Cliver, 2003) and it has also been shovm 
that high temperatures destabilise and disrupt the viral capsid of poliovirus subsequently 
releasing RNA (Koch and Koch, 1985). However, it has also been reported that following 
exposure to heat (>60°C) the number of infectious virus particles (using MNV-1), as 
determined by infectivity assays, does not correlate with the number of genome copies 
detected by qRT-PCR (Baert et al., 2008a). These findings suggest that to some extent viral 
RNA may survive (and hence remain detectable by qRT-PCR) exposure that damages the 
capsid. Following heat and other inactivation treatments the viral genome may possibly 
remain protected by a damaged capsid and non-infectious particles of this type might in 
theory contribute to positive qRT-PCR results from BMS samples. However,
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bioaccumulation of either non-infectious, inactivated NoV or of norovirus RNA fragments in 
BMS has not previously been demonstrated. Binding of NoV particles within oyster digestive 
tissues has been found to be mediated by interactions with type A-like HBGAs in the tissues 
(Le Guyader et al., 2006; Tian et al, 2006; Xian et al, 2007), and it has therefore been 
suggested that close genetic similarity to human NoV is a necessary prerequisite for surrogate 
viruses used in BMS studies. It has been reported that human NoV GII.4 (using virus like 
particles) may recognize a sialylated carbohydrate motif present in oyster tissues (Maalouf et 
al, 2010) while MNV-1 has also been shown to use carbohydrates during attachment, 
particularly sialic acid (Taube et a/., 2009). Furthermore, bioaccumulation of MNV-1 by 
BMS has already been described (Nappier et al, 2008). For these reasons MNV-1 is the most 
suitable cultivable surrogate for investigations into viral accumulation in BMS.
In this study the bioaccumulation of fragments of the human NoV genome, and heat- 
inactivated human NoV and MNV-1 is subsequently assessed. Human NoV GII.4 was used 
in these studies as this genotype of NoV possesses similar binding characteristics (sialic acid) 
to MNV (Maalouf et al, 2010; Taube et al, 2009).
5.2 Aims
The ability of Pacific oysters to bioaccumulate short fragments of the NoV genome 
will be assessed.
The ability of Pacific oysters to bioaccumulate heat-inactivated NoV and MNV-1 
particles will be evaluated.
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5.3 Materials and Methods
5.3.1 Production of RNA sequences
Purified ssRNA species of 126 bases (NoV GI; Figure 20) and 131 bases (NoV GII), carrying 
the qRT-PCR target sequence (spanning the ORF1/2 junction of the NoV genome) were 
transcribed from plasmids (supplied by Dr. Soizick LeGuyader, Ifremer, Nantes, France) as 
described in Section 4.3.1.
5.3.2 Comparative bioaccumulation of human NoV RNA and human NoV in faecal 
material by Pacific oysters
Thirty L of artificial seawater] (Peacock Salt, Ayr, UK), made with distilled water following 
the manufacturers’ instructions, were added to 2 aerated 48 L tanks and equilibrated to 18°C. 
Thirty Pacific oysters were then added to each tank and left to acclimatize for 96 hours to 
allow resumption of filter-feeding activity. Ten oysters were removed for testing for NoV 
contamination using the method described in Section 2.11. Suspended solids were then 
sedimented from separate 400 ml volumes of natural seawater by centrifugation at -4000 x g  
then resuspended in separate 50 pi volumes of natural seawater. Aliquots of a NoV 
GII.4.2004 positive faecal sample and of human NoV GII RNA transcripts, each containing 
approximately 6x10^ copies as determined by qRT-PCR were added to separate suspensions 
and incubated for 30 min at 22°C to allow adsorption to suspended solids, then spiked into
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separate tanks [RNA sequences were added to the suspended solids to account for the 
potential of RNA to bind to particulate material and thus affect bioaccumulation by Pacific 
oysters. Artificial seawater seawater was used as the starting material as it was unlikely to 
contain endogenous RNases that could potentially affect RNA degradation]. In addition, 
aliquots of a GI.4 positive faecal sample (96.2% sequence homology in 0RF2 to Chiba virus 
(AB022679)) containing approximately 6 x 1 0 ^  copies were added to each tank to act as a 
bioaccumulation control (Figure 5.1)0ysters were allowed to bioaccumulate for 16 hours 
then tested for NoV GI and GII as described in Section 2.11. This procedure was repeated on 
four separate occasions. Statistical analysis was performed using Microsoft Excel 2007.
Tank 1 -  GI and GII NoV from 
faecal material
GII NoV adsorbed to  pelleted 
suspended solids
20 Pacific oysters
GI NoV (Bioacc. 
Conrol).
Tank 2 -  GI NoV from faecal 
material and GII RNA fragments
GII RNA fragm ents adsorbed 
to  pelleted suspended solids
20 Pacific oysters
GI NoV (Bioacc. 
Conrol).
10 oysters from each tank tested for GI and GII
Figure 5.1: Experimental design for bioaccumulation of human NoV GII (from faecal 
material) and human NoV GII RNA fragments.
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5.3.2.1 Heat treatment of human NoV GII.4 and MNV-1
One hundred pi volumes of a NoV GII.4.2004 positive faecal sample and MNV-1 cell culture 
supernatant were transferred to separate thin-walled 0.5 ml centrifuge tubes, then placed on a 
thermal cycler at 99°C for 5 minutes (HT5) or 20 minutes (HT20). Following heat treatment, 
the 100 pi volumes were pooled into respective tubes and vortex mixed. Total nucleic acid 
was extracted from untreated heat treated faecal material and MNV-1 samples, using the 
method described in Section 2.1. The remaining faecal and MNV-1 samples were 
immediately frozen at -80°C until required for plaque assay (MNV-1) or for subsequent 
experiments.
S.3.2.2 qRT-PCR quantitation of heat treated human NoV and MNV-1
Extracted nucleic acid from all faecal and MNV-1 samples was tested and quantified for NoV 
GII or MNV-1 RNA respectively using qRT-PCR as described in Section 2.9.
S.3.2.3 Plaque assay quantitation of heat treated MNV-1
Heat-treated MNV-1 lysates were thawed and quantified in pfu/ml using the plaque assay 
method described in Section 2.10.3.
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53.2.4 Bioaccumulation of heat treated human NoV and MNV-1
Seven 48 L tanks (six experimental and one negative control tank) were each filled with 30 L 
of seawater (Salinity: 35 ppt, Turbidity: 0.1 NTU). Seawater in each tank was equilibrated to 
18±1°C. Thirty Pacific oysters were added to each tank and were allowed to acclimatise for 
96 hours. Following acclimatisation, 10 randomly selected oysters were removed from the 
negative control tank and tested for human NoV and MNV-1 RNA by qRT-PCR as 
previously described in Section 2.11, 2.1 and 2.9. Each experimental'tank was then spiked 
with a total of 6 x 10  ^copies (adjusted to take account of losses in detectable RNA caused by 
heat-treatment; equivalent to 2 x 10  ^ copies/oyster) of either untreated, 5 mins or 20 mins 
heat treated human NoV or untreated, 5 mins or 20 mins heat treated MNV-1. Samples of ten 
randomly selected oysters were removed from each tank and tested for human NoV or MNV- 
1 RNA by qRT-PCR as previously described in Sections 2.11,2.1 and 2.9.
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5.4 Results
5.4.1 Comparative bioaccumulation of NoV GII RNA fragments and NoV GII from 
positive faecal material
Levels of GI and GII NoV in genome copies per gram of digestive glands in oysters exposed 
to both human GI NoV positive faecal material and either human GII NoV positive faecal 
material or GII NoV RNA transcripts (containing similar numbers of PCR detectable copies 
as the faecal material) are given in Table 5.1. Pacific oysters in both experimental tanks 
accumulated GI NoV to similar levels (3137 and 597 genome copies per g respectively; Table 
5.1) indicating that both sets of oysters were effectively bioaccumulating NoV present in the 
water. However, results for GII NoV demonstrated that detection was only possible from 
oysters exposed to virus from faecal material and not to GII NoV RNA transcripts, even 
though similar numbers of copies as determined by PCR were present in both spikes.
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Table 5.1: qRT-PCR bioaccumulation results for NoV GI, NoV GII and NV GII RNA
sequences in Pacific oysters.
NoV Quantity (detectable copies/g digestive gland)
Tank 1“
GI and GII Faecal 
Material
Tank 2“
GI Faecal Material, GII 
RNA
Logio tank-to-tank 
difference**
Experiment GI GII GI GII GI GII
1 5.97x10^ 1.09x10^ 3.14E x103 <l o d '’ -0.72 2.86
2 7.05 xlQ: 2.79 xlO" 9.77x10= <l o d ’’ -0.14 3.27
3 2.00x103 1.08 xlO^ 5.47x10= 1.99x10= -0.44 1.74
4 1.95x10^ 8.12 xlO* 5.20x10= =LOD= 0.58 3.73
Average - - - - OAT 2.90
® Tank 1 bioaccumulated with GI and GII faecal material, tank 2 bioaccumulated with GI faecal material and GII R N A  
transcripts
 ^<LOD =  not detected; less than limit o f  detection (-1 5  copies/g)
‘^ -LOD =  positive at the limit o f  detection (-1 5  copies/g)
 ^results -L C D  or <LOD treated as 15 copies/g  
® average o f  absolute values regardless o f  direction o f  difference
5.4.2 Bioaccumulation of untreated and beat treated buman NoV and MNV-1
5.4.2.1 qRT-PCR quantitation from beat treated GII.4.2004 positive faecal material
The effect of heat treatment on NoV levels in positive faecal material is given in Table 5.2. 
Untreated faecal material contained 6.17 x 10  ^ copies/ml of NoV GII RNA. After heat 
treatment at 99°C for 5 minutes, the faecal material contained 6.83 x 10  ^ copies/ml of NoV 
GII RNA. After heat treatment at 99°C for 20 minutes, the faecal material contained 5.45 x 
10  ^copies/ml of NoV GII RNA.
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Table 5.2: Copies/ml of NoV detected in untreated faecal material and faecal material after 
heat-treatment at 99°C for 5 and 20 minutes.
Untreated
(Copies/ml)
Heat Treated for 5 minutes 
(Copies/ml)
Heat Treated for 20 minutes (Copies/ml)
6.17x10*' 6.83 X 10' 5.45 X 10^
5.4.2.2 qRT-PCR and plaque assay quantitation of beat treated MNV-1 cell culture 
lysates
Table 5.3 shows the genome copies/ml and pfu/ml of MNV-1 quantified by qRT-PCR and 
plaque assay respectively before and after heat treatment at 99°C for 5 and 20 minutes. 
Following heat treatment at 99°C for 20 minutes, MNV-1 was not detected by plaque assay. 
However, following heat treatment, reductions in genome titre were smaller, with a 1 logio 
reduction in genome titre. No further reduction in genome titre was observed from 5 minutes 
to 20 minutes of heat treatment.
Table 5.3: MNV-1 lysate plaque assay titres before and after heat treatment
Sample Name MNV-1 lysate MNV-1 lysate heat treated for MNV-1 lysate heat treated
Untreated 5 minutes at 99°C for 20 minutes at 99°C
Copies/ml 2.09 X 10* 1.12 X 10’ 2 .0 9 x 1 0 ’
pfu/ml 9.70 X 10= 4.10x10* ND"
‘N D = N o t  Detected
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S.4.2.3 qRT-PCR quantitation of Human NoV GII and MNV-1 in bioaccumulated
Pacific oysters
Before and after heat treatment, the bioaccumulation of human NoV GII.4 and MNV-1 by 
Pacific oysters was analysed. Neither MNV-1 nor human NoV was detected in Pacific oysters 
prior to contamination. Pacific oysters exposed to 6 x 10  ^copies of untreated and heat treated 
(5 minute and 20 minute incubations at 99°C) human NoV GII.4 and MNV-1 respectively 
were tested by qRT-PCR as described previously (Sections, 2.1, 2.9 and 2.11). MNV-1 or 
human GII NoV RNA was detected by qRT-PCR in all relevant oyster samples post­
contamination, as shown in Table 5.4.
Table 5.4: qRT-PCR data for detection of untreated and heat-treated human NoV GII.4 and 
MNV-1 after bioaccumulation by Pacific oysters.
Spiking Material Untreated (copies/g) Heat Treated for 5 Heat Treated for 20
minutes (copies/g) minutes (copies/g)
GII.4.2004 1.06 X 10= 1.74 X 10" 3.65 X lO'*
MNV-1 1.87x10= 1.45x10= 1.35x10=
For bioaccumulation, the amount of GII.4.2004 positive faecal material or MNV lysate added 
to seawater was based on qRT-PCR data (6 x 10  ^copies added per tank). For MNV-1, 6 x 10  ^
genome copies (equivalent to -280 pfti, -22 pfti and -0  pfti for untreated, HT5 and HT20 
bioaccumulation respectively. Pacific oysters bioaccumulated heat treated human GII.4.2004 
and MNV-1 at similar levels to human NoV GII.4.2004 and MNV-1 that were not heat 
treated. When compared to the bioaccumulation of untreated human NoV GII.4.2004, 0.78 
and 0.46 logio less were bioaccumulated by Pacific oysters when faecal material was treated
-118
at 99°C for 5 minutes and 20 minutes respectively. Similarly, when compared to the 
bioaccumulation of untreated MNV-1, 0.11 and 0.14 logio less were bioaccumulated by 
Pacific oysters when MNV-1 virus lysate was treated in the same way.
5.5 Discussion
5.5.1 Comparative bioaccumulation of NoV GII RNA fragments and NoV GII from 
positive faecal material
Previous studies in this and other laboratories have shown that oysters rapidly concentrate 
NoV particles from sewage or faecal material under a variety of conditions (Nappier et al., 
2008; Schwab et al, 1998). The bioaccumulation of viruses in bivalve molluscs may be 
assisted by the ionic bonding of viral particles to the mucopolysaccharide moiety of shellfish 
mucus (DiGirolamo et al, 1977) and by the presence of human blood group antigen-like 
structures in oyster gastrointestinal tissues (Tian et al, 2006). Furthermore, GI and GII 
strains may have different affinities to oyster digestive tissue (Comelli et al, 2008) based 
upon specific carbohydrate structures with a terminal N-acetylgalactosamine residue in a 
linkages (Le Guyader et al, 2006). In this study Pacific oysters in both experimental tanks 
accumulated GI NoV to similar levels in each set of experiments (average tank-to-tank 
difference of 0.47 logio; Table 5.1) indicating that in each case both sets of oysters were filter 
feeding effectively. Results for GII NoV demonstrated that in experiments 1 and 2, detection 
was only possible from oysters exposed to virus from faecal material and not to GII NoV 
RNA transcripts, even though similar numbers of copies as determined by PCR were present
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in both spikes. In experiment 3 bioaccumulation of NoV GII RNA fragments was apparent 
(oysters were positive at levels well in excess of the limit of detection; oysters tested negative 
for human NoV GII.4 prior to bioaccumulation experiment), however at considerably lower 
levels (1.74 logio less detected) than those found when oysters were exposed to virus from 
faecal material, however this may be attributed to cross contamination. In experiment 4, 
NoV GII was detected at the limit of detection in oysters bioaccumulated with RNA 
transcripts; however oysters from the same batch which had not been bioaccumulated tested 
positive at the same level (at the limit of detection) suggesting low level contamination of the 
harvesting area (i.e. presence of NoV RNA due to natural contamination) as opposed to 
accumulation of transcripts. On average, there was a 2.9 logio difference between NoV GII 
detected in oysters exposed to virus particles (in faecal material) to NoV GII detected in 
oysters exposed to NoV GII RNA fragments. This difference in bioaccumulation of NoV GII 
particles and NoV GII RNA fragments was statistically significant (paired t-test of logic 
copies/g; p  = 0.007).
5.5.2 The effect of heat on human NoV GII.4 genome titres and MNV-1 genome titres 
and plaque forming units
5.5.2.1 qRT-PCR quantitation from heat treated GII.4 positive faecal material
It has been suggested that infectious viral particles are degraded more rapidly than viral 
genomes when compared using PCR and cell culture analyses (Gasilloud et al, 2003). The 
data presented in this study agree with these findings, with comparatively modest reductions 
in genome titre observed after heat treatment at 99°C for up to 20 minutes. Hewitt et a l
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(2009) found that qRT-PCR signal was reduced by a maximum of 1 logio genome copies 
following heat-treatment of HAV- and MNV-1-spiked drinking water and milk samples at 
63°C and 72°C. Human NoV strains showed lower reductions in genome titre (<0.25 logio 
decrease) when treated with the same temperatures (Hewitt et al, 2009). In this study larger 
genome titre reductions (2.05 logio reduction after 20 minutes) were observed after heat 
treatment for human NoV GII.4.2004, using a higher treatment temperature of 99°C.
5.5.2.2 qRT-PCR and plaque assay quantitation of heat treated MNV-1 lysates
MNV-1 was not detected by plaque assay after heat treatment at 99°C for 20 minutes 
indicating an effective concentration of viable virus particles of <1 pfu/ml (a reduction of 
>3.98 logio). However, similar reductions in genome titre by heat treatment were not 
apparent; treatment at 99°C reduced copy numbers by a maximum of 1.27 logio. This 
disparity between the two rates of reduction demonstrates unequivocally that qRT-PCR 
methods are able to detect non-infectious viruses. It has been suggested that the viral genome 
may withstand environmental pressures or heat treatment and remain detectable by qRT-PCR 
even though infectivity is lost (Baert et al, 2008a; Gassilloud et al, 2003). Heat inactivation 
of human NoV and surrogates for NoV is well documented (Baert et al, 2008a; Duizer et al, 
2004a; Topping et a l, 2009) while Hewitt et a l (2009) and Baert et a l (2008a) found 
reductions in infectivity (by cell culture quantitation) in a number of viruses including MNV- 
1 much higher than reductions in genome titre. In particular, Hewitt et a l (2009) reported 
reductions in genome titre occurring after 1 minute of heat treatment, but thereafter slowing 
as time elapses.
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5.5.23 qRT-PCR quantitation of Human NoV GII and MNV-1 in bioaccumulated
Pacific oysters
Using MNV-1 as a surrogate, it was observed that levels of genome copies/g detected in 
Pacific oysters bioaccumulated with untreated and heat treated virus were largely unaffected 
by the relative proportions of infectious and non-infectious virus particles in the preparations, 
suggesting that non-infectious viruses were accumulated at similar rates to infectious 
particles. Extrapolating loss-of-infectivity data from MNV-1 to human NoV suggests that 
non-infectious human NoV might also have been efficiently accumulated although the lack of 
a direct culture method means this conclusion must be treated with caution. Heat treatment is 
thought to damage the viral capsid by changing its structure (Hewitt et al, 2009) and specific 
interactions between the capsid and HB G A-like receptors in BMS tissues are postulated as a 
major mechanism for bioaccumulation or NoV (Le Guyader et al, 2006; Maalouf et al, 
2010; Tian et al, 2006). On the basis of this previous evidence it would therefore have been 
reasonable to expect a reduction in bioaccumulation efficiency following capsid damage 
induced by heat treatment. That this was not observed in our experiments possibly indicates 
that bioaccumulation can occur in the absence of specific interactions with HBGA-like 
receptors in the digestive diverticula. There is evidence for non-specific attachment of viruses 
in BMS (Bedford et al, 1978; Burkhardt and Calci, 2000; Di Girolamo et al, 1977) although 
it has been argued that these interactions are less efficient than specific receptor-mediated 
interactions (Maalouf et al, 2010). Future work to determine whether the apparent binding of 
heat-treated NoV undermines the model of receptor-mediated binding would be aimed at 
analysing the depuration kinetics of BMS bioaccumulated with untreated and heat-treated 
NoV, to determine whether treated NoV persist for similar time periods as untreated viruses.
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or whether damage to the viral capsid affects the long-term binding of NoV within the 
tissues.
To our knowledge, this is the first study that analyses the bioaccumulation of inactivated 
NoV by BMS. It is not known to what extent NoV and other viruses become inactivated in 
the environment, and little is known about how NoV virions are damaged by sewage 
treatment processes or by environmental factors, however the data presented here supports 
the theory that an element of the qRT-PCR signal from human NoV positive BMS samples 
may derive from non-infectious virus. Furthermore, this suggests that qRT-PCR methodology 
may not always be suitable to directly determine health risks to BMS consumers.
5.6 Conclusions
The data presented in this study indicate that although free RNA is not efficiently 
accumulated by BMS and therefore unlikely to contribute to positive qRT-PCR results in 
such samples to any great extent, BMS appear to be able to bioaccumulate inactivated NoV. 
It is therefore possible that the use of PCR as a monitoring tool for NoV in BMS may be 
over-estimating risk to the consumer. However, data from this laboratory indicate that lower 
level qRT-PCR results from BMS samples are less likely to be associated with outbreaks and 
detection of higher levels of human NoV RNA by qRT-PCR correlates with an increased 
likelihood of NoV gastroenteritis outbreaks (Lowther et al, 2010). It has been suggested that 
BMS that contain levels of human NoV RNA at levels above 1000 copies/g are most likely to 
cause outbreaks of illness (Doré et al, 2010), while in published accounts of BMS-related 
NoV outbreaks, the BMS implicated have contained NoV RNA. levels in excess of 2000
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copies/g (Doré et al, 2010) and 8000 copies/g (Le Guyader et al, 2008; Lowther et al, 
2010), although other outbreak-related samples tested at this laboratory have contained 100- 
1000 copies/g (Dr J. LovTher, personal communication). The development of a robust and 
useful management strategy based upon an acceptable level of risk using qRT-PCR 
quantified human NoV in BMS may therefore be possible through the interpretation of 
surveillance results, coupled with the collection of epidemiological information from BMS 
associated outbreaks, despite the apparent imperfect correlation with infectivity.
Future work assessing the bioaccumulation of inactivated NoV should focus on inactivation 
of NoV (and MNV-1 as a cultivable surrogate) by relevant environmental factors (e.g. UV 
light, seawater temperature changes, seawater type, presence of microbes) or by simulating 
specific points within the wastewater treatment process. This would highlight whether NoV 
in sewage effluents and in the marine environment, as detected by qRT-PCR, are inactivated 
and whether these inactivated NoV could contribute to qRT-PCR detection of human NoV in 
BMS. Furthermore, analysing the efficiency of post-harvest processes including depuration, 
high-pressure processing, cooking, gamma irradiation and ozone treatments to remove 
infectious NoV, using MNV-1 as a surrogate, should be further investigated.
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6.0 Differentiation of viable and non-viable noroviruses using pre-extraction treatments
6.1 Introduction
Previous studies have suggested an overestimation of viable virus numbers using PCR 
quantitation for MNV-1 lysates (Baert et al., 2008a), for adenovirus detection in rivers (Choi 
and Jiang, 2005) and for Poliovirus-1 and FCV in mineral water (Gasilloud et al, 2003) 
while in Chapter 5 of this thesis it has been demonstrated that viral inactivation does not 
necessarily result in the degradation of qRT-PCR signal and also that inactivated NoV can be 
bioaccumulated by Pacific oysters under controlled laboratory conditions. It is therefore not 
clear whether detection of the viral genome using qRT-PCR is correlated with the presence of 
infectious virus, and thus human health risk. In this study, a pre-extraction treatment was 
examined in an attempt to further elucidate the biological interpretation of positive PCR data 
for NoV in BMS. The ability of a ribonuclease enzyme to differentiate between viable and 
non-viable NoV was subsequently assessed.
Ribonucleases (RNases) degrade RNA sequences into smaller fragments. The use of RNases 
in the development of methods for the differential detection of infectious viruses has been 
examined previously (Mormann et al, 2010; Nuanualsuwan and Cliver, 2002; Nuanualsuwan 
and Cliver, 2003; Topping et al, 2009). It has been hypothesized that RNA present in virions 
with damaged capsids may be degraded by exposure to RNases and positive PCR signals 
generated from samples pre-treated with RNase may therefore indicate the presence of intact 
viral capsids (and therefore potentially infectious virions), and provide a better prediction of a 
health risk to the consumer. Topping et a l (2009) studied the use of a pre-treatment stage
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with RNaseONE (Promega) coupled with qRT-PCR detection of human NoV from positive 
faecal material and FCV from virus preparations. Virus preparations were subjected to heat 
treatment in order to induce capsid damage and to inactivate them, and then qRT-PCR results 
after pre-treatment were compared to infectivity data collected by plaque assay. It was 
reported that RNaseONE pretreatment resulted in the detection using qRT-PCR only of those 
virus particles that protect their genomic RNA and which are therefore viable. Previous 
attempts to develop similar techniques using FCV, canine calicivirus and a human NoV GII.4 
have shown that reductions in viral RNA copy number are related to reductions in infectivity 
only after inactivation at high temperatures, at the extremes of the pH scale and at high UV 
doses (Duizer et al, 2004a). Previous studies have suggested that when treated with low 
temperatures, RNA might continue to experience some degree of residual protection by the 
viral capsid separate to a loss of infectivity (Baert et a l, 2008a; Nuanualsuwan and Cliver, 
2003).
6.2 Aims
• To assess the ability of RNaseONE to eliminate qRT-PCR signal from NoV RNA and 
NoV particles (from faecal material) with and without prior exposure to heat.
• To determine whether RNaseONE treatments could be integrated into the BMS 
testing method to provide a better prediction of the presence of viable NoV 
contamination and health risk.
-127-
6.3 Materials and Methods
6.3.1 The use of RNaseONE treatment on human NoV GII.4 positive faecal material 
and NoV GII RNA fragments
A previously genotyped human NoV GII.4 positive frozen faecal sample (10% w/v) was 
thawed and diluted to 1 x 10' .^ Four volumes of 100 pi of the diluted faecal material were 
added into separate tubes. One microlitre volumes of GII RNA fragments (each containing 6 
X 10  ^copies) were added to 2 tubes containing faecal material and to 2 tubes containing 100 
pi of molecular grade water. Ten microlitres (10 U) of RNaseONE (Promega) were added to 
1 tube containing faecal material only, 1 tube containing faecal material and RNA and 1 tube 
containing molecular grade water and RNA. Ten microlitres of RNaseONE reaction buffer 
(lOx; Promega) were added to all tubes, and these were then incubated at 37°C for 15 
minutes (Figure 6.1). After incubation, samples were placed on ice prior to nucleic acid 
extraction (Section 2.1). An adaptation to the extraction method was introduced whereby 100 
pi of sample was extracted. Once extracted, samples were analysed using one step qRT-PCR
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as described in Section 2.9. This experiment was repeated on 4 separate occasions.
S
â
1s
No Treatm ent
RNase Treated
+ 6 X10® copies RNA
+ 6 X10® copies RNA RNase T reated
Extraction and qRT-PCR
+ 6 X10® copies RNA
• o
+ 6 X10® copies RNA RNase Treated
Figure 6.1: Experimental design for RNase treatment of NoV positive faecal material and 
molecular grade water with and without the addition of ‘free’ NoV RNA fragments
6.3.2 The use of RNaseONE on heat-treated human faeeal material and MNV-1 lysates 
(capsid protection assay)
A human NoV GII.4 positive frozen faecal sample (10% w/v) and an MNV-1 lysate were 
thawed and each diluted 1 in 100 in molecular grade water (‘neat’). The diluted faecal sample 
and MNV-1 lysate were split into 4 equal volumes of 100 pi in thin walled 0.5 ml centrifuge 
tubes. Two 100 pi volumes of both faecal material and MNV-1 lysate were treated at 22°C 
and 2 were treated at 99°C for 5 minutes each. Volumes of 10 pi (10 U) of RNaseONE were 
added to 1 tube which had been heat treated at 22°C and 1 which had been heat treated at
-129
99°C. Ten microlitre aliquots of molecular grade water were added to each of the remaining 
heat treated (22°C and 99°C) tubes as controls. Ten microlitres of lOx reaction buffer was 
added to all tubes, and then they were incubated at 37°C for 15 minutes. After incubation, 
100 pi of each sample was subjected to nucleic acid extraction and one-step qRT-PCR 
analysis (Sections 2.1 and 2.9). This experiment was repeated on 3 separate occasions.
6.3.3 The use of RNaseONE on BMS digestive glands
Thirty Pacific oysters (C.gigas) were placed in a 48 L glass tank filled with 30 L of filtered 
seawater (50 pm filter; equilibrated to 18°C) and allowed to acclimatise for 72 hours. During 
this time, a human NoV GII.4 positive faecal sample was heated at 99°C for 5 minutes on a 
thermal cycler, and quantified using qRT-PCR. Approximately 2x10^ copies of heat treated 
human NoV GII.4 were added to the tank. After 18 hours, all oysters were removed, opened 
aseptically and the digestive glands removed as described in Section 2.11. The digestive 
glands were finely chopped using a sterile razor blade. Four 1 g portions of chopped glands 
were aliquoted into separate 50 ml Falcon tubes. To two tubes, 100 pi of RNaseONE and 100 
pi of reaction buffer were added, vortex mixed and incubated at 37°C for 15 minutes with 
shaking at 420 rpm. The other tubes were stored at 4°C for 15 minutes. After the 15 minute 
incubation period, 1 ml of Proteinase K (lOOpg/ ml) was added to each tube. Tubes were 
incubated at 37°C for 1 hour with shaking at 320 rpm. After incubation, the tubes were 
incubated at 60°C for 15 minutes then the reaction mixtures were centrifuged at 3000 x g  for 
5 minutes, the supernatant removed and 500 pi was removed for nucleic acid extraction 
(Section 2.1) and subsequent qRT-PCR detection (Section 2.9). This method was also applied 
to previously artificially contaminated Pacific oysters (frozen animals from Cefas archive;
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GII faecal material not heat-treated prior to bioaccumulation) and to naturally contaminated 
Pacific oysters from a UK BMS harvesting area.
6.3.4 Statistical Analyses
All stastical analyses were carried out using Microsoft Excel 2007.
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6.4 Results
6.4.1 The use of RNaseOne on faecal material and faecal material plus RNA transcripts
The use of RNaseONE on RNA fragments in molecular grade water resulted in an average 
reduction of 2.04 Igio genome copies (Table 6.1) as determined by qRT-PCR. On the other 
hand there was on average no reduction in genome copies when faecal material was treated 
with RNaseONE (average logio reduction of -0.03; Table 6.2). Treatment of a mixture of 
RNA fragments with faecal material showed consistent reductions in genome copies (average 
logio reduction of 1.03; Table 6.3), however actual reductions in numbers of RNA fragments 
may have been greater as the qRT-PCR signal was reduced in these experiments to the levels 
that would have been produced by faecal material alone (data not shown). The reductions 
observed when RNaseONE was applied to RNA transcripts in molecular grade water were 
significantly greater than when RNaseONE was applied to faecal material alone (unpaired t- 
test on logio reductions, < 0.001). Also, when RNaseONE was applied to RNA transcripts 
in NoV positive faecal material, the reductions observed were significantly greater than when 
RNaseONE was applied to NoV positive faecal material alone (unpaired Mest on logic 
reductions, = 0.001).
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Table 6.1: Reductions in genome titre as determined by qRT-PCR following treatment of
RNA fragments with RNaseONE.
H2O + RNA fragments with no 
RNase (logio copies/ml)
H2O + RNA fragments with 
RNase treatment (logic copies/ml)
logic reduction
6.41 4.04 2.37
5.04 3.33 1.71
5.51 3.83 1.68
5.85 3.46 2.39
Average logic reduction 2.04
Table 6.2: Reductions in genome titre as determined by qRT-PCR following treatment of 
GII.4 positive faecal material with RNaseONE.
Faecal sample with no RNase 
(logic copies/ml)
Faecal sample with RNase 
treatment ( Oogio copies/ml)
logic reduction
4.65 4.57 0.08
5.04 4.99 0.05
4.62 4.78 -0.16
4.75 4.83 -0.08
Average logic reduction -0.03
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Table 6.3: Reductions in genome titre as determined by qRT-PCR following treatment of a
mixture of RNA fragments and GII.4 positive faecal material with RNaseONE.
Faecal sample + RNA fragments 
with no RNase (logic copies/ml)
Faecal sample + RNA fragments with 
RNase treatment (logic copies/ml)
logic reduction
5.64 4.49 1.15
5.72 4.77 0.95
5.62 4.38 1.24
5.48 4.70 0.78
Average logic reduction 1.03
6.4.2 The use of RNaseONE on heat treated human NoV and MNV-1
The reductions in genome titre after the addition of RNaseONE to aliquots of faecal material 
or MNV-1 lysates treated at 22°C or 99°C for 5 minutes as measured by qRT-PCR are given 
in Tables 6.4 and 6.5.
Table 6.4: The application of RNaseONE to NoV GII.4 positive faecal samples treated 
at22°Cand99°C.
22°C with no 
RNAse (logic 
copies/ml)
22°C with RNase 
treatment (logic 
copies/ml)
logic reduction
99°C with no 
RNAse (logic 
copies/ml)
99°C with RNase 
treatment (logic 
copies/ml)
logic
reduction
9.26 83 9 0.87 8.07 6.30 1.78
9.30 8.37 0.93 8.10 6.85 1.24
9 3 2 8.31 1.01 7.71 5.97 1.74
Average logic reduction 0.94 Average logi Q reduction 1.59
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Table 6.5: The application of RNaseONE to MNV-1 samples treated at 22°C and 99°C.
22°C with no 
RNAse (logio 
copies/mi)
22°C with RNase 
treatment (logic 
copies/ml)
logic reduction
99°C with no 
RNAse (logic 
copies/ml)
)9°C with RNase 
treatment (logic 
copies/ml)
logic
reduction
5.35 4.80 0.55 6.30 6.11 1.89
5.40 4.89 0.51 6.85 6.09 1.52
5.42 4.99 0.43 5.97 6.05 1.57
Average logic reduction 0.49 Average logic reduction 1.66
The application of RNaseONE to human NoV GII.4 positive faecal samples and MNV-1 
lysates treated at 22°C gave average logio reductions of 0.94 and 0.49 respectively. This 
result seemingly contradicted the findings described in Section 6.4.1 where no reduction in 
genome titre was observed following treatment of NoV positive faecal material with 
RNaseONE given that exposure to a temperature of 22°C ought to be unlikely to elicit 
damage to the virus. However, larger reductions in genome titre were observed when 
RNaseONE was applied to both human NoV GII.4 positive faecal samples and MNV-1 
lysates that had been treated at 99°C, (average logio reductions of 1.59 and 1.66 respectively). 
The reductions in genome titre were significant at both temperatures for both materials 
(unpaired Mest on untreated and RNaseONE treated faecal samples; p  < 0.001 and p  = 0.005 
respectively, unpaired Mest on untreated and RNaseONE treated MNV-1 lysates; p  = 0.001 
and p  < 0.001 respectively). Differences in reductions in genome titres of NoV GII.4 positive 
faecal samples following RNAse treatment between samples heat treated at 22°C and at 99°C 
were also significant (unpaired /-test of logio genome reductions p  = 0.02) as were those with 
MNV-1 lysates {p< 0.01).
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6.4.3 The use of RNaseONE on human NoV positive BMS digestive glands
RNaseONE when applied to Pacific oyster digestive glands artificially bioaccumulated with 
heat treated human NoV GII.4 resulted in an average reduction of 0.64 logio genome copies/g 
as determined by qRT-PCR analysis (Table 6.6) while the same treatment applied to digestive 
glands from Pacific oysters artificially contaminated through bioaccumulation with non heat- 
treated faecal material, and to naturally contaminated Pacific oysters (both samples from 
Cefas’ archive of frozen BMS glands) produced reductions of 0.47 logic and 0.22 logic 
genome copies/g respectively. The differences observed between genome titre measured for 
glands before and after RNaseONE treatment were not significant, but approaching 
significance (paired /-test on logic genome reduction; p  = 0.07).
Table 6.6: The application of RNaseONE to artificially and environmentally contaminated 
Pacific oyster digestive glands.
Untreated (logio genome 
copies/g)
RNase treated (logic 
genome copies/g) logic reduction
Bioaccumulation with heat- 
treated faec; replicate 1 3.86 3.27 n/a
Bioaccumulation with heat- 
treated faec; replicate 2 3.95 3.25 n/a
Average 3.91 3.26 0.64
Bioaccumulation with 
untreated faec (Cefas 
archive)
2.21 1.74 0.47
Environmentally
contaminated 3.67 3.45 0.22
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6.5 Discussion
6.5.1 The use of RNaseOne to degrade unprotected RNA
Application of RNaseONE to RNA fragments diluted in molecular grade water resulted in a 
significant reduction in detectable genome copies (average 2.04 logio). The presence of 
residual signals in all treated preparations of RNA fragments indicates that RNaseONE did 
not degrade “free” (unencapsidated) RNA with 100% efficiency however the significant 
reductions illustrate the potential utility of this method for discriminating between protected 
and unprotected RNA. The same treatment when applied to a diluted human NoV positive 
faecal sample resulted in no observed reduction in genome copies. This observed difference 
was apparently not due to any inhibition of the RNase enzyme by factors present in the faecal 
preparations as when an excess of RNA fragments was added to the faecal sample, 
RNaseONE treatment was able to reduce the copies of NoV RNA detected by qRT-PCR. 
This finding suggested that in the faecal preparation the majority of RNA detected was from 
either fully encapsidated virions, or possibly from non-viable virions with partially damaged 
capsids that were nonetheless able to protect the RNA genome from degradation by RNase.
After heat treatment at 22°C and 99°C for 5 rninutes, reductions in genome titres for both 
MNV-1 and human NoV GII.4 were observed with significantly larger reductions at 99°C 
however. Compared with the results from the previous experiment the reduction in titres 
observed in samples treated at 22°C was somewhat surprising as this temperature would not 
normally be expected to induce damage to the virus capsid, however the proportion of fully 
encapsidated virus particles in the faecal preparations may have been different between the
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two experiments. The results obtained following heat treatment at 99°C suggest that 
RNaseONE, to some extent, can degrade RNA from virions with damaged capsids.The 
results of these experiments as a whole suggest that RNaseONE treatment may be able to 
degrade free RNA and RNA from virions with damaged capsids prior to qRT-PCR detection 
and thus provide a better prediction for the levels of infectious NoV in test samples.
6.5.2 .The use of RNaseONE on human NoV positive BMS glands
The data observed suggested that positive qRT-PCR results for NoV in BMS potentially 
derive from both viable and non-viable virus with damaged capsids. Treatment of digestive 
glands from Pacific oysters artificially bioaccumulated with heat treated and untreated human 
NoV from faeces, and also from naturally contaminated oysters with RNaseONE resulted in 
reductions in detectable genome titres of 0.64, 0.47 and 0.22 logio respectively, although the 
relatively modest reductions in detectable levels in naturally contaminated oysters, coupled 
with the previous observations that Pacific oysters do not bioaccumulate free RNA efficiently 
(Chapter 5) suggest that a large component of the qRT-PCR signal observed from norovirus 
positive field samples of BMS may be derived from fully encapsidated, possibly viable, virus. 
It would be useful however to investigate the reduction of genome titre following application 
of RNaseONE to BMS digestive glands spiked with RNA transcripts and/or heat treated NoV 
(from faecal material) in order to determine whether the enzyme can function properly in the 
presence of the BMS matrix.
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6.6 Conclusions
The development of PGR assays for the detection of NoV has been studied since the mid 
1990s (Lees, 2000), and PCR is favoured for use with environmentally contaminated samples 
including BMS as other methods, such as the ELISA, have not been shown to be sensitive 
enough to detect viruses in these type of matrices. The further increased sensitivity of qRT- 
PCR detection for NoV has enabled the detection and quantitation of low-level contamination 
in BMS, however, by its nature this methodology does not discriminate between RNA from 
viable and non-viable virus particles or naked RNA, and it therefore lacks the power to 
unambiguously determine whether the levels of RNA detected indicate risk of clinical 
disease. Previous experiments described in this thesis have demonstrated that BMS may 
bioaccumulate both non-infectious fragments of the NoV genome (although with very low 
efficiency) and inactivated NoV. It is unknown to what extent this type of material is 
contributing to positive results in ‘real’ samples, and in the absence of an established cell 
culture system for the detection and quantitation of human NoV, and with the suitability of 
surrogate viruses open to question, there is a need to examine other ways to differentiate 
infectious and non-infectious NoV. To this end, the potential use of RNaseONE as a pre­
extraction treatment was analysed in this study.
Initial results were promising, indicating that RNase treatment can significantly reduce PCR 
signal due to naked RNA and virus particles with heat-damaged capsids and that for instance 
application of RNase to oysters bioaccumulated with heat damaged virus resulted in a greater 
reduction of signal than when it was applied to oysters bioaccumulated with undamaged 
virus. Howeverurther work to confirm the applicability and demonstrate the utility of this
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method for determining the proportion of PCR signal derived from intact (viable) viruses in 
positive field samples of BMS is necessary.
In addition alternative approaches to pre-extraction treatments may merit investigation. In 
this regard, compounds such as Ethidium bromide monoazide (EMA) and propidium 
monazide (PMA) are photo-activated intercalating dyes consisting of a nucleic acid ligand 
that covalently and irreversibly cross-links with nucleic acids following activation of the 
azide group by visible light irradiation (Hixon et a l, 1975). It is suggested that the nucleic 
acid-EMA complex cannot be detected by PCR, but that EMA is unable to penetrate the 
interior of intact virus particles and is therefore unable to bind to the genome and 
subsequently interfere with PCR detection of such viruses (Kim et al, 2009). Kim et a l 
(2009) reported that EMA can however penetrate the capsid of damaged virions, highlighting 
the potential for the development of an EMA-based method as a means for distinguishing 
between intact and damaged viruses using qRT-PCR. Graiver et a l (2010) analysed the use 
of EMA pre-treatment of avian influenza virus in water, to determine whether it could be 
used in conjunction with RT-PCR to quantify viable RNA virions, while Kim et a l (2009) 
successfully applied the method first to MNV-1 as a surrogate for human NoV then directly 
to NoV contaminated water samples, enabling differentiation between fully encapsidated and 
partially encapsidated NoV. It is not known however whether the application of this method 
could be transferred to more complex matrices such as BMS digestive tissues, but this may be 
a useful avenue for further studies.
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7.0 Final Conclusions
Contamination of BMS with viruses and other pathogens occurs because these animals are 
filter feeders, and obtain food from ingesting small particles from the waters in which they 
reside. Gastroenteritis has been recognized as a potential clinical consequence of the 
consumption of contaminated BMS for many years (Richards, 1985; Rippey, 1994). The 
principal agent of BMS-associated gastroenteric illness worldwide is NoV. Although a 
method for cultivation of human NoV has been reported (Straub et al, 2007), this method has 
not been successfully reproduced in any other laboratories. Human NoV are therefore 
generally acknowledged as non-cultivable and there are no direct viability assays to routinely 
determine the level of infectious NoV present in clinical, environmental and diagnostic 
samples matrices. This factor, coupled with the typically low levels found in environmentally 
contaminated samples including BMS, means methods for the detection of NoV in such 
complex matrices generally utilise the sensitivity of molecular based methods that detect only 
a predetermined fragment of the viral genome.
An abundance of PCR methods for the detection of NoV in BMS have been published in
recent years. At the time of writing there is no international or European standard method
published, however a European standardization working group (CEN.WG6.TAG4) is
currently developing a two-part (quantitative and qualitatative) standard qRT-PCR method
for the detection of viruses in foodstuffs including BMS. This developing standard method
possesses the potential to be incorporated into EU legislation as a reference method (Lees and
CEN.WG6.TAG4, 2010). A high prevalence of NoV in oysters from a range of harvesting
areas throughout Europe has been shown by PCR (Croci et al, 2007; Formiga-Cruz et al,
2002). A legal standard based on presence/absence of human NoV as determined by PCR is
therefore likely to have significant effects on the BMS production sector, and due to the
nature of the PCR assay, positive results may not always represent a genuine risk to human
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health. This study aimed to determine whether detection of viral genome always correlates 
with human health risk.
In the absence of a cell culture method for human NoV, other indirect methods for assessing 
viral viability were examined in this study. MNV-1, the first cultivable NoV, was chosen as a 
surrogate for human NoV. To enable the use of this virus as a model for subsequent studies 
into the behaviour of human NoV in BMS and their growing waters, an existing plaque assay 
method (Wobus et al, 2006) for MNV-1 was further developed in order to try to facilitate the 
detection of MNV-1 from such complicated matrices. Some promising results from seawater 
and with spiked BMS tissues were observed, however the development of a plaque assay 
method from bioaccumulated BMS was unsuccessful, thus requiring further investigation and 
development. In parallel a one-step qRT-PCR assay for MNV-1 using a previously published 
primer and probe set (Baert et al, 2008a) was characterised, in order to enable direct 
comparisons between genome titres of human NoV and MNV-1 in relative terms. The qRT- 
PCR method characterised in this study showed similar performance to the well characterised 
method used for the detection of human NoV at this laboratory.
In order to assess the potential for naked RNA to contaminate BMS in the environment, 
studies were designed to determine how long human NoV, MNV-1 and fragments of the 
human NoV genome would remain detectable in the environment. These studies found that 
human NoV RNA persists in seawater in conditions simulating those of winter in the UK 
(T90: - 1 4 1  hours; detectable after 2 weeks; Dancer et al, 2010). The persistence of human 
NoV GI particles (from faecal material) and MNV-1 as determined by qRT-PCR was also 
analysed under the same conditions. Unfortunately, cell culture assays to assess the 
persistence of viability in MNV-1 did not produce any usable data. In order to enable 
prediction of whether NoV remains infectious (and therefore a risk to the consumer if 
bioaccumulated by BMS) for long periods of time in seawater, it would therefore be
-142-
necessary to further develop the MNV-1 plaque assay to ensure it possesses the necessary 
robustness for use with seawater.
As a result of the finding that short fragments of the NoV RNA genome persist in the 
environment, it was considered important to determine whether such material, in addition to 
encapsidated but inactivated NoV, can be bioaccumulated by BMS. The findings presented in 
this study indicate that such naked RNA is not efficiently bioaccumulated by Pacific oysters, 
and therefore even if it is present in BMS growing waters, it is not likely to have a significant 
effect on qRT-PCR positive results. However, when Pacific oysters were allowed to feed in 
seawaters spiked with heat treated (and therefore inactivated) NoV, qRT-PCR results for 
human NoV and MNV-1 were similar to those obtained for Pacific oysters challenged with 
untreated human NoV and MNV-1. These data suggest that qRT-PCR results for NoV in 
BMS may include inactivated NoV, and may therefore not accurately predict whether 
consumption of contaminated BMS will be a risk to the consumer. Studies using antigen- 
capture methods (Tang et al, 2010) have indicated that infectivity of MNV-1 is lost when the 
receptor binding proteins are damaged and attachment to host receptors can no longer occur. 
The high temperature and periods of treatment used in this study have previously been shown 
to eradicate infectivity (Baert et al, 2008a) and this was confirmed by the eradication of CPE 
(negative plaque assay results) after treatment at 99°C for 20 minutes in this study.
The integration of pre-treatment procedures into NoV testing methods for water and BMS to 
degrade naked RNA as well as RNA from non-infectious virus particles may possess the 
most potential to determine whether contaminated samples are a risk to human health. In this 
study, the use of RNaseONE was evaluated. This enzyme successfully reduced PCR signal 
due to non-infectious fragments of the RNA genome spiked into human NoV positive faecal 
material and molecular grade water. Experiments were also carried out to determine whether 
RNaseONE could be integrated into the BMS testing method. Reductions in genome titre
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were observed from BMS glands bioaccumulated with heat treated and untreated human NoV 
as well as those BMS that were naturally contaminated, although further work to evaluate the 
use of RNaseONE on BMS glands would be required. Future work should be aimed at 
evaluating the efficiency of RNaseONE when applied to NoV RNA and heat treated human 
NoV in the presence of the BMS matrix, to ensure that the action of the enzyme is not 
adversely affected by the matrix. It may also be worthwhile to couple RNase treatment with 
another procedure that could potentially make the RNA from non-infectious NoV available 
for degradation by RNases. Critically however, it would be important in future investigations 
to ensure that no qRT-PCR signal is lost from infectious NoV as a result of the application of 
any such pre-treatment and that the risk to the consumer using such methods is therefore not 
underestimated.
Taken as a whole the data obtained in this study highlights the problem of linking qRT-PCR 
results to human health risks and also provides some initial ideas to circumvent these 
problems. While naked RNA appears unlikely to play a significant part in generating positive 
results in BMS, at least part of the qRT-PCR signal may be derived from non-viable virus 
particles. Introducing modifications to the detection method may decrease this effect, 
however in the interim qRT-PCR results provide an unequivocal indication that BMS testing 
positive have been contaminated by material from norovirus positive human faeces and 
remain an extremely valuable tool for risk managers particularly if they are combined with 
other approaches such as classification of harvesting areas, identification and mitigation of 
specific contamination threats and improvement of post harvest purification treatments. 
Comparing qRT-PCR results from long-term surveillance of BMS from numerous harvesting 
areas, with outbreak data from BMS associated with clusters of gastroenteritis glean 
additional insights and may lead to the determination of a pragmatic ‘safe’ level below which
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consumers are unlikely to become ill. However, much further work remains to be undertaken 
in order to improve the predictive capacity of norovirus testing methods in BMS.
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Foreword
Attention is drawn to the possibility that some elements of this Standard may be the subject 
of patent rights. ISO shall not be held responsible for identifying any or all such patent rights
This document has been prepared by the Technical Committee CEN/TC275 “Food analysis- 
Horizontal methods”
Introduction
Hepatitis A virus (HAV) and norovirus (NoV) are important agents of food-home human 
viral illness. No routine methods exist to culture these viruses from food matrices. Detection 
is therefore reliant on molecular methods using the reverse-transcriptase polymerase chain 
reaction (RT-PCR). As many food matrices contain substances that are inhibitory to RT-PCR, 
it is necessary to use a vims/RNA extraction method that produces highly clean RNA 
preparations that are fit-for-purpose. For food surfaces vimses are removed by swabbing. For 
soft fmit and salad vegetables vims extraction is by elution with agitation followed by
-182 -
precipitation with PEG/NaCl. For bottled water adsorption/elution using positively charged 
membranes followed by concentration by ultrafiltration is used and for bivalve molluscan 
shellfish viruses are extracted from the tissues of the digestive glands using treatment with a 
proteinase K solution. All matrices share a common RNA extraction method based on virus 
capsid disruption with chaotropic reagents followed by adsorption of RNA to silica particles. 
Real-time RT-PCR monitors amplification throughout the PCR cycle by measuring the 
excitation of fluorescently labelled molecules. In the 5’ fluorogenic nuclease real-time RT- 
PCR assay the fluorescent labels are attached to a sequence-specific nucleotide probe 
(hydrolysis probe) that also enables simultaneous confirmation of target template. These 
modifications increase the sensitivity and specificity of the PCR method, and obviate the 
need for additional amplification product confirmation steps post PCR. Due to the complexity 
of the method it is necessary to include a comprehensive suite of controls. The method 
described in this part of the Standard enables quantitative determination of levels of virus 
RNA in the test sample.
1 Scope
This procedure describes liberation, concentration and quantification of HAV and NoV 
genogroups I (GI) and II (GII), from foodstuffs and food surfaces. Viral RNA extraction is by 
lysis with guanidine thiocyanate and adsorption to silica. Extracted viral RNA is amplified 
and detected by real-time RT-PCR. This part of the Standard describes a method for 
quantitative determination of levels of virus RNA in the test sample.
This approach may also be relevant for detection of the target viruses on fomites, or of other 
human viruses in foodstuffs, food surfaces or fomites following appropriate validation and 
using target-specific primer and probe sets.
2 Normative references
ISO 22174, Microbiology of food and animal feeding stuffs- Polymerase chain reaction 
(PCR) for the detection of food-home pathogens- General requirements and definitions.
ISO 7218, Microbiology of food and animal feeding stuffs- General requirements and 
guidance for microbiological examinations.
3 Terms and definitions
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3.1 Foodstuff
A substance that can be used or prepared for use as food. For the purposes of this Standard 
this definition includes bottled water.
3.2 Food surfaces
For the purposes of this Standard this definition includes surfaces of foods in addition to food 
preparation surfaces.
3.3 Hepatitis A virus (HAV)
Hepatitis A virus (HAV) is a member of the Picornaviridae family responsible for infectious 
hepatitis. Genetically, HAV can be subdivided into six genotypes on the basis of the VP 1/2A 
region (genotypes 1,2 and 3 have been found in humans, while genotypes 4,5 and 6  are of 
simian origin). There is only one serotype. Transmission occurs via the faecal-oral route by 
person-to-person contact, through the consumption of contaminated foodstuffs, contact with 
contaminated water or food surfaces, or contact with contaminated fomites. Hepatitis A virus 
is classified as an ACDP Hazard Group 2 pathogen.
3.4 Norovirus
Noroviruses are members of the Caliciviridae family responsible for sporadic cases and 
outbreaks of acute gastroenteritis. Genetically, norovirus can be subdivided into five separate 
genogroups. Three of these genogroups, GI, GII and GIV have been implicated in human 
gastrointestinal disease. GI and GII are responsible for the vast majority of clinical cases. 
Transmission occurs via the faecal-oral route by person-to-person contact, through the 
consumption of contaminated foodstuffs or through contact with contaminated water or food 
surfaces or contact with contaminated fomites. Genogroup I and II noro viruses are classified 
as ACDP Hazard Group 2 pathogens.
3.5 Detection of hepatitis A virus/norovirus
The quantitative determination of HAV or norovirus RNA in a predetermined mass/volume 
of foodstuff, or area of food surface when carried out in accordance with this Standard.
3.6 Process control virus
A virus added to the sample portion at the earliest opportunity prior to virus extraction to 
control for extraction efficiency.
-184
3.7 Process control virus RNA
RNA released from the process control virus in order to produce standard curve data for the 
estimation of extraction efficiency.
3.8 Negative RNA extraction control
Control free of target RNA carried through all steps of the RNA extraction and detection 
procedure to monitor any cross-contamination events.
3.9 Negative process control
Control free of target RNA carried through all steps of the virus extraction, RNA extraction 
and detection procedure to monitor any cross-contamination events.
3.10 Hydrolysis probe
An oligonucleotide probe labelled with a fiuoresecent reporter and quencher at the 5’ and 3’ 
ends respectively. Hydrolysis of the probe during real-time PCR due to the 5'-3' exonuclease 
activity of Taq DNA polymerase results in an increase in measurable fluorescence from the 
reporter.
3.11 Negative RT-PCR control
An aliquot of highly pure water used as template in a real-time RT-PCR reaction to control 
for contamination in the real-time RT-PCR reagents.
3.12 External control RNA
Reference RNA that can serve as target for the real-time PCR assay of relevance, e.g. run-off 
transcripts from a plasmid carrying a copy of the target gene, which is added to an aliquot of 
sample RNA in a defined amount to serve as a control for amplification in a separate 
reaction.
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3.13 Cq value
Quantification cycle; the PCR cycle at which the target is quantified in a given real-time PCR 
reaction. This corresponds to the point at which reaction fluorescence rises above a threshold 
level.
3.14 Theoretical limit of detection (tLOD)
A level that constitutes the smallest quantity of target that can in theory be detected. This 
corresponds to one genome copy per volume of RNA tested in the target assay but will vary 
according to the test matrix and the quantity of starting material.
3.15 Practical limit of detection (pLOD)
The lowest concentration of target in a test sample that can be reproducibly detected (95% 
confidence interval), as demonstrated by a collaborative trial or other validation (Annex L).
3.16 Limit of quantification (LOQ)
The lowest concentration of target in a test sample that can be quantitatively determined with 
acceptable level of precision and accuracy, as demonstrated by a collaborative trial or other 
validation (Annex L).
c. For additional terms and definitions relevant to this Standard see ISO 22174.
4 Principle
4.1 Virus extraction
The foodstuffs and food surfaces covered by this Standard are often highly complex matrices 
and the target viruses can be present at low concentrations. It is therefore necessary to carry 
out matrix-specific virus extraction and/or concentration in order to provide a substrate for 
subsequent common parts of the process. The choice of method will depend upon the matrix.
4.2 RNA extraction
It is necessary to extract RNA using a method that yields clean RNA preparations to reduce 
the effect of PCR inhibitors. In this Standard the chaotropic agent guanidine thiocyanate is 
used to disrupt the viral capsid. RNA is then adsorbed to silica to assist purification through 
several washing stages. Purified viral RNA is released from the silica into a buffer prior to 
real-time RT-PCR.
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4.3 Real-time reverse transcription polymerase chain reaction (real time RT-PCR)
PCR is a highly sensitive procedure that is a useful approach for the detection of non- 
culturable or difficult to culture viruses (including norovirus and HAV) in foodstuffs and 
food surfaces.
This Standard uses one-step real-time RT-PCR using hydrolysis probes. In one-step real-time 
RT-PCR, reverse transcription and PCR amplification are carried out consecutively in the 
same tube.
Real-time PCR using hydrolysis probes utilises a short DNA probe with a fluorescent label 
and a fluorescence quencher attached at opposite ends. The assay chemistry ensures that as 
the quantity of amplified product increases, the probe is broken down, and the fluorescent 
signal from the label increases proportionately. Fluorescence may be measured at each stage 
throughout the cycle. The first point in the PCR cycle at which amplification can be detected 
for any reaction is proportional to the quantity of template, therefore analysis of the 
fluorescence plots enables determination of the quantity of target sequence in the sample.
Due to the low levels of virus template often present in foodstuffs and the strain diversity in 
the target viruses, selection of fit-for-purpose one-step real-time RT-PCR reagents and PCR 
primers and hydrolysis probes for the target viruses is important. Guidelines for selection of 
these are given in 5.2.16 and 5.2.17. Details of the reagents, primers and probes used in the 
validation of this Standard are provided in Annexes D and E (informative).
Control materials
e. This suite of controls may be subject to simplification following validation studies.
-187-
4.4.1 Process control virus
Losses of target virus can occur at several stages during sample virus extraction and RNA 
extraction. To control for these losses samples are spiked prior to processing with a 
defined amount of a process control virus. The level of recovery of the process control 
virus should be determined for each sample.
The virus selected for use as a process control should be a culturable non-enveloped 
positive-sense ssRNA virus of a similar size to the target viruses to provide a good 
morphological and physicochemical model. The process control virus should exhibit 
similar persistence in the environment to the targets. The virus must be sufficiently 
distinct genetically from the target viruses that PCR assays for the target and process 
control viruses do not cross-react, and should not normally be expected to occur naturally 
in the foodstuffs under test.
Details of preparation of the process control virus used in the validation of this Standard 
are provided in Annex G.
4.4.2 Double-stranded DNA (dsDNA) control
For quantification of target virus results should be related to a standard of known 
concentration. A dilution series of double-stranded DNA carrying the target sequence of 
interest (5.3.8) and quantified using spectrophotometry should be used to produce a 
standard curve in template copies/pl. Reference to the standard curve enables 
quantification of the sample in detectable virus genome copies/pl.
4.4.3 External amplification control (EC) RNA control
Many foodstuffs contain substances inhibitory to RT-PCR, and there is also a possibility 
of carryover of further inhibitory substances from upstream processing. In order to 
control for RT-PCR inhibition in individual samples external control (EC) RNA (an RNA 
species carrying the target sequence of interest, 5.3.9) is added to an aliquot of sample 
RNA and tested using the RT-PCR method. Comparison of the results of this with the 
results of EC RNA in the absence of sample RNA enables determination of the level of 
RT-PCR inhibition in each sample under test.
4.5 Test results
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This method will provide a result expressed in detectable virus genome copies per ml/g/cm^. 
In samples where virus is not detected, results should be reported as “not detected; <z 
detectable virus genome copies per ml/g/cm^” where z is the limit of detection (LOD) for the 
sample.
Reagents
5.1 General
For current laboratory practice, see ISO 7218.
5.2 Reagents used as supplied
5.2.1 Polyethylene Glycol (PEG), MW 8000
5.2.2 Sodium chloride (NaCl)
5.2.3 Potassium chloride (KCl)
5.2.4 Disodium hydrogen phosphate (Na2HP0 4 )
5.2.5 Potassium dihydrogen phosphate (KH2PO4)
5.2.6 Tris base
5.2.7 Glycine
5.2.8 Beef extract powder
5.2.9 Proteinase K (30U/mg)
5.2.10 Pectinase
5.2.11 Chloroform
5.2.12 Butanol
5.2.13 Sodium hydroxide (NaOH)
5.2.14 Hydrochloric acid (HCl)
5.2.15 Silica, lysis, wash and elution buffers for extraction of viral RNA
Reagents must enable processing of 500pl of extracted virus, using lysis with a 
chaotropic buffer containing guanidine thiocyanate^^^ and using silica as the RNA 
binding matrix. Following treatment of silica-bound RNA with wash buffer(s) to 
remove impurities, RNA must be eluted in lOOpl elution buffer.
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The RNA preparation must be of a quality and concentration suitable for the intended 
purpose. See Annex C (informative) for details of the RNA extraction reagents used 
in the validation of this Standard.
5.2.16 Reagents for one-step real-time RT-PCR.
Reagents must allow processing of 5 pi RNA in 25 pi total volume. They must be 
suitable for one-step RT-PCR using hydrolysis probes (the DNA polymerase used 
must possess 5-3' exonuclease activity) and sufficiently sensitive for the detection of 
levels of virus RNA as typically found in virus-contaminated foodstuffs. See Annex E 
(informative) for details of the one-step real-time RT-PCR reagents used in the 
validation of this Standard.
5.2.17 Primers and hydrolysis probes for detection of HAV and norovirus GI and 
GII.
Primer and hydrolysis probe sequences must be published in a peer-reviewed journal 
and be verified for use against a broad range of strains of target virus. Primers for 
detection of HAY should target the 5’ non-coding region of the genome. Primers for 
detection of norovirus GI and GII should target the 0RF1/0RF2 junction of the 
genome. See Annex D (informative) for details of the primers and hydrolysis probes 
used in the validation of this Standard.
5.2.18 Primers and hydrolysis probes for detection of the process control virus.
Primer and hydrolysis probe sequences must be published in a peer-reviewed journal 
and be verified for use against the strain of process virus used. They should 
demonstrate no cross-reactivity with the target virus.
5.2.19 Nuclease free water
5.3 Prepared reagents
Note. Because of the large number of reagents requiring individual preparation details of composition 
and preparation are given in Annex B.
5.3.1 5x PEG/NaCl solution (50% (w/v) PEG 8000, 1.5M NaCl)
See Annex B.l
■ \
5.3.2 Chloroform:Butanol 
See Annex B.2
5.3.3 Proteinase K solution 
See Annex B.3
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5.3.4 Phosphate buffered saline (PBS)
See Annex B.4
5.3.5 Tris glycine 1% beef extract (TGBB) buffer 
See Annex B.5
5.3.6 Process control virus material
Process control virus stock should be diluted by a minimum factor of 10 in a 
suitable buffer, e.g. PBS. This dilution must allow for inhibition-free detection 
of the process control virus genome using real-time RT-PCR but still be 
sufficiently concentrated to allow reproducible detection of the lowest dilution 
used for the process control virus RNA standard curve (9.4.2.2). Split the 
diluted process control virus material into single use aliquots and store at - 
80±5°C. See Annex G (informative) for details of the preparation of process 
control virus used in the validation of this Standard.
5.3.7 Real-time RT-PCR mastermixes for target and process control virus
Reagents should be added in quantities as specified by the manufacturers 
(5.2.16) to allow 20pl mastermix per reaction in a 25pi total volume. Optimal 
primer and probe concentrations should be used after determination following 
the recommendations of the reagent manufacturers. See Annex E (informative) 
for details of the real-time RT-PCR mastermixes used in the validation of this 
Standard.
5.3.8 Double-stranded DNA (dsDNA) control material
Separate purified plasmids carrying the target sequence for each target virus 
should be used. The preparations should not cause RT-PCR inhibition. The 
concentrations of each dsDNA stock in template copies/pl should be 
determined then the stock should be diluted to a concentration of 1x 1 0 "^ -  
1x10^ template copies/pl. Split the diluted dsDNA preparation (dsDNA 
control material) into single use aliquots and store frozen at <-15°C. See 
Annex H (informative) for details of the preparation of dsDNA used in the 
validation of this Standard.
5.3.9 External control (EC) RNA control material
Separate purified ssRNA carrying the target sequence for each target virus 
should be used. They should contain levels of contaminating target DNA no 
higher than 0.1% and should not cause RT-PCR inhibition. The concentrations 
of each EC RNA stock in copies/pl should be determined and stock should be 
diluted to a concentration of 1x10^ -  1x10^ template copies/pl. Split the
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diluted EC RNA preparation (EC RNA control material) into single use 
aliquots and store frozen at <-15°C. See Annex J (informative) for details of 
the preparation of EC RNA used in the validation of this Standard.
6 Apparatus and equipment
Standard microbiological laboratory equipment (ISO 7218) and in particular the following.
6.1 Micropipettes and tips of a range of sizes, e.g. lOOOpl, 200pl, 20pl, lOpl.
6.2 Pipette filler and pipettes of a range of sizes, e.g. 25ml, 10ml, 5ml.
6.3 Vortex mixer.
6.4 Shaker capable of operating at approximately 500 rpm.
6.5 Shaking incubator operating at 37±1.0°C and 320+20 rpm or equivalent.
6 .6  Rocking platform(s) or equivalent for use at room temperature and 4±2°C at 
60+5 rpm.
6.7 Aspirator or equivalent apparatus for removing supernatant.
6 .8  Heating block capable of operating at 95±1.0°C or equivalent.
6.9 Waterbath capable of operating at 60±2.0°C or equivalent.
6.10 Refrigerated centrifuge(s) and rotor(s) capable of running at 10,000 x g  with
capacity for tubes for >20ml and for narrow gauge (15mm is too large) 
chloroform resistant tubes.
6.11 Bench centrifuge and rotor capable of running at 4,000 x g  with capacity for 
15/50ml tubes.
6.12 Microcentrifuge.
6.13 Centrifuge and microcentrifuge tubes and bottles of a range of sizes, 1.5ml,
5ml, 15ml, 50ml, etc. Narrow gauge (15mm is too large) chloroform resistant
tubes with 1ml capacity are necessary.
6.14 pH meter (or pH testing strips).
6.15 Sterile cotton swabs.
6.16 Mesh filter bags (400ml).
6.17 Positively charged membrane filters with 0.45pm pore size (47mm diameter).
6.18 Centrifugal filter concentration devices with 15ml capacity and lOOkDa MW 
cutoff.
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6.19 Vacuum source or equivalent positive pressure apparatus for filtering and 
filtration tower with aperture for 47mm diameter membrane.
6.20 Sterile shucking knife (for opening shellfish).
6.21 Rubber block for opening shellfish.
6.22 Scissors.
6.23 Forceps.
6.24 Sterile Petri dishes.
6.25 Razor blades or equivalent homogenizer.
6.26 Heavy duty safety glove.
6.27 Apparatus and equipment necessary for the extraction of RNA using silica and 
associated reagents (5.2.15). See Annex C (informative) for details of the 
RNA extraction apparatus used in the validation of this Standard.
6.28 PCR machine(s) with real-time capacity capable of supporting hydrolysis 
probe chemistry. See Annex K (informative) for details of the PCR machines 
used in the validation of this Standard.
6.29 Associated consumables for real-time RT-PCR, e.g. optical plates and caps, 
suitable for use with the selected PCR machine.
7. Sampling
It is important that the sample has not been obviously damaged or affected during transit or 
storage.
Sampling is not considered in this Standard.
8. Replication
Requirements for replication are not considered in this Standard.
9 Procedure
9.1 General laboratory requirements
Unfrozen samples arriving at the laboratory should not be frozen prior to testing. Sample 
extraction and PCR should be carried out in separate working areas/rooms as required in ISO 
22174.
9.2 Virus extraction
The selection of method is dependent upon the food matrix under test.
9.2.1 Process control virus material
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Immediately before a batch of samples is processed, pool together sufficient aliquots of 
process control virus material for all individual samples (allow lOpl per sample plus 25pi 
• excess).
Dilute a 20±0.5pl sub-sample of pooled material to 10'  ^ using nuclease-free water and store 
at 5±3°C for a maximum of 24 hrs or in single-use aliquots at <-15°C for longer periods.
9.2.2 Negative process control
A negative process control sample should be run in parallel to test samples at a frequency 
determined as part of the laboratory quality assurance programme.
9.2.3 Food surfaces
Using a sterile cotton swab pre-moistened in PBS, intensively swab surface (maximum area 
of lOOcm^) under test, applying a little pressure to detach virus particles. Record the 
approximate area swabbed in cm^.
Immerse the swab in a tube containing 490±5pl lysis buffer, then press against the side of the 
tube to release liquid. Repeat the immersion/pressing cycle three or four times to ensure 
maximal yield of virus.
Add 10±0.1 pi of process control virus material (9.2.1).
^ote. For rough surfaces that may cause deterioration of the swab, more than one swab may be 
iquired to completely treat the target surface.
Retain for RNA extraction.
9.2.4 Soft fruit and salad vegetables
Coarsely chop 25±0.3g of soft fruits or salad vegetables into pieces of approximately 2.5cm x 
2.5cm X 2.5cm (it is not necessary to chop if e.g. individual fi-uits are smaller than this) and 
transfer to the sample compartment of a 400ml mesh filter bag.
Add 40+1ml TGBE buffer (for soft fruit samples 30 units pectinase should be added to the 
buffer) and 10+0.1 pi of process control virus material (9.2.1).
Incubate at room temperature with constant rocking at approximately 60rpm for 20+1 min. 
For acidic soft fruits, the pH of the eluate should be monitored at 10 min intervals during 
incubation. If the pH falls below 9.0 it should be adjusted to 9.5+0.1 with NaOH. Extend the 
period of incubation by 10 min for every time the pH is adjusted. Decant the eluate from the 
filtered compartment into a centrifuge tube (use two tubes if necessary to accommodate 
volume).
Clarify by centrifugation at 10,000 x g  for 30+5min at 5+3°C.
Decant the supernatant into a single clean tube/bottle and adjust the pH to 7.0+0.5 with HCl.
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Add 0.25 volumes of 5x PEG/NaCl solution (to produce a final concentration of 10% PEG 
0.3M NaCl), homogenise by shaking for 60+5 sec then incubate with constant rocking at 
around 60rpm at 5±3°C for 60+5 min.
Centrifuge at 10,000 x g  for 30+5min at 5±3°C (split volume across two centrifuge tubes if 
necessary).
Decant and discard the supernatant, then centrifuge at 10,000 x for 5+1 min at 5±3°C to 
compact pellet.
Discard the supernatant and resuspend pellet in 500+1 Opl PBS. If a single sample has been 
split across two tubes resuspend both pellets stepwise in the same aliquot of PBS.
For extraction from salad vegetables, transfer suspension to a suitable tube and retain for 
RNA extraction.
For extraction from soft fruits a further clarification step is required. Transfer suspension to a 
narrow gauge chloroform resistant centrifuge tube. Add 500+1 Opl chloroform-butanol, vortex 
to mix, then incubate at room temperature for 5 min.
Centrifuge at 10,000 x g for 15+1 min at 5+3°C. Carefully transfer the aqueous phase to a 
fresh tube and retain for RNA extraction.
9.2.5 Bottled water
This Standard is appropriate for volumes between 0.3 and 5 litres. For each sample record the 
volume tested.
Add 10+0.1 pi of process control virus material (9.2.1) to the sample under test. Shake to mix.
Using a vacuum or positive pressure source, filter entire sample through a positively charged 
47mm membrane using aseptic techniques. Transfer the filter into a sterile tube then add 
4+0.1 ml of TGBE buffer.
Add 10+0.2ml TGBE buffer to the empty bottle. Shake both tube and bottle at approximately 
500 rpm for 20+5 min.
Pool the eluates from the tube and bottle together in a single clean tube.
Rinse the interior walls of the bottle with an additional 2+0.1ml TGBE buffer by gentle 
shaking/inversion by hand and add to the tube.
Adjust the pH of the eluates to 7.0+0.5 with O.IN HCl and transfer to a centrifugal filter 
concentration device.
Centrifuge at 4000 x g  for 15+1 min. Transfer concentrate to a clean tube.
Adjust volume to 500+1 Opl with PBS. Retain for RNA extraction.
9.2.6 Bivalve molluscan shellfish (BMS)
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BMS for analysis should be live, or if frozen, undamaged. Mud adhering to the shell should 
be removed. BMS should not be re-immersed in water.
Open the shells of a minimum of 10 BMS with a sterile shucking knife. When opening, . 
ensure that the hand holding the animal is protected with a heavy-duty safety glove.
Dissect out the digestive glands from all animals using scissors and forceps and transfer to a 
clean petri dish. A minimum combined gland weight of 2.0+ 0.2 g is required.
Finely chop the digestive glands with a razor blade or equivalent homogenizer to a paste-like 
consistency then transfer a 2.0+ 0.2 g portion into a centrifuge tube.
Add 10+0.1 pi of process control virus material (9.2.1).
Add 2.0+ 0.2ml of proteinase K solution and mix. Incubate at 37+1.0°C with shaking at 
approximately 320 rpm in a shaking incubator or equivalent for 60+5 min.
Carry out a secondary incubation by placing the tube in a water-bath or equivalent at 
60+2.0°C for 15+1 min.
Centrifuge at 3000 x g for 5 min ± 30 sec, decant the supernatant into a clean tube, measure 
and record the volume of supernatant in ml, and retain for RNA extraction.
9.3 RNA extraction
Extract RNA from 500±10pl of each sample using an appropriate guanidine thiocyanate 
disruption and silica adsorbtion based method. Elute purified RNA into 100±2pl of elution 
buffer and retain for real-time RT-PCR analysis. Extracted RNA should be processed 
immediately, stored at 5±3°C for <8hr or <-l5°C for up to 6 months.
te. For long term storage a temperature of -80±5°C is recommended.
For each batch of samples tested a negative extraction control should be included unless the 
batch includes a negative process control (9.2.2). RNA extraction should be carried out using 
the same method in parallel on 500+1 Opl of nuclease free water.
-196-
See Annex C (informative) for details of the RNA extraction method used in the validation of 
' this Standard.
9.4 Real-time RT-PCR
9.4.1 General requirements
The minimum requirements for the amplification and detection of nucleic acid sequences by 
, real-time PCR are laid out in ISO 22174.
9.4.2 Real-time RT-PCR
Note. This Standard describes methods for the detection of HAV, norovirus genogroup I and norovirus 
genogroup IT Under certain circumstances testing for all three viruses in a single sample may not be 
necessary. The procedure described below enables a test sample to be analysed for one virus (i.e. 
HAV, norovirus genogroup I or norovirus genogroup II) and includes a full set of recommended 
controls. Laboratories wishing to test for more than one target should adjust the reaction format to 
accommodate additional tests. A typical plate layout is included as Annex F.
Note. Reaction format and control material are subject to rationalization following method validation.
I 9.4.2.1 Analysis of target virus
Prepare 10'  ^dilutions of each sample RNA in nuclease fi'ee water.
i  : ;
: Prepare 10'\l0'^,10'^ and lO’"^ dilutions of target dsDNA control material in nuclease free 
water.
For each sample prepare
I
- 2 wells of an optical plate with 5±0.1 pi of undiluted sample RNA
- 2 wells with 5+0.1 pi of 10’^  sample RNA
- 1 well with 5+0.1 pi of undiluted sample RNA and l±0.05pl of undiluted EC
RNA
1 well with 5+0.1 pi of 10'  ^ sample RNA and l±0.05pl of undiluted EC RNA 
For the EC RNA control prepare:
1 well with 5+0.1 pi of nuclease-free water and l+0.05pl of undiluted EC RNA 
For the dsDNA standard curve prepare:
- 2 wells with 5+0.1 pi of undiluted dsDNA
- 2 wells with 5+0.1 pi of 10'  ^dsDNA
I  - 2 wells with 5+0.1 pi of 10’^  dsDNA
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- 2 wells with 5±0.1 pi of 10'  ^dsDNA
- 2 wells with 5+0.1 pi of 10'"^  dsDNA 
For negative controls prepare:
1 well with 5+0.1 pi of nuclease-free water
1 well with 5+0.1 pi of negative extraction control or negative process control 
RNA
Add 20±0.5pl of the relevant real-time RT-PCR mastermix (5.3.7) to each well (mastermix 
may also be pre-added to all relevant wells before addition of template material).
9.4.2.2 Analysis of process control virus
Defrost if necessary one aliquot of diluted (10'^) process control virus material (9.2.1) for the 
batch used with the samples under test.
Heat at 95±2°C for 5 min ±30 secs using a heating block or equivalent to release RNA.
Chill tubes rapidly, centrifuge at > 3000 x g for Imin., then transfer the supernatant (“process 
control virus RNA”) to a fresh tube.
Prepare 10 '\ 10'^ and 10'  ^dilutions of process control virus RNA in nuclease free water for 
each batch of process control virus material.
For each sample prepare
1 well with 5+0.1 pi of undiluted sample RNA 
1 well with 5+0.1 pi of 10'  ^ sample RNA 
For the process control virus RNA standard curve prepare:
1 well with 5+0.1 pi of undiluted process control virus RNA 
1 well with 5+0.1 pi of 10"^  process control virus RNA 
1 well with 5+0.1 pi of 10'^ process control virus RNA 
1 well with 5±0.1 pi of 10'  ^process control virus RNA 
For negative controls prepare:
1 well with 5+0.1 pi of nuclease-free water
1 well with 5+0.1 pi of negative extraction control or negative process control 
RNA
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Add 20±0.5pl of process control virus real-time RT-PCR mastermix (5.3.7) to each well 
(mastermix may also be pre-added to all relevant wells before addition of template material).
9.4.2.3 Amplification
Seal all wells used with optical caps or film.
Subject the plate to a reaction cycle including an initial stage for reverse transcription and at 
least 45 cycles of PCR. The duration and temperatures of each stage (reverse transcription, 
RT deactivation, dénaturation, annealing, extension) will depend on the reagents used; they 
should be based on the manufacturer’s recommendations but can be further optimized.
For machines where the user can set the point of fluorescence data collection, this should be 
set at the end of the extension stage.
See Annex E (informative) for details of the amplification method used in the validation of 
this Standard.
9.4.2.4 Analysis of fluorescence data
The minimum requirements for the analysis of amplification data are laid out in ISO 22174. 
Amplification plots should be analysed using the approach recommended by the 
manufacturer of the real-time PCR machine. The threshold should be set so that it crosses the 
area where the amplification plots (logarithmic view) are parallel (the exponential phase).
All amplification plots should be checked to identify false positive results (reactions with Cq 
values not associated with amplification) caused by high or uneven background signal. This 
should be noted and results for any reactions affected in this way should be regarded as 
negative. In addition all true positive fluorescent plots should be checked to ensure that the 
Cq value generated by the analysis software corresponds to the exponential phase of 
amplification for that reaction (and is not distorted by high or uneven background signal). 
Where Cq values are distorted corrected Cq values should be recorded in addition to the 
value generated by the software. Corrected Cq values should be used for quantity 
calculations.
10 Interpretation of results
e. Interpretation of results is subject to rationalization following method validation.
10.1 General
Each control (dsDNA, EC RNA, process control virus RNA) has an expected valid value or 
range of values. If the observed result for any control is different from the expected value 
samples may require retesting.
Negative controls (nuclease-free water and negative extraction/process control) should 
always be negative; if positive results occur in these controls then any samples giving 
positive results should be retested.
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10.2 Construction of standard curves
Check Cq values of all standard curve dilution series (process control virus RNA, target 
dsDNA) for any points that do not fall close to the line of best fit. These Cq values should not 
be incorporated into standard curve calculations.
Use the remaining Cq values of each dilution series to create standard curves for each control. 
Points from a minimum of 3 (process control virus RNA) or 4 dilutions (dsDNA) must be 
included. Curves with r  ^values of <0.98 should not be used for calculations.
10.3 Calculation of amplification efficiency
In this Standard amplification efficiencies are used as quality assurance parameters only and 
not used to adjust test results.
Use the undiluted sample RNA + EC RNA well Cq value to estimate amplification efficiency 
by reference to the Cq value of the water + EC RNA well and the slope of the dsDNA 
standard curve.
If the amplification efficiency is >25% results for the undiluted RNA should be used for that 
sample. If the amplification efficiency is <25% repeat calculation with the 10'  ^sample RNA 
+ EC RNA wells.
If the amplification efficiency using the 10'  ^RNA is >25% results for the 10'  ^RNA should be 
used for that sample. If amplification efficiencies for both undiluted and 10'  ^sample RNA are 
<25 results are not valid and the sample should be retested.
Note. A sample producing the same Cq value as undiluted EC RNA will have an amplification 
efficiency of 100%.
ote. The threshold for acceptable amplification efficiency is subject to revision following validation.
Note. A sample showing an unacceptable amplification efficiency but producing an otherwise valid 
positive result may, if appropriate, be reported as positive as described in section 11.
10.4 Calculation of extraction efficiency
In this Standard extraction efficiencies are used as quality assurance parameters only and not 
used to adjust test results.
Use the Cq value for the process control virus assay from the test sample RNA well 
(undiluted or 10'  ^dependent on the amplification efficiency results; 10.3) to estimate process 
control virus recovery by reference to the process control virus RNA standard curve (if 10'  ^
sample RNA results are used multiply by 10 to correct for the dilution factor).
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For bivalve shellfish samples calculate the extraction efficiency by dividing the recovery by 
0.5 and multiplying by the total measured homogenate volume.
For other sample matrices the extraction efficiency is equal to the process control virus 
recovery.
Where the extraction efficiency is <1% sample results are not valid and the sample should be 
retested.
Note. A sample producing the same Cq value as undiluted process control virus RNA will have an 
e):traction efficiency of 100%.
Note. The threshold for acceptable extraction efficiency is subject to revision following validation.
Note. A sample showing an unacceptable extraction efficiency but producing an otherwise valid 
positive result may, if appropriate, be reported as positive as described in section 11.
10.5 Sample quantification
For each target virus, take the Cq values for the sample RNA only wells (undiluted or 10'  ^
dependent on the amplification efficiency results; 10.3) and use these to calculate target 
concentrations (in detectable virus genome copies/pl RNA) for each replicate by reference to 
the dsDNA standard curve. Negative replicates should be ascribed zero quantities. For each 
sample calculate the average of the concentrations for both replicates.
Multiply this value by 100 (undiluted RNA) or 1000 (10‘^  RNA) to calculate the quantity of 
target in lOOpl RNA/ 50001 extracted virus (the entire sample for non-shellfish matrices).
For shellfish samples calculate the detectable quantity in the entire sample by dividing the 
above value by 0.5 and multiplying by the total homogenate volume.
To obtain the estimated quantity of target virus in detectable virus genome copies per 
ml/g/cm^ divide the number of genome copies in the entire sample by the starting volume 
(bottled water), weight (shellfish, soft fruits, salad vegetables) or area (hard surfaces) of the 
sample.
10.6 Theoretical limit of detection
For each hard surface, soft fruit, salad vegetable or bottled water sample the theoretical 
minimum quantity of target in the entire sample that is detectable in theory is 10 (results 
using undiluted sample RNA) or 100 genome copies (10'^ RNA).
For shellfish samples the theoretical minimum quantity detectable is obtained by dividing the 
above values by 0.5 and multiplying by the total homogenate volume.
To obtain the tLOD of each sample in detectable virus genome copies per ml/g/cm^ divide the 
number of theoretically detectable genome copies in the entire sample by the starting volume
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(bottled water), weight (shellfish, soft fruits, salad vegetables) or area (hard surfaces) of the 
sample.
11 Expression of results
Positive results for each target virus should be expressed as “x  detectable virus genome 
copies per ml/g/cm^” where x is the calculated quantity for that sample, provided that this 
level is above the limit of quantification (LOQ) of the method (please refer to annex L).
If target RNA is detected at levels <LOQ, results should be expressed as “virus genome 
detected at levels below the limit of quantification (y detectable virus genome copies per 
ml/g/cm^)” where y  is the LOQ of the method.
If target virus is not detected results should be expressed as “not detected (<z detectable 
virus genome copies per ml/g/cm^)” where z is the limit of detection of the method (LOD).
If a valid result is not obtained results should normally be expressed as “no result”. If 
however, an otherwise valid positive result is obtained from a sample showing an 
unacceptable amplification or extraction efficiency, results may, if appropriate, be expressed 
as “virus genome detected in b ml/g/cm^; not quantifiable” where b is the amount of 
sample tested. Details should be included in the test report.
e. If results from 10'  ^ RNA are used, LOD and LOQ values should be adjusted upwards by 
multiplying by 10.
12 Test report
a) The test report should contain at least the following information: pLOD (3.15) and LOQ 
(3.16) of the method (adjusted to account for use of 10'  ^ RNA if appropriate) and the 
matrix it was established in.
b) The tLOD of the sample (3.14).
c) A reference to the RNA extraction and RT-PCR methods used.
d) The results expressed according to Section 11.
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Annex B
(normative)
Composition and preparation of reagents and buffers
B .l 5x PEG/NaCl solution (50% (w/v) PEG 8000,1.5M NaCl) 
B.1.1 Composition
Polyethylene (PEG) 8000 500±2g
NaCl 87± lg
B.l.2 Preparation
Dissolve the solids in 450±5ml molecular grade water, heating gently if  necessary. Adjust 
volume to 1000+10ml with molecular grade water and mix well. Sterilise by autoclaving.
B.2 Chloroform:butanol
B.2.1 Composition
Chloroform lOiO.lm!
B.2.2 Preparation
Mix the components together.
B.3 Proteinase K solution 
B.3.1 Composition
Proteinase K (30U/mg) 20±0.1mg
B.3.2 Preparation
Dissolve Proteinase K in the water. Mix thoroughly.
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Store in working volumes at -20±5°C for a maximum of six months. Once defrosted store at
4±2°C and use within one week.
B.4 Phosphate buffered saline (PBS)
B.4.1 Composition
NaCl 8.0±0.1g
Potassium chloride 0.2±0.01g
Disodium hydrogen phosphate 1.15+O.Olg
Mix me components togetner, aajust tne pti, ii necessary, to /.j±v.z at z5°C.
Proteinase K solution 
B.4.2 Preparation
Dissolve the solids in the water, adjust the pH, if necessary, to 7.3+0.2 at 25°C. Sterilise by 
autoclaving.
B.5 Tris Glycine 1% beef extract (TGBE) buffer
B.5.1 Composition
Tris base 12.1±0.2g
Glycine 3.8±0.1g
B.5.2 Preparation
Dissolve the solids in the water, adjust the pH, if necessary, to 9.5+0.2 at 25°C. Sterilise by 
autoclaving.
Annex C
(informative)
RNA extraction using the BioMerieux NucliSens system
C.l Reagents
BioMerieux NucliSens lysis buffer.
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BioMerieux NucliSens magnetic extraction reagents (comprising magnetic silica solution, 
wash buffers 1, 2 and 3 and elution buffer).
C.2 Apparatus and equipment
BioMerieux NucliSens miniMAG or easyMAG instrument.
BioMerieux NucliSens magnetic rack.
Thermoshaker or equivalent apparatus for shaking 1.5ml tubes at 60±2°C and approximately 
1400rpm.
1.5ml tubes with screw caps suitable for use with the NucliSens instrument.
C.3 Procedure
Add 2+0.1ml of NucliSens lysis buffer to a tube. Add 500+1 Opl of sample (shellfish) or 
entire sample (other matrices) and mix by vortexing briefly.
Incubate for 10+1 min at room temperature.
Add 5 0+2pi of well-mixed magnetic silica solution to the tube and mix by vortexing briefly. 
Incubate for 10±1 min at room temperature.
Centrifuge for 2 min ±10 secs at 1,500 x g  then carefully discard supernatant by e.g 
aspiration.
Add 400±10pl wash buffer 1 and resuspend the pellet by pipetting/vortexing.
Transfer suspension to a 1.5ml screw-cap tube. Wash for 30±2 sec using the automated wash 
steps of the miniMAG/easyMAG extraction systems. After washing allow silica to sediment 
using magnet of the miniMAG/easyMAG extraction systems. Discard supernatant by e.g 
aspiration.
Separate tubes from magnet, then add 400±10pl wash buffer 1. Resuspend pellet, wash for 
30±2 sec, allow silica to sediment using magnet then discard supernatant.
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Separate tubes from magnet, then add 500±10pl wash buffer 2. Resuspend pellet, wash for 
30+2 sec, allow silica to sediment using magnet then discard supernatant. Repeat.
Separate tubes from magnet, then add 500±10pl wash buffer 3 (samples should not be left in 
wash buffer 3 for more time than necessary). Wash for 15±1 sec, allow silica to sediment 
using magnet then discard supernatant.
Add 100±2pl elution buffer. Cap tubes and transfer to thermoshaker or equivalent and 
incubate for 5 min ± 30 secs at 60±1°C with shaking at approximately 1400 rpm.
Place tubes in magnetic rack and allow silica to sediment, then transfer eluate to a clean tube.
Annex D 
(informative) 
Real-time RT-PCR primers and hydrolysis probes for the detection of HAV, norovirus 
GI and GII and mengo virus (process control) 
D.l HAV
HAV68(FW): TCA CCG CCG TTT GCC TAG [2]
HAV240 (REV): GGA GAG CCCTGG AAG AAA G [2]
HAVl50(-) (PROBE): CCT GAA C C I GGA GGA ATT AA [2]
Probe labelled 5’ 6-carboxyfluorescein (FAM), 3’ MGBNFQ (minor groove binder/non- 
fluorescent quencher)
Sequence alignment using all sequences available in GenBank of the assay target region 
demonstrates that this primer/probe set is adequate for the quantification of all HAV 
genotypes. In addition, quasispecies analysis of the mutant spectrum indicates that this region 
is not prone to variability, and this assay should therefore provide long-term robustness. The 
specificity of the primers was verified with ten different picomaviruses: polio virus (serotype 
1 vaccine strain), human enterovirus B (echovirus 1), human enterovirus B (echovirus 11), 
human enterovirus B (echovirus 30), human enterovirus B (coxsackievirus-B5), human 
enterovirus C (coxsackievirus-A24), human enterovirus D (enterovirus 70), bovine 
enterovirus, porcine teschovirus (porcine enterovirus 1) and encephalomyocarditis virus, and 
other enteric viruses such as hepatitis E virus, human and porcine rotavirus (group A),
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norovirus, mamastro virus (human astro virus type 1) and human adenovirus F (enteric 
adenovirus type 40) were also employed. None of the tested viruses gave positive results 
either at high concentration (10^ -  10  ^ TCID50/ml or undiluted 10% fecal suspensions) or 
low concentration (10^  ^TClD50/ml or 1/10 dilutions of 10% fecal suspensions). The LOD of 
the assay is 10 ssRNA molecules, 1 viral RNA molecule and 0.05 infectious viruses per 
reactiom^l
D.2 Norovirus GI
QN1F4 (FW): CGC TOG ATG CGN TTC CAT [3]
NVILCR (REV): CCT TAG ACG CCA TCA TCA TTT AC [4]
NVGGlp (PROBE): TGG ACA GGA GAY CGC RAT CT [4]
Probe labelled 5’ 6-carboxyfluorescein (FAM), 3’ 6-carboxy-tetramethylrhodamine 
(TAMRA)
D.3 Norovirus GII
QN1F2 (FW): ATG TTC AGR TGG ATG AGR TTC TCW GA [5]
C0G2R(REV): TCG ACG CCA TCT TCA TTC ACA [6]
QNIFS (PROBE): AGC ACG TGG GAG GGC GAT CG [5]
Probe labelled 5’ 6-carboxyfluorescein (FAM), 3’ 6-carboxy-tetramethylrhodamine 
(TAMRA)
The area selected for norovirus detection is the well-conserved region at the 5' end of 0RF2 
Sequence alignments using all sequences available in GenBank of the assay target region 
demonstrate that these primer/probe sets are adequate for the quantification of all GI and Gil 
NoV respectively. In addition the efficacy and sensitivity of the primers and probes was 
verified using eighteen NoV reference strains: Gl.l (Norwalk virus), G1.2 (Whiterose), G1.3 
(Southampton), G1.4 (Malta), G1.5 (Musgrove), G1.6 (Mikkeli), G1.7 (Winchester), Gl.lO 
(Boxer), Gll.l (Hawaii), G11.2 (Melksham), G11.3 (Toronto), G11.4 (Grismby), G11.6 
(Seacroft), G11.7 (Leeds), Gil. 10 (Erfurt), Glib and Gllc variants and GIV (Alphatron).
The specificity of the primers was verified with six different human enteric viruses: 
poliovirus (serotype 1 vaccine strain), hepatitis A virus, hepatitis E virus, Aichi virus, 
astrovirus and rotavirus. The specificity was also tested on seven bacteria that could be 
detected in shellfish: Escherichia coli, Shewenella putrefaciens, Chromohacterium 
violaceum, Aeromonas sohria, Vibrio alginolyticus. Vibrio paraheamolyticus and Vibrio 
cholerae). None of the tested viruses or bacteria gave positive results. The LODs of the
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assays are 1 to 10 viral RNA molecules (dependant on the strain of NoV)^^’^ .^
D.4 Mengo virus
Mengo 110 (FW): GCG GGT CCT GCC GAA AGT [8]
Mengo 209 (REV): GAA GTA ACA TAT AGA CAG ACG CAC AC [8]
Mengo 147 (PROBE): ATC ACA TTA CTG GCC GAA GC [8]
Probe labelled 5’ 6-carboxyfluorescein (FAM), 3’ MGBNFQ (minor groove binder/non- 
fluorescent quencher)
The target region selected for the quantification of mengo virus is as similar as possible to 
that of HAV in terms of structure, length and base composition^^l The primer sequences do 
not align with any other sequences available in GenBank.
Annex E
(informative)
Composition of one-step real-time RT-PCR mastermixes using the Invitrogen RNA 
Ultrasense One-step qRT-PCR system and cycling parameters
E.l Mastermix
Reagent Final concentration 
(in 25fil)
Volume per reaction (pi)
; reaction mix 1 X 5+0.1
FW Primer 500nM as required
REV Primer 900nM as required
Probe 250nM as required
Rox reference dye (50 x) as required" as required
RNA Ultrasense enzyme mix - 1.25+0.05
Water - as required
-209-
Total Volume 20+0.2
" With Applied Biosystems real-time machines, Rox should be used at 1 x concentration; for 
the Stratagene MX3000, Rox can be either used at 0.1 x concentration, or omitted from the 
mastermix. For other manufacturers consult the machine instructions.
E.2 Cycling parameters
Step
description
Temperature and 
time
Number o f  
cycles
RT 55 °C for 1 h 1
Preheating 95 °C for 5 min 1
Amplification
Dénaturation 95 °C for 15 s
45Annealing-
extension
60 °C for 1 min 
65 °C for 1 min
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Annex G
(informative)
Growth of mengo virus strain MCo for use as a process control
Mengo virus is a murine virus of the Picornaviridae family. Mengo virus strain MCo (ATCC 
VR-1597) is a recombinant (deletant) virus which lacks the poly(C) tract in comparison to the 
wild-type Mengo virus, with identical growth properties to those of the wild-type virus but 
with an avirulent phenotype^^^. This strain has been used as a process control virus in 
detection methods for HAV and noroviruses^^’^  ^ and was used as the process control for the 
validation of this Standard.
Note. Mengo virus strain MCq is a genetically modified organism (GMO); for laboratories where use 
of a GMO is prohibited or problematic a different process control should be used.
G.l Reagents, equipment and apparatus
Recommended cell culture medium for HeLa cells is Eagle’s minimum essential medium 
with 2mM L-glutamine and Earle’s BSS, adjusted to 1.5g/l sodium bicarbonate, 0.1 mM non- 
essential amino acids, l.OmM sodium pyruvate, 1% streptomycin/penicillin, 10% (growth) or 
2% (maintenance) foetal bovine serum.
For preparation of cell cultures and growth of virus cell culture facilities including 
incubator(s) with controllable CO2 levels, and cell culture consuniables (flasks etc.) are 
required.
G.2 Procedure
Mengo virus should be grown in a 5+1% CO2 atmosphere (with open vessels) or an 
uncontrolled atmosphere (closed vessels) on 80-90% confluent monolayers of HeLa cells 
(ATCC CCL-2) until at least 75% cytopathic effect has been reached.
Subject the cell culture vessel to a single freeze-thaw cycle, then centrifuge the contents at 
3000 X g for 10+1 min.
Retain the (cell culture) supernatant for preparation of the process control virus material 
(5.3.6).
Annex H
(informative)
Generation of double-stranded DNA (dsDNA) control stocks
For HAV control plasmid was constructed by ligating the target DNA sequence into the 
pGEM-3Zf(+) vector (Promega; www.promega.com/tbs/tb086/tb086.pdf) at a H indi 
restriction site such that the target sequence was downstream of a promoter sequence for the
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SP6 RNA polymerase. For norovirus GI and GII control plasmids were separately 
constructed by ligating the target DNA sequence into the pGEM-3Zf(+) vector at a Smal 
restriction site such that in each case the target sequence was downstream of a promoter 
sequence for the T7 RNA polymerase.
H.l Reagents, equipment and apparatus
JM109 strain competent cells
LB broth (10 g/1 Bactotryptone, 5 g/1 yeast extract, 10 g/1 NaCl, adjusted to pH 7.0)
LB agar (LB broth plus 15g/l agar)
Ampicillin
QIAGEN QIAprep spin miniprep kit 
Ice
37+1 °C incubator
Shaking incubator or equivalent operating at 37+1 °C and approximately 160rpm 
H.2 Transformation
Add 1-lOOng of previously purified dsDNA control to 50±0.5pl of JM109 competent cells 
and mix gently. Chill on ice for 20+1 min.
Incubate at 42+1 °C for 45+2 secs then immediately chill on ice for 2 min ±10 secs.
Add 950+1 Opl of LB broth to the cells then shake at 37±1°C at approximately 160rpm for 
90+10 min.
Spread 100+2pl of inoculated broth onto an LB agar plate supplemented with 50pg/ml 
ampicillin.
Incubate plate at 37+1 °C overnight, check for growth of colonies, then store at 4+2°C until 
required for purification of plasmid DNA.
H.3 Purification of plasmid DNA
-213
Inoculate 5±0.1ml of LB broth supplemented with lOOpg/ml ampicillin with a Single colony 
containing the plasmid of interest.
Incubate at 37+1 °C overnight.
Purify plasmid DNA from the culture using the minprep kit following the manufacturer’s 
instructions; elute in 100±2pl EB buffer.
Store plasmid DNA stock at -20+5 °C until required for preparation of the dsDNA control 
material (5.3.8).
H.4 Quantification of plasmid DNA
Determine the absorbance at 260nm of the plasmid stock using spectophotometry.
Multiply the absorbance reading by 5x10'^ to give the concentration of DNA in g/pl.
Divide this number by the mass in g of a single plasmid molecule* to calculate the 
concentration of DNA in copies/pl.
*The mass of an individual plasmid molecule may be calculated by multiplying the plasmid 
length in bp by 607.4 (the molecular weight of an average bp) and dividing by the Avogadro 
constant (6.02x10^^) e.g. a plasmid of 3000bp will have a mass of 3.02x10'^^g.
Annex J 
(informative)
Generation of external control RNA (EC RNA) stocks
Double-stranded DNA control plasmids as described in Annex H were used for the 
production of EC RNA.
J.l Reagents, equipment and apparatus
Restriction enzymes for linearisation {EcdPl and XbaY) and associated buffers.
QIAGEN QIAquick PGR purification kit.
Promega Riboprobe in vitro transcription system.
- 214 -
QIAGEN RNeasy mini kit.
Reagents and equipment for DNA gel electrophoresis.
Reagents and equipment for one-step real-time RT-PCR using hydrolysis probes.
37±1°C incubator.
J.2 Linearisation of plasmid DNA
Add 100-500ng of purified plasmid DNA to a reaction mix containing the specific 
linearisation enzyme (jE^ coRI for HAV, Xbal for norovirus GI and GII plasmids) and buffers 
as recommended by the manufacturer of the enzyme.
Incubate at 37±1 °C for 2 hours ± 5 min.
Purify DNA from the mastermix using PCR purification kit, eluting in 50+0.5pi EB buffer.
Check for linearisation using gel electrophoresis (compare an aliquot of purified linearised 
plasmid with non-linearised).
J.3 In-vitro RNA transcription
Add 100-500ng of purified linearised plasmid DNA to an in-vitro RNA transcription reaction 
mix using the Riboprobe system. Use SP6 (HAV) or T7 (norovirus GI and GII) RNA 
polymerase.
Incubate at 37+1 °C for 2 hours + 5 min.
Add RNase-free DNase to the reaction and incubate at 37±1°C for 15+1 min.
Purify the RNA using the RNeasy mini kit, eluting in lOO+I pi RNase-free water.
J.4 DNA contamination check
Prepare target-specific real-time RT-PCR mastermix (5.3.7), split into two and deactivate the 
RT enzyme in one portion by heating at 95±2°C for 5 min ±30 secs.
Using both portions of the mastermix subject EC RNA stock to real-time RT-PCR alongside 
a dsDNA dilution series as a standard curve (9.4).
If detectable levels in the portion of EC RNA stock tested with the heat-treated mastermix are 
>0.1% than those in the portion tested with untreated mastermix, the stock is contaminated 
with DNA and should be retreated with DNase (J.3). If levels are <0.1% store at -20±5°C 
until required for preparation of the EC RNA control material (5.3.9).
J.5 Quantification of EC RNA
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Determine the absorbance at 260nm of the DNase-treated EC RNA stock using 
spectophotometry.
Multiply the absorbance reading by 4x10’^  to give the concentration of RNA in g/pl.
Divide this number by the mass in g of a single EC RNA molecule* to calculate the 
concentration of RNA in copies/pl.
*The mass of an individual RNA molecule may be calculated by multiplying the RNA length 
in ribonucleotides by 320.5 (the molecular weight of an average ribonucleotide) and dividing 
by the Avogadro constant (6.02x10^^) e.g. an RNA molecule of 200 ribonucleotides will have 
a mass of 1.06x10'^^g.
Annex K 
(informative)
Real-time PCR machines used in interlaboratory validation trial
Annex L 
(informative)
Data from interlaboratory validation trial
Annex M
(informative)
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Research Note
Human Norovirus RNA Persists in Seawater under Simulated 
Winter Conditions but Does Not Bioaccumulate Efficiently in 
Pacific Oysters (Crassostrea gigas)
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ABSTRACT
Norovirus (NoV) is the principal agent o f  bivalve molluscan shellfish-associated gastroenteric illness worldwide. Currently, 
noncultivable human NoV s can be detected in bivalve molluscan shellfish by using molecular methods such as real-time reverse 
transcription PCR assays (qRT-PCR). In addition to infectious viruses, this methodology may also detect noninfectious NoV, 
including fragments o f the N oV  genome. This study addresses, in part, the implications o f  qRT-PCR results for the detection o f  
N oV  in shellfish in the absence o f  an infectivity assay. To evaluate environmental persistence, the stability o f  a short fragment o f  
the N oV  genome, spanning the qRT-PCR target in the open reading frame 1/2 junction, was assessed in seawater under artificial 
environmental conditions simulating winter in the United Kingdom (1 mW/cm^ U V  irradiation, 8°C) during a 4-week period. 
Detectable RN A levels decreased exponentially (Tgo o f  approximately 141 h); however, sequences were still detectable for up to 
2 weeks. The ability o f Pacific oysters (Crassostrea gigas) to bioaccumulate N oV  particles (from human feces) and RN A  
fragments was also compared using qRT-PCR. Oysters exposed to N oV  particles subsequently were positive for N oV  by qRT- 
PCR at levels several orders o f magnitude in excess o f  the theoretical limit o f  detection, whereas oysters exposed to similar 
quantities o f  N oV  RNA were either negative or positive at significantly lower levels. Therefore, although noninfectious fragments 
o f  N oV  RNA may persist in the environment under winter conditions, this type o f material w ill not be efficiently bioaccumulated 
by Pacific oysters and should not significantly contribute to positive qRT-PCR results.
Human norovirus (NoV) is the most common cause of 
nonbacteiial gastroenteritis globally, with high attack rates 
in both children and adults (1, 37). NoV can be found in 
high levels in the feces of infected individuals, raw sewage, 
rivers, and estuarine and marine waters (5). Transmission 
can be person to person via the fecal-oral route or from 
consumption of contaminated water or foodstuffs. Filter- 
feeding bivalve molluscan shellfish have frequently been 
linked to outbreaks of NoV infection (18), particularly 
during winter months (9).
NoV cannot currently be routinely cultured in the 
laboratory. Therefore, existing methods, such as real-time 
reverse transcription PCR assays (qRT-PCR) for detection 
of NoV in food and environmental samples are based upon 
detection of a fragment of the viral genome. However, it is 
not clear whether detection of such fragments is correlated 
with the presence of infectious virus and thus corresponds to 
a health risk. If free or particle-associated NoV RNA can be 
concentrated in bivalve molluscan shellfish tissues, use of 
qRT-PCR may produce NoV-positive results that do not 
reflect consumer risk.
A utho r fo r correspondence. T el: 44 (0)1305 206721; Fax: 44  (0)1305 
206718; E -m ail: daniel.dancer@ cefas.co.uk.
NoV particles are stable both inside the human host and 
in the environment and may survive in seawater or in 
bivalve molluscan shellfish and consequently remain a risk 
to public health for extended periods (IS). Several authors 
have reported that most viruses and pathogenic bacteria 
occur in the environment as particle-associated organisms 
(2, 26, 29). Various factors affect virus survival in the 
environment, including water temperature and the extent of 
UV irradiation. Many enteric viruses can survive longer 
during low-temperature periods in the winter than during 
summer months (13, 21, 22). The higher temperatures may 
damage both viral capsids and nucleic acids, possibly 
preventing binding of the virus to host receptors or causing 
inactivation of enzymes required for replication by damag­
ing genes encoding these enzymes (3). The germicidal and 
inactivation properties of UV radiation are well documented 
(11, 16). Several authors have suggested that because NoV  
possesses a single-stranded RNA (ssRNA) genome, it could 
be less resistant to UV radiation than double-stranded DNA  
or RNA virases (12, 34). The survival of free RNA in the 
environment is thought to be transient (31 ).
In this study, we assessed the persistence of NoV RNA 
in seawater under artificial winter conditions and examined 
the potential for the uptake of particulate-adsorbed NoV
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genomic RNA fragments in Pacific oysters (Crassostrea 
gigas) to provide a better understanding of the significance 
of qRT-PCR results in bivalve molluscan shellfish with 
respect to consumer health risks.
MATERIALS AND METHODS
Production o f  N oV  RN A. Purified ssRNA o f  126 bases (NoV  
genogroup 1 [GI]) and 131 bases (NoV genogroup n  [Oil]) carrying 
the qRT-PCR target sequence (which spanned the open reading 
frame [ORF] 1/2 junction o f the N oV  genome) were transcribed 
from plasmids (Dr. Soizick LeGuyader, Ifremer, Nantes, France) 
produced by ligating the target sequences from the Norwalk strain o f  
NoV GI or the Lordsdale strain o f  N oV  G il into vector pGEM-3Zf 
( + )  (Promega, Madison, W l). Before RNA transcription, the 
plasmids were linearized; 37.5 pi o f  molecular grade water, 5 pi o f  
reaction buffer (Promega), and 2.5 pi o f  Xbal restriction enzyme 
(Promega) were added to 5 pi (—500 ng) o f  each plasmid and 
incubated at 37°C for 2 h. The linearized plasmid D N A  was then 
purified using the QIAquick PCR purification kit (Qiagen, Valencia, 
CA) following the manufacturer’s instructions. In vitro RNA  
transcription was carried out using the Riboprobe in vitro 
transcription system (Promega). A  reaction mix containing 20 pi 
o f transcription buffer (5 x  ), 10 pi o f  100 mM  dithiothreitol, 2.5 pi 
o f RNasin, 20 pi o f  a m ix o f  2.5 mM  concentrations o f  rATP, rGTP, 
rCTP, and rUTP, 3 pi o f T7 polymerase, and 39.5 pi o f  nuclease-free 
water was added to 5 pi o f  linearized DN A. The reactions were 
mixed by pipetting and incubated at 37°C for 2 h. After incubation, 
5 pi o f  R Q l RNase-free DNase was added to each reaction and 
incubated at 37°C for 15 min to degrade the remaining D N A  
template. The RN A transcripts were then purified using the RNeasy  
mini kit (Qiagen) following the manufacturer’s instructions. The 
RNA preparations were then checked for DN A contamination with 
qRT-PCR mastermix in which the RT enzyme had been heat 
inactivated at 95°C. In both cases, there was <0.03%  DN A  
contamination (data not shown). The concentration o f  RNA in 
copies per microliter was calculated for each preparation by 
extrapolation from absorbance at 260 nm as measured using a 
NanoDrop spectrophotometer (Thermo Scientific, Pittsburgh, PA). 
RNA transcripts were stored at — 20°C until required.
Stability o f  N oV  RNA fragm ents in seawater. A  500-ml 
volume o f natural seawater was equilibrated to 8 ±  0.5°C and then 
exposed to U V  light at 1 mW/cm^ (SOL 500 U V  transilluminator, 
Honle, Grafelfing, Germany). The U V  radiation intensity was 
adjusted with plastic filter sheets, simulating average winter 
conditions in the southern United Kingdom as measured from 
November 2008 through March 2009 (data not shown). The water 
was then spiked with approximately 1 x  10^ copies o f  N oV  GI 
RNA transcripts. Duplicate samples o f  1 ml were removed after 
0  min, 15 min, 30 min, 1 h, 2 h, 4  h, 8 h, 1 day, 2 days, 1 week, and 
weekly thereafter up to 4 weeks. Seawater was mixed by stirring 
before sample collection. A ll samples were frozen at — 20°C until 
the end o f the sampling period to enable simultaneous testing.
Adsorption o f  N oV  R N A  and v im s particles to  solids from  
seawater. Suspended solids were sedimented from 400 ml o f  
natural seawater by centrifugation at 4 ,000 x  g and then 
resuspended in 50 pi o f  natural seawater. N oV  RNA or viral 
particles (see below) were added to this suspension and incubated 
for 30 min at 22°C to allow adsorption to suspended solids.
Bioaccum ulation in  Pacific oysters. Thirty liters o f  artificial 
seawater, made by adding Seamix (Peacock Salt, Ayr, UK) to
distilled water, was added to two aerated 48-liter tanks and 
equilibrated to 18°C. Thirty Pacific oysters were then added to 
each tank and left to acclimatize for 96 h to allow resumption o f  
filter-feeding activity. Aliquots o f  a N oV  G11.4.2004-positive fecal 
sample (99.7% sequence hom ology in 0R F 2  to Monastir strain, 
EU650225) and N oV  G il RN A transcripts, each containing 
approximately 6 x  10^ PCR-detectable copies, were allowed to 
adsorb to the suspended solids. Ten oysters were removed for 
testing for prior N oV  contamination using methods described 
below, and then adsorbed N oV  RN A transcripts and fecal material 
were added to the tanks. Aliquots o f  a G1.4-positive fecal sample 
(96.2% sequence hom ology in 0 R F 2  to Chiba vim s, A B 022679) 
containing approximately 6 x  10*^  PCR-detectable copies were 
added to each tank to act as a bioaccumulation control. Oysters 
were allowed to bioaccumulate for 16 h and then tested for N oV  GI 
and G il as described below. This procedure was repeated on four 
occasions.
Preparation  o f  oyster hom ogenate. Oysters were opened 
aseptically, and the animals were removed from their shells. The 
peripheral flesh and organs were cut away from the digestive 
glands (stomach and digestive diverticula), which were pooled and 
finely chopped with a sterile razor blade. Homogenates were then 
prepared by treating a 2-g portion o f  chopped digestive glands with 
100 pg/ml Proteinase K solution (30 U/mg; Promega) as described 
previously (17) but modified to include a secondaiy incubation o f  
60°C instead o f  65°C for 15 min. Homogenates were stored at 4  ±  
0.5°C until RN A extraction and qRT-PCR analysis.
R N A  extraction. Total RNA was extracted from 500 pi o f  
seawater or shellfish homogenate using a NucliSENS miniMAG  
extraction machine and NucliSENS magnetic extraction reagents 
(bioMérieux, Marcy l ’Etoile, France) following the manufacturer’s 
instmctions (eluting in 100 pi o f  elution buffer). A  negative 
extraction control (water only) was included with each set o f  
samples extracted. Eluted RNA was stored at — 20°C until 
required.
O ne-step qRT-PCR. For both N oV  genogroup-specific qRT- 
PCR primer and probe sets (Table 1), duplicate or triplicate 
aliquots (depending on the particular experiment) o f  5 pi o f  sample 
or extraction control RNA were added to adjacent wells o f  a 96- 
well optical reaction plate, and the volum e was increased to 25 pi 
with one-step reaction mix prepared using the R N A  Ultrasense 
one-step qRT-PCR system (Invitrogen, Carlsbad, CA) (final 
concentrations o f  1 x  reaction mix, 500 nM forward and 900 nM  
reverse primers, and 250 nM probe, plus 0.5 pi o f  Rox and 1.25 pi 
o f enzyme mix per reaction). W ells containing nuclease-free water 
and the same one-step reaction m ixes also were included on each 
plate as negative controls. To enable quantification o f  each sample 
RNA in copies per microliter, log dilution series o f  the GI and G il 
plasmids (range: 1 x  10"^  t o i  x  10® copies per pi) were included 
on each qRT-PCR plate. The plate was incubated at 55°C for 
60 min, 95°C for 5 min, and then 45 cycles o f 95°C for 15 s, 60°C  
for 1 min, and 65°C for 1 min on an SD S7000 real-time PCR  
machine (Applied Biosystems, Foster City, CA).
RESULTS AND DISCUSSION
Stability of NoV RNA fragments in seawater. NoV GI
RNA spiked into seawater and held under conditions similar 
to those of a northern European winter (8°C, 1 mW/cm^ 
UV radiation) was detected by qRT-PCR for up to 14 days 
postcontamination. Decay of detectable RNA was exponen­
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TABLE 1. Sequences of norovirus primers and probes used in this study
Prim er o r probe Sequence R eference
Norovirus GI assay 
QNIF4 
NVILCR 
TM9
CGC TGG ATG CGN TTC CAT 
CCT TAG ACG CCA TCA TCA TTT AC 
FAM-TGG ACA GGA GAT CGC-MGB
7
33
Adapted from 7 5
Norovirus GII assay 
QNIF2 
C0G2R 
QNIFS
ATG TTC AGR TGG ATG AGR TTC TCW GA 
TCG ACG CCA TCT TCA TTC ACA 
FAM-AGC ACG TGG GAG GGC GAT CG-BHQ-1
23
24
Adapted from 23
tial (/^ =  0.966, P <  0.001) with a Tgo (time needed for 90% 
of the PCR signal to disappear) of 141 h (Fig. 1). This finding 
is in accordance with those of Tsai et al. (36), who found that 
naked poliovirus 1 RNA was detectable in filtered seawater at 
4°C for up to 21 days. In previous studies, poliovirus 1 and F- 
specific RNA bacteriophage genome fragments persisted to 
some extent in solution after exposure to high levels of 
germicidal UV radiation (31). Tsai et al. suggested that 
survival was a function of fragment size, with preferential 
survival of small fragments (<145 bases). In the present 
study, NoV RNA transcripts (126 to 131 bases) complemen­
tary to the ORFl-2 region primer-probe binding site o f  the 
NoV were used. In previous studies, viral RNA has been 
more stable in artificial, filtered, or sterile seawater than in 
natural seawater because of the antiviral activity of natural 
seawater, e.g., from RNases (derived from natural marine 
microflora) (10, 36). Because double-stranded RNA vimses 
have been reported to be more resistant to the effects of UV 
radiation (14), the potential for secondary stmcture formation 
from NoV GI RNA sequences used in this study was checked 
using RNAfold software (University of Vienna RNA Web 
server: http://ma.tbi.univie.ac.at). The results indicated that 
formation of RNA complexes was theoretically possible (a 
minimum free energy of —27.60 kcal/mol was determined for 
the optimal secondary structure), potentially reducing the rate 
of degradation due to UV irradiation. Regardless of this 
possibility, detection of NoV RNA fragments for extended 
periods revealed the potential for naked RNA to persist in the 
marine environment.
Comparative bioaccumulation of NoV particles and 
NoV RNA fragments by Pacific oysters. Levels of GI and
100000
R*= 0.066
g 10000
1000
100
0 50 100 150 200 250 350300
hours posl<onlaminalion
FIGURE 1. Survival of human NoV GI RNA transcripts in 
seawater under simulated winter conditions.
Gn NoV (genome copies per gram of digestive glands) in 
oysters exposed to both human GI NoV-positive fecal 
material and either human GII NoV-positive fecal material 
or Gn NoV RNA transcripts (containing similar numbers of 
PCR-detectable copies) are given in Table 2. In previous 
studies in this and other laboratories (27,30), oysters rapidly 
concentrated NoV particles from sewage or fecal material 
under a variety of conditions. Some researchers have 
suggested that bioaccumulation of vimses in bivalve molluscs 
may be assisted by the ionic bonding of viral particles to the 
mucopolysaccharide moiety of shellfish mucus (8) and by the 
presence of human blood group antigen-like stmctures in 
oyster gastrointestinal tissues (35). NoV GI and GII strains 
may have different affinities to oyster digestive tissue (6) 
based upon specific carbohydrate stmctures with a terminal N- 
acetylgalactosamine residue in a linkages (79). In this study. 
Pacific oysters in each set of experiments and in both 
experimental tanks accumulated GI NoV to similar levels 
(mean tank-to-tank difference of 0.47 log unit; Table 2), 
indicating that both sets of oysters were effectively bioaccu- 
mulating NoV present in the water. For GII NoV, in two of 
four experiments detection was possible only from oysters 
exposed to vims from fecal material, not from oysters exposed 
to Gn NoV RNA transcripts, even though similar numbers of 
RNA copies (as determined by PCR) were present in both 
spikes. On the fourth occasion, NoV GII was detected at the 
limit of detection in oysters allowed to bioaccumulate RNA 
transcripts; however, oysters from the same batch that had not 
been bioaccumulating tested positive at the same level, 
suggesting low level contamination of the harvesting area as 
opposed to accumulation of transcripts. In experiment 3, 
bioaccumulation of NoV GII RNA fragments was apparent 
(oysters were positive at levels well in excess of the limit of 
detection), however at considerably lower levels (1.74 log 
units fewer detected) than those found when oysters were 
exposed to vims from fecal material. On average, there was a 
2.9-log difference between NoV GII detected in oysters 
exposed to vims particles in fecal material and the NoV GII 
detected in oysters exposed to NoV GII RNA fragments. This 
difference in bioaccumulation of NoV GII particles and NoV  
Gn RNA fragments was significant (paired t test o f log copies 
per gram; P  =  0.007).
When important risk management decisions are made 
on the basis of qRT-PCR results, it is important that these 
results be understood in the context of risk. Several authors 
have suggested that because qRT-PCR does not distinguish
2126 DANCER ET AL. J. Food Prot., Vol. 73, No. 11
TABLE 2. Comparative bioaccumulation of human NoV GII particles and RNA fragments in Pacific oysters
E xpt
N oV  (detectable copies/g o f  d igestive gland)" 
T ank  1 T ank  2
;
L og tank-to-tank difference*
GI GH GI Gn GI Gn
1 597 10,941 3,137 < L O D - 0 .7 2 2.86
2 705 27,941 977 < L O D - 0 .1 4 3.27
3 2,000 108,444 5,466 1,994 - 0 .4 4 1.74
4 19,540 81,217 5,197 « L O D 0.58 3.73
Mean‘S 0.47 2.90
“ Tank 1 contained GI and GII fecal material; tank 2 contained GI fecal material and GII RNA transcripts. <L O D , less than the limit o f  
detection (~ 1 5  copies per g); *«LOD, positive at the limit o f  detection.
* Results «=LOD or < L O D  treated as 15 copies per g.
Mean o f  absolute values regardless o f  direction o f difference.
between infectious viruses and nonviable virus materials 
(e.g., RNA fragments), a positive sample may be suggestive 
of contamination but not necessarily of consumer health risk 
(20, 28 ,32 ,38)  and have questioned the use of qRT-PCR in 
the management of shellfisheries (4, 25). Our findings 
indicate that short fragments of nonencapsulated NoV RNA 
can persist in the marine environment for up to 2 weeks and 
that bioaccumulation of such materials can occur. However, 
the efficiency of uptake of RNA is significantly lower (mean 
of 2.9 log units) than that of virus particles, and in three of 
four repeated experiments NoV GII was detected by qRT- 
PCR at levels above the environmental background only in 
oysters exposed to virus particles from fecal material, not in 
oysters exposed to RNA fragments.
The RNA fragments used in this study may have been 
too small to efficiently concentrate in the oyster digestive 
diverticula, the various enzymes and RNases present within 
the digestive system may have degraded the NoV RNA 
fragments rapidly rendering the majority undetectable, or 
NoV accumulation in bivalve molluscs may be dependent 
predominantly upon interactions between intact virus and 
receptor sites in the digestive tissues. The outcome of this 
series of studies indicates that the presence of NoV RNA 
fragments in the environment is unlikely to make a major 
contribution to positive qRT-PCR signals. This finding is of 
significance with respect to interpretation of qRT-PCR 
results for NoV in Pacific oysters and other shellfish 
species.
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